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1.1 Introduction
In this first chapter, a brief overview will be presented of the background, primary
aims and the clinical and theoretical notions that have lead to the research on which
this thesis is based.
1.2 Background
In the year 2000, unipolar major depression was the fourth leading cause of disease
burden worldwide in terms of Disability Adjusted Life Years, causing the largest
amount of non-fatal burden and accounting for almost 12% of all years lived with
disability worldwide (Ustun et al. 2004). A growing body of literature has shown
that, at a later age as well as in younger adults, depression is associated with a
diminished quality of life, significantly higher levels of disability, functional decline,
demands on caregivers and service utilization (Charney et al. 2003;Hays et al.
1995;Katon et al. 2003;Wells et al. 1989). With a prevalence of depression requiring
clinical attention in community dwelling older persons of around 13.5 % (Beekman,
Copeland, & Prince 1999), the importance of depression in terms of both individual
suffering and public health is uncontested. As the population in western countries is
rapidly ageing, adequate recognition and, if possible, prevention of the negative con-
sequences of late-life depression is becoming a major public health issue. It is esti-
mated that in the Netherlands, the percentage of the population over the age of 65
years will increase from 13.8% in 2003 to 23.3% in 2040 (Centraal Bureau voor de
Statistiek 2004). 
In spite of these facts, only 15 years ago little systematic research had been per-
formed on prevalence and natural history of geriatric depression (Blazer 1989;Cole
1990). Studies in the community were relatively rare, and the issue of late-life psy-
chopathology had not yet received the amount of attention from policy makers and
researchers that it is currently experiencing. Research in old age psychiatry mainly
focused on patients in secondary care facilities, and both recognition and adequate
treatment of late-life depression in primary care settings were poor. The study of
late-life psychopathology thus mimicked an earlier description by David Goldberg
and Peter Huxley in their book ‘Mental Illness in the Community’ (1980). They point-
ed out that psychiatry urgently needed more extensive knowledge on prevalence,
course and risk profiles of types of psychopathology that do not reach through the
consecutive filters in health care up to the specialist level of psychiatry (Goldberg &
Huxley 1980).
Since then, a number of epidemiological studies have been initiated to study late-
life psychopathology in the community. The Amsterdam Study of the Elderly (AMS-
TEL) was initiated in 1988 by the Department of Psychiatry of the Vrije Universiteit
Amsterdam. In light of the demographic changes and the increase of age-related
physical and mental problems, an urgent need was felt for research in geriatrics and
psychogeriatrics. AMSTEL was designed to study incidence and course of dementia
or cognitive impairment, depression and generalised anxiety disorder in elderly peo-
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ple living in the community. The study also aimed to investigate diagnostic instru-
ments that would differentiate between early stages of dementia, age-related cogni-
tive impairment and other forms of somatic or psychiatric pathology in later life. The
study was supervised by Prof.dr.W. van Tilburg. The project was directed by
Prof.dr.C.Jonker and Dr.C.Hooijer. AMSTEL was supported by the Netherlands
Health Research Promotion Programme (Stimuleringsprogramma Gezondheids
Onderzoek, SGO).
This thesis is based on data from the AMSTEL study, collected from 1990 until 2001.
1.3 Aims of this thesis
The primary aims of this thesis were to study late-life depression and its longitudinal
associations with a comprehensive set of risk factors in a large community sample. 
This general topic was subdivided into the following research domains;
1 The onset of depression in later life and the factors associated with onset.
2 The natural course of depression in later life, and the associations of risk factors
with course types.
3 Comorbidity patterns and temporal associations between depression and 
generalised anxiety disorder, and between depression and cognitive decline
4 The associations of depression with excess mortality
5 A research agenda for prevention of depression in primary care according to 
vulnerability characteristics of community living older persons.
Specific research questions originating from these aims will be addressed in the sub-
sequent chapters of this thesis.
1.4 Depression as a clinical concept; from       
black bile to bio-psycho-social disorder
In his comprehensive work on the history of the depression concept, ‘Melancholia
and depression’, Stanley W. Jackson has demonstrated how descriptions of the core
symptoms of depression have remained remarkably stable over more than 2500
years of medical writings (Jackson 1986). Another consistent factor is that through-
out history depression has been considered to be the result of an interaction
between internal (personal) and external causes, the shape and meaning of which
were determined by the dominant beliefs of the different eras. In the works of
Hippocrates (460-357 BC), melancholia is characterised as a chronic condition with
‘aversion to food, despondency, sleeplessness, irritability and restlessness’.
According to the humoral theory, diseases were the result of a disturbance of the
equilibrium between the four humours, and melancholia was believed to be associat-
ed with a pathological excess of black bile, a ‘cold and dry’ condition that affected
the brain. A link between depression and anxiety was already noted, and the Roman
Galen (131-201 AD) stated that melancholia manifested itself in ‘fear and depression,
discontent with life, and hatred of all people’. Almost fifteen hundred years later, in
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1621, Burton published his ‘Anatomy of Melancholy’ in which he referred to the ideas
of the ancient Greeks and Romans. Burton also described different pathways to
depression. He distinguished ‘congenite or inward causes of depression’ such as
inheritance and temperament, but also exogenous causes that could either be super-
natural (‘from God or the devil immediately, or mediated by magicians or witches’)
or natural (e.g. diet, alcohol, sleeping and other biological rythms, and ‘passions and
perturbations of the mind’ due to factors such as ‘intense love’). Amongst others,
Burton specifically mentioned the risk of ‘love of learning, and study in excess’,
responsible for the ‘misery of scholars’ and the melancholy of the muses [Figure 1]. 
Today, we define depression as a result of the interplay between stress factors
such as loss events and a wide array of endogenous/genetic, social and personality
characteristics. In their milestone work “social origins of depression” (1978) Brown
and Harris described the results of their research on the onset of depression in
women of different social classes and ‘life-stages’ (Brown & Harris 1978). They were
especially interested in the position of women with young children who did, or did
not, have an outside job, and the level of depressive symptomatology they experi-
enced. The “vulnerability-stress model”, that clusters variables according to their role
in a causal model of the development of depression, is the underlying concept for
the studies presented in this thesis [figure 2]. 
Provoking agents A great number of authors have stressed the importance of loss
events, most often the death of a loved one, as precursor to depression. In
‘Mourning and Melancholia’, Freud made clear that the object of love need not have
died to cause such a reaction, but merely has been lost as an object of love (Freud S.
1917). He stated that the difference between grief and depression is that the melan-
cholic patient feels a profound loss of self-esteem, accompanied by self-reproach
and guilt, while the mourner maintains a reasonably stable sense of self-esteem after
the actual loss of a significant figure. Brown and Harris defined loss events as the
deprivation of sources of value or reward. Apart from loss, also (perceived) threat of
loss, and long-term difficulties (household, health or other) qualified as provoking
agents. It was found that such difficulties were much more prevalent in lower social
classes, which was seen as an explanation for the differences in morbidity depending
on socio-economic status. The importance of these provoking agents in the genesis
of depression is that it ‘leads to an inability to hold good thoughts about ourselves,
our lives, and those close to us’ (Brown & Harris 1978). It causes ‘loss of faith in
ones ability to attain an important and valued goal’ and may generalise to a state of
hopelessness, a crucial factor in the development of depression (Melges & Bowlby
1969). Still, similar circumstances may cause entirely different reactions in different
people. Therefore a second crucial aspect is introduced; that of the interpretation of
events by the individual.  
Vulnerability or protective factors In line with the work of Beck (Beck 1971;Kovacs
& Beck 1978) and others, Brown and Harris stressed the importance of the cognitive
interpretation of events as a necessary mediator in developing or not developing
hopelessness and depression. Phrased otherwise; if a person experiences loss or
long term difficulties but believes that he or she is able to face it, or will find the
resources to overcome some of these difficulties, the chances of becoming
depressed are limited. It is here that self-esteem, and a sense of mastery may exert
12 Epidemiology of late life depression
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Figure 1: Burtons Anatomy of Melancholy (1621)
their influence. Although such features may in part be an aspect of personality, and
thus relatively stable characteristics, it is stressed that concurrent (and preferably
less negative) experiences in other social roles may play an important part in limiting
vulnerability. As an example of this, Brown and Harris found that for women lack of
a full- or part-time job, and/or having three or more children under 14 at home, were
associated with higher vulnerability. Evidence-based forms of psychotherapy such as
Interpersonal Psychotherapy, have acknowledged the importance of these phenome-
na and explicitly focus on the restoration of role functioning in different interperson-
al relationships after a loss event that has lead to depression (Weissman & Klerman
1977). Another factor determining vulnerability in the Brown and Harris studies was
loss of mother before the age of 11. This most probably affects a child’s learning of
mastery of the environment and self reliance, for the development of which a secure
attachment with a principal (mother) figure is essential(Bowlby 1969). Early loss
events may thus create a heightened vulnerability to subsequent stressors. An inter-
personal determinant of vulnerability is the absence of a confiding relationship.
Having an intimate relationship may reduce the risk of depression in several ways. It
may help provide a basic sense of self-worth, especially in the context of major loss-
es, when the individual may be inclined to completely loose his of her self-esteem. A
confiding relation may also facilitate the working through of grief, and counteract
defense mechanisms such as denial that may result in prolonged and dysfunctional
mourning (Brown & Harris 1978). 
Symptom formation factors were believed to determine the nature and severity of
the depressive disorder that may result from the interplay of the above influences. It
was argued that earlier losses would ‘affect the way an individual looks at the world,
and particularly the way one reacts to losses’. Loss by death would, irreversible as it
is, be associated with feelings of uselessness, reactions of denial and possible devel-
opment of psychotic depression in the future. Other types of separation would result
in ‘neurotic’ feelings of rejection and possibly result in ‘neurotic depression’ as a
reaction to new life stresses (Brown & Harris 1978).
Over the years, other authors have elaborated and refined the model proposed by
Brown and Harris. Genetic influences have received much more attention (Kendler
et al. 1993;Kendler et al. 2001). In the dynamic stress-vulnerability model proposed
by Ormel and Neeleman, vulnerability is further subdivided into psychobiological
vulnerability, consisting of genetic factors and temperamental style, physiological
dysfunctions and cognitive deficits, and social vulnerability consisting of socio-eco-
nomic factors, urbanisation and familial surroundings (Ormel & Neeleman 2000).
Still, the essential idea of a stress-buffer interaction has remained the dominant con-
cept in understanding the etiology of depression. The studies described in this the-
sis pay tribute to this underlying concept of the pathogenesis of disease. It is howev-
er important at this stage to define in what way epidemiological studies may con-
tribute to a better understanding of depression, and hopefully also to more effective
preventative or treatment strategies of depression.
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Figure 2; Vulnerability-Stress model (adapted from Brown&Harris)
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1.5 Epidemiology
In general, longitudinal epidemiological studies offer an opportunity to study both
determinants of onset and course, and public health aspects of disease (Bouter &
Van Dongen 2000;Rothman & Greenland 1998).
First of all, the importance of a variety of potential risk factors and their mutual
interaction on the outcome measure can be studied, thus shedding light on their
importance in both the development and course of disease. As the large number of
subjects, both predictors of depression, significant interactions or comorbidity pat-
terns with other disorders, and the consequences of these in terms of prognosis fil-
ter out individual variation, disability and survival may be detected. Such associa-
tions may serve as a starting point for further research of underlying psychological or
pathophysiological mechanisms. 
Another characteristic of epidemiology is, that it is relatively unbiased by any of
the dominant theoretical frameworks in psychiatry. Both biological/genetic, psycho-
logical and social determinants of disease can be studied in comprehensive and
combined models for onset and course of illness. Epidemiological studies thus offer
an opportunity to incorporate and study a wide variety of potential determinants and
their associations with depression, regardless of the bio-psycho-social background
(Beekman & Ormel 1999).
Thirdly, epidemiological studies can determine the contribution of specific risk
factors to the total amount of disease in the population. The increasing costs of
health care are a major public concern, and rational choices may have to be made
regarding the allocation of resources. Risk factors identified in epidemiological stud-
ies can be targeted in naturalistic and randomised trials to assess the potential pre-
ventative effects (Beekman 2004). The epidemiological approach may thus be help-
ful in generating valuable information on the effectiveness and scale of different
types of intervention, on the corresponding demands on the health care services,
and importantly, also on the associated costs. 
Still, one has to bear in mind that, although epidemiology can uncover overall pat-
terns and determinants that may be relevant to the understanding of depression as a
disorder, these can by definition not be rigidly applied to the individual patient. It
remains the task of the clinician, in dialogue with his or her patient, to translate and
apply scientific data from these and other sources to a meaningful and effective
treatment.
1.6 Depression in later life
Considering the negative influence of late-life depression on various aspects of daily
life, a number of which will be discussed in more detail in this thesis, there may be
more similarities than differences in comparison to depression in younger adults. In
line with this, theoretical models seeking to explain the etiology of depression often
do not make clear distinctions between these age groups. Still, the distribution of
potential risk factors for depression in old age is considerably different from the situ-
ation in younger adulthood. Specific life events and changes in both physical and
social functioning are common in later life, and relatively rare in younger age groups.
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In the third phase of life, at least in western countries, people have less (profession-
al) obligations, children are often living separate lives, friends are becoming more
sparse, and people are more likely to lose partners and acquire physical illnesses or
cognitive decline. If depression is defined as a prolonged, more severe and dysfunc-
tional response to a loss event, later life offers an amalgamation of these; losses of
dear ones, losses of social roles, and loss of physical and cognitive abilities. All of
these may be risk factors for the onset of depression. In addition, many older per-
sons in western societies live in large cities in which the social framework is less
tightly knit. Social interaction and support have become less available, and people of
a later age may be limited in their abilities to circulate and interact with others. As
has been stated earlier, ‘successful ageing’ is an attractive but rather fragile concept
(Deeg et al. 2002). 
Perhaps the most prominent difference characterising later life is the high preva-
lence of chronic physical illnesses. In the age group from 65 to 74 years, 64 % of
Dutch older persons have one or more chronic illnesses, and over 75 years only 29%
of older adults do not have any chronic illnesses (Kriegsman et al. 1998). Poor
health may be the principal risk factor for depression in old age (Kennedy et al.
1989;Prince et al. 1998). Apart from psychological/emotional reactions to these phe-
nomena, there may also be biological links between physical illnesses and depres-
sion. The most important biological dysregulations associated with depression will
be discussed in this thesis. Recently, syndromes that are most probably specific to
old age psychiatry, such as ‘vascular depression’ (Alexopoulos et al. 2002;Thomas,
Kalaria, & O’Brien 2004) have also received growing attention. 
Dementia is another form of comorbidity that is prominent in later life.
Alzheimer’s disease and other forms of cognitive deterioration range from approxi-
mately 1% at age 65 to as much as 30% at age 90 (Hofman et al. 1991;Lobo et al.
2000). The co-occurrence, or subsequent occurrence of depression and cognitive
decline has attracted the attention of many researchers, and may be explained by
biological as well as psychological mechanisms (Bassuk, Berkman, & Wypij
1998;Yaffe et al. 1999). Depression itself may lead to impaired cognition through
attention deficits. The so-called ‘pseudo-dementia’ concept reflected the idea that
cognitive deterioration may in part be due to depression, and may recover when
depression remits. However, the validity of this concept has often been questioned,
and other mechanisms, either psychological or biological, appear more convincing
in explaining the association between depression and cognitive decline (Nussbaum
1994). It is currently stated that depression may be an emotional reaction to subjec-
tive (perceived) cognitive decline in the individual, that it may be caused by the neu-
rodegenerative process of Alzheimer’s disease, and that it may be associated with
subcortical white matter hyperintensities found in ‘vascular depression’ (Raskind
1998;Steffens, Taylor, & Krishnan 2003). Lastly, the co-occurrence of cognitive decline
and depression may also be due to recurrence in later life of earlier and midlife
depressive disorder. Community-based studies may provide more information on
predictors of cognitive decline and depression, and on their temporal associations,
and may thus be helpful to further disentangle these two phenomena.
Another form of comorbidity is that between depression and anxiety disorders.
Studies in younger age groups have shown considerable overlap between depression
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and anxiety disorders, the latter of which may either antedate, or co-occur with the
onset of depression (de Graaf et al. 2003;Kessler et al. 1996;Liebowitz et al. 1990).
Until recently, the idea was that this type of comorbidity was less pronounced in later
life when compared with younger adulthood. It was stated that in the elderly, anxiety
disorders are less common than in younger adults, with generalized anxiety disorder
and phobias accounting for most anxiety in late life and panic disorder being rela-
tively rare (Flint 1994). Lately however, this view has been questioned (Lenze et al.
2000;Lenze et al. 2001). Also in older adults, comorbidity of depression and anxiety
may frequently occur and may be associated with an untoward course and less opti-
mal response to treatment. The question whether these are specific disorders, or
whether they represent different dimensions of a single disorder, has been subject to
considerable debate in the literature (Tyrer 1996). Apart from studying differences
and similarities in course patterns, this aspect may also be elucidated by investigat-
ing risk profiles for either disorder (Beekman et al. 2000). Although community-
based studies may provide valuable information in this respect, only a limited num-
ber of studies have investigated late life anxiety disorders and the overlap with
depression.
There has also been growing attention for the association between major depres-
sive disorder and an increased risk of death, especially in clinical and general hospi-
tal populations (Frasure-Smith, Lesperance, & Talajic 1995;Lesperance et al.
2000;Tsuang & Woolson 1978). Much less is known about these associations in
more prevalent minor, or ‘mild’ depressive syndromes that frequently occur in com-
munity living older persons. This issue is relevant to clinical practice, but also under-
lines the growing interest in depression from a public health perspective. The high
prevalence of depression and the different types of comorbid conditions merit fur-
ther study of the prognostic implications. The relatively wide array of possible mech-
anisms that may be associated with the depression – medical illness – mortality tri-
angle are also intriguing from a scientific angle. If an association between late-life
depression and excess mortality can be established, how can it be explained?
Considering the enormous adverse individual and public health consequences of
late-life depression, the potential health gains could be substantial if depression
could be prevented. The fact that even optimal evidence-based treatment of all
depressed patients could reduce the burden of depressive illness by only one third
(Andrews et al. 2004), warrants a more thorough study of preventative options. Still,
preventive strategies aimed at reducing the incidence of late life depression in com-
munity living older persons have only very recently come into focus in mainstream
psychiatry (Smit et al. 2004b;Smit et al. 2004a). For reasons of cost-effectiveness,
studies on preventative measures should be targeted at subjects with a high a priori
risk of developing depression through exposure to multiple risk factors (Cuijpers
2003). As a large number of depressed patients go unnoticed by the health services,
community based studies may provide necessary information on both risk profiles
and on the potential costs and benefits of preventative action.
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1.7 Classification of psychopathology
One of the crucial issues in diagnosing psychopathology is the decision whether a
patient’s complaints are of sufficient severity to be classified as a psychiatric disor-
der. For clinicians, a dichotomy is a useful basis for the decision whether or not to
intervene, and treatment protocols have been developed and validated according to
pragmatic diagnostic criteria. Still, it is doubtful whether in nature such thresholds
of psychopathology exist, especially when the diagnosis is based on a syndrome or a
cluster of symptoms rather than on an etiologically defined disease entity.
Epidemiological data suggest that psychiatric symptoms may have a much wider dis-
tribution in the population than those included in the official classifications of a dis-
order (Beekman, Copeland, & Prince 1999;Blazer et al. 1988;van Os 2003).
Furthermore, the negative effects of depression in terms of human suffering and dis-
ability appear to be directly related to the number of depressive symptoms, and not
to diagnostic threshold levels (Hays, Wells, Sherbourne, Rogers, & Spritzer
1995;Ormel et al. 1998). When investigating depression in a population sample, it is
therefore vital to use a research instrument that generates both a clinical diagnosis
according to standardised criteria and a continuous assessment of depressive symp-
toms. This enables the comparison of psychopathology in clinical patients and in
community living persons, a considerable number of whom may never reach the
health services. Even more importantly, the whole array of symptoms occurring in
community samples can thus be determined. 
The DSM (Diagnostic Statistical Manual of Mental Disorders)(American
Psychiatric Association, American Psychiatric Association, & Task Force on DSM-IV
1994) and ICD (WHO) classification systems have been extremely helpful in distin-
guishing psychiatric disorders according to clear-cut diagnostic criteria, and enabling
international and cross-cultural comparisons and research. Both for clinical purpos-
es and for treatment evaluation in Evidence-Based Medicine, the value of these diag-
nostic standards cannot be underestimated. Still, the recent history of the develop-
ment of subsequent DSM-versions shows that, although the core symptoms of
depression have remained relatively stable, even these diagnostic reference or ‘gold-
standard’ categories and thresholds have sometimes been somewhat arbitrarily cho-
sen on the basis of consensus, and were subsequently adapted according to both
dominant concepts of psychopathology and clinical and epidemiological evidence
that was available at that moment (Spitzer 1991;Spitzer 2001;Wilson 1993). The
fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV) distinguishes several types of unipolar affective disorders, the criteria of which
are given in table 1 (American Psychiatric Association 2000). The most severe type
of depression according to DSM-IV criteria is Major Depressive Disorder or Major
Depression. Dysthymic disorder is characterized by the presence of symptoms that
are less severe than the symptoms of major depressive disorder, but with a duration
of over two years. A relatively new concept is that of ‘minor depression’, listed as a
proposed (research) category, in which a lower number of depressive symptoms
allows the diagnosis. This new category reflects the growing interest in the so-called
subthreshold depression (Pincus, Davis, & McQueen 1999) that is clinically relevant
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but does not meet all of the criteria for major depressive episode (Tannock & Katona
1995). Apart from these categories of mood disorder, DSM-IV also recognises
Adjustment disorder with depressed mood, and Depression due to a General
Medical Condition. 
When considering symptomatology of geriatric depression, it has been argued
that this may differ somewhat from that of depression earlier in life. A so-called
‘depletion syndrome’ characterised by ‘negative symptoms’ such as loss of interest
or pleasure, loss of appetite and hopelessness may predominate over ‘positive’ emo-
tional and cognitive symptoms such as sadness and inappropriate feelings of guilt
(Gallo & Rabins 1999;Gottfries 1998;Newmann, Engel, & Jensen 1991). As geriatric
depression often co-occurs with other psychiatric and/or somatic disorders, this may
further complicate its assessment. This can be seen as an argument favouring the
use of research instruments that specifically recognize late-life depressive sympto-
matology.
Apart from severity, diagnostic thresholds and symptomatology, the issue of etiol-
ogy also merits discussion in the context of the classification of psychiatric disor-
ders. Reflective of the fact that the etiology of psychopathology is probably multi-
causal and largely unclear for most disorders, classification systems such as DSM
and ICD strive to be etiologically neutral. An exception to this is made for the catego-
ry of ‘mood disorder due to a general medical condition’ and ‘substance-induced
mood disorder’, as the causal mechanisms are better understood in these cate-
gories. Still, it is only recently that depression was subdivided into and endogenous
and an exogenous form. Especially in the Anglo-Sacksan tradition, psychotic
(endogenous) depression was described as a more severe form of depression with a
course type including both relapses and remittances, a biologically / genetically
determined etiology, and a relatively good response to biological treatments such as
antidepressant medication. Neurotic depression was considered to be of mild to
moderate severity depending on co-occurring external circumstances, with a pre-
dominantly chronic course and a strong association with (neurotic) personality char-
acteristics (Andrews et al. 1990;Kiloh & Garside 1963;Lewis 1938). The Geriatric
Mental State schedule (GMS), the diagnostic instrument that formed the basis for
the assessment of psychopathology in the study on which this thesis is based,
reflects this tradition and generates both a general depression diagnosis and a sub-
division into neurotic and psychotic depression (Copeland et al. 1976;Copeland,
Dewey, & Griffiths-Jones 1986;Gurland et al. 1976). It also distinguishes both individ-
ual depression symptoms and so-called case-levels according to the severity of
depression. These properties are especially attractive when studying the depression
concept in the general population. In contrast with other diagnostic instruments,
GMS-AGECAT provides both a diagnosis of clinically relevant depression, an assess-
ment of severity, and the whole array of subsyndromal depression symptoms. It thus
combines the properties of frequently used screening instruments such as the CES-
D (Radloff 1977) that measure symptoms but do not provide diagnoses, and diag-
nostic criterion instruments that are often more time and personnel consuming, and
not so easily applicable to study depression in large samples such as the AMSTEL
study.
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1.8 The Amsterdam Study of the Elderly
The population base for AMSTEL included all non-institutional individuals in the 65-
84 age bracket who lived in the city of Amsterdam and were registered with a general
practitioner at baseline. The study was actively supported by the general practition-
ers, whose lists were used as the sampling frame. In the Netherlands, general practi-
tioners are the gate-keepers to the health care system and almost every citizen is
enlisted by a general practitioner. In this role, general practitioners in the
Netherlands generally provide social support and have a long-standing personal rela-
tionship with their patients. Thus, the source population consisted of almost all of
the non-institutionalised population. The sample was drawn from a list of 30 general
practices spread throughout the city; practices were selected from all practices regis-
tered within the city of Amsterdam, 22 randomly and 8 by convenience from a net-
work of general practitioners participating in medical research. The mean proportion
of elderly individuals (15%), and the profile of the over-65 general practice-popula-
tion in terms of age and gender, correspond to the non-institutionalised Amsterdam
population (Launer et al. 1993;Launer, Wind, & Deeg 1994)(Launer et al., 1993).
Within each practice, respondents were randomly selected from four age strata span-
ning five years each (65-69 to 80-84). In order to obtain equally sized age-strata at
follow-up, the older old were oversampled. Out of a sampled total of 5666, 4051
(71,5%) responded and formed the baseline sample (Figure 3).
At follow-up three years later, 2244 (55,4%) subjects were reinterviewed (median
38 months). By then, 656 (16, 2%) people had died, 662 (16,3%) persons refused
further co-operation, 282 (7,0%) were too ill or cognitively impaired to respond, and
207 (5,1%) were not available for interview due to a variety of other reasons. 
Both in 1996 and in 2001, data on vital status were obtained from the community
registers. This enabled studying the association between depression and mortality,
both in the 4051 subjects who attended the baseline assessment and in the 2244
subjects who also attended the follow-up measurement.
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N=656
Died
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assessment  
N=4051
10 year vital status
assessment  
Figure 3. AMSTEL: Flow Chart 
1.9 Measures
A one-hour interview was developed to gather information on psychiatric symptoms,
demographic and medical status, previous history and family history. The interview
consisted of the Dutch translation of the Mini-Mental State Examination (Folstein,
Folstein, & McHugh 1975), all Geriatric Mental State Examination-items related to
organic, affective and anxiety syndromes (Copeland, Dewey, & Griffiths-Jones
1986;Hooijer, Jonker, & Dewey 1991), the Activities of Daily Living (ADL) scale (Katz
et al. 1963), the Instrumental Activities of Daily Living (IADL) scale (Lawton & Brody
1969), and part of the Cambridge Mental Disorders of the Elderly Examination
(CAMDEX) (Roth et al. 1986). Included from the CAMDEX were years of education,
marital status and living status. Socio-economic status was assessed by asking
respondents about the highest level of professional occupation they had reached,
and the highest level their partner had reached. The highest occupational level of
respondent or partner was taken as the socio-economic status. Social support was
ascertained by the question: ‘Do you get help from children or neighbours?’.
Respondents were then asked to specify whom they received support from. A per-
sonal history of psychiatric disorder was ascertained by the relevant CAMDEX-ques-
tion, asking subjects whether they had ever experienced depression and/or anxiety of
such severity that treatment had been sought. The question was considered affirma-
tive if treatment had been requested and if treatment had been prescribed this was
interpreted as an indicator of the severity of the illness. Age at first onset was record-
ed. Also translated from the CAMDEX-questionnaire was a family history of psychi-
atric illnesses.
Diagnoses of dementia, depression and generalised anxiety were made according
to the GMS-AGECAT system (Copeland et al. 1988;Copeland, Dewey, & Griffiths-
Jones 1986). Diagnostic levels 3-5 correspond reliably to cases of depression requir-
ing clinical attention in both the community (Copeland, Dewey, & Griffith-Jones
1990) and in elderly hospital patients (Ames & Tuckwell 1994). GMS-AGECAT has
proven reliability for epidemiological work in replication studies (Copeland, Dewey,
Henderson, Kay, Neal, Harrison, McWilliam, Forshaw, & Shiwach 1988). The Dutch
language version has also proved to be reliable (Hooijer, Jonker, & Dewey 1991).
Depression caseness at baseline and follow-up was defined as a GMS-AGECAT level
3 or higher. GMS-AGECAT generates both a non-hierarchical syndrome level and a
more narrowly defined diagnostic level. The diagnostic case level is calculated from
the syndrome level using a hierarchy from organic to depression to anxiety disorder. 
The interview was administered during home visits by lay interviewers who were
specially trained using video sessions and regularly supervised. The same GMS-AGE-
CAT package with an identical algorithm was used in the second wave of the study.
When re-interviewing, raters were unaware of previous data and diagnoses. 
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1.10 Contents of this thesis
The primary research aim of this thesis is to model onset and course of late life
depression, in view of the specific characteristics of later life and the vulnerability-
stress paradigm. This is then further developed into studies of depression and
comorbidity with other psychiatric disorders in later life, studies on prognosis and
excess mortality associated with depression, and an exploration of the possible use
of these epidemiological data to develop a research agenda for prevention of depres-
sion in primary care.
In Chapter 2 the question is put forward whether, in line with the Brown and
Harris concept, different etiologic pathways for the onset of late-life depression
(through genetic/familial vulnerability, organic vulnerability or environmental vulner-
ability) can be demonstrated in a longitudinal study of community-living older per-
sons. Chapter 3 assesses whether risk factors related to incidence of late-life depres-
sion are also related to prognosis, and whether a vulnerability-stress model can also
be established for the course of late-life depression.
Subsequently, comorbidity patterns of late-life depression with generalised anxi-
ety disorder and cognitive decline are investigated, as both of these disorders fre-
quently either overlap with depression, may affect the prognosis of depression, and
may also be difficult to distinguish from depression due to overlapping symptoms.
Chapter 4 reports on a cross-sectional study of risk patterns and comorbidity of
depression and generalised anxiety disorder, and in Chapter 5 the course types of
pure depression, pure generalised anxiety disorder and mixed anxiety-depression are
described. Chapter 6 examines whether depression may be indicative of subsequent
cognitive decline and Alzheimer’s Disease in older adults with normal cognition.
The section on associations between depression and mortality starts with a study
examining the overall pattern in a community population of older persons. Chapter 7
examines this association according to different severity levels of depression and
according to gender, controlling for potential confounders. Chapter 8 provides a
review article examining mechanisms that may theoretically be responsible for the
excess mortality associated with depression. Subsequently, Chapter 9 then examines
whether specific characteristics of depression may be specifically related to excess
mortality.  
The final study, described in Chapter 10 of this thesis, presents an attempt to
determine which older individuals are at high risk to develop depression, and pro-
poses a rational model to guide preventative measures to reduce the incidence of
depression. 
Chapter 11 presents a brief summary of findings, their relevance is commented on
and the merits and limitations of the studies are discussed.
The work described in the thesis is the result of the combined efforts of a large
number of people. Their contributions are gratefully acknowledged here, and in the
final section of this thesis.
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Table 1: DIAGNOSES OF DEPRESSIVE DISORDERS (DSM IV-TR, APA 2000)
Diagnostic Criteria Major Depressive Episode 
A. Five (or more ) of the following symptoms have been present during the last 2-week period and repre-
sent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or
(2) loss of interest or pleasure.
1   Depressed mood most of the day, nearly every day, as indicated by either subjective report 
(e.g. feels sad or empty) or observation made by others (e.g. appears tearful). 
2   Markedly diminished interest or pleasure in all, or almost all, most of the day, nearly every day 
(as indicated by either subjective account or observation made by others). 
3   Significant weight loss when not dieting or weight gain (e.g. a change of more than 5% of body
weight
in a month), or decrease or increase in appetite nearly every day. 
4   Insomnia or hypersomnia nearly every day. 
5   Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective 
feelings of restlessness or being slowed down). 
6   Fatigue or loss of energy nearly every day. 
7   Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly 
every day (not merely self-reproach or guilt about being sick). 
8   Diminished ability to think or concentrate, or indecisiveness, nearly every day 
(either by subjective account or as observed by others). 
9   Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specifi plan, 
or a suicide attempt or a specific plan for committing suicide. 
B.  The symptoms do not meet criteria for a Mixed Episode. 
C.  The symptoms cause clinically significant distress or impairment in social, occupational, or other
important areas of functioning.
D.  The symptoms are not due to the direct physiological effects of a substance (e.g. a drug of abuse, 
a medication) or a general medical condition (e.g. hypothyroidism).
E.  The symptoms are not better accounted for by Bereavement, i.e. after the loss of a loved one, 
the  symptoms persist for longer than 2 months or are characterised by marked functional 
impairment, morbid preoccupation with worthlessness, suicidal ideation, psychotic symptoms, or 
psy chomotor retardation. 
Diagnostic Criteria for Major Depressive Disorder
A.  Presence of a Major Depressive Episode
B.  The Major Depressive Disorder is not better accounted for by Schizoaffective Disorder and is not 
superimposed on Schizophrenia, Schizophreniform Disorder, Delusional Disorder, 
or Psychotic Disorder Not Otherwise Specified.
C.  There has never been a Manic Episode, a Mixed Episode, or a Hypomanic Episode.
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Research Criteria for Minor Depressive Disorder
A.  A mood disturbance, defined as follows:
1  at least two (but less than five) of the nine symptoms mentioned above have been present during 
the same 2-week period and represent a change from previous functioning; at least one of the 
symptoms is either (a) or (b):
2  The symptoms cause clinically significant distress or impairment in social, occupational, 
or other important areas of functioning.
3  The symptoms are not due to the direct physiological effects of a substance (e.g. a drug of abuse, 
a medication) or a general medical condition (e.g. hypothyroidism).
(4) The symptoms are not better accounted for by Bereavement, i.e. after the loss of a loved one 
B.  There has never been a Major Depressive Episode, and criteria are not met for Dysthymic Disorder
C. There has never been a Manic Episode, a Mixed Episode, or a Hypomanic Episode, and criteria are 
not met for Cycisorder, delusional Disorder, or Psychotic Disorder Not Otherwise Specified.
Diagnostic Criteria Dysthymic Disorder
A. Depressed mood for most of the day, for more days than not, as indicated either by subjective  
account or observation by others, for at least 2 years. 
B. Presence, while depressed, of two (or more) of the following: 
1   Poor appetite or overeating
2   Insomnia or hypersomnia
3   Low energy or fatigue
4   Low self-esteem
5   Poor concentration or difficulty making decisions
6   Feelings of hopelessness 
C.  During the 2-year period of the disturbance, the person has never been without the symptoms in  
Criteria A and B for more than 2 months at a time. 
D.  No Major Depressive Episode has been present during the 2 first years of the disturbance; i.e. the dis
turbance is not better accounted for by chronic Major Depressive Disorder, or Major Depressive 
Disorder, in Partial Remission.
E.   There has never been a manic episode, a Mixed Episode, or a Hypomanic Episode, and criteria have  
never been met for Cyclothymic Disorder.
F.   The disturbance does not occur exclusively during the course of a Chronic Psychotic Disorder, such 
as Schizophrenia or Delusional Disorder.
G.  The symptoms are not due to the direct physiological effects of a substance (e.g. a drug of abuse, a 
medication) or a general medical condition (e.g. hypothyroidism).
H.  The symptoms cause clinically significant distress or impairment in social, occupational, or other  
important areas of functioning.
Diagnostic Criteria Adjustment Disorder with Depressed Mood
The predominant manifestations are symptoms such as depressed mood, tearfulness, or feelings of hope-
lessness.
A.   The development of emotional or behavioural symptoms in response to an identifiable stressor(s)   
occurring within 3 months of the onset of the stressor(s). 
B.   These symptoms or behaviours are clinically significant as evidenced by either of the following: 
Marked distress that is in excess of what would be expected from exposure to the stressor 
Significant impairment in social or occupational (academic) functioning 
C.   The stress-related disturbance does not meet the criteria for another specific Axis I disorder (clinical
disorder) and is not merely an exacerbation of a pre-existing Axis I or Axis II disorder (Personality
Disorder or Mental Retardation).
D.  The symptoms do not represent Bereavement. 
E.   Once the stressor (or its consequences) has terminated, the symptoms do not persist for more than 
an additional 6 months. 
Diagnostic Criteria Mood Disorder due to a General Medical Condition, with depressive features.
A.   A prominent and persistent disturbance in mood predominates in the clinical picture and is charac 
terized by a depressed mood or markedly diminished interest or pleasure in all, or almost all, activi
ties.
B.   There is evidence from the history, physical examination, or laboratory findings that the disturbance 
is the direct physiological consequence of a general medical condition.
C.   The disturbance is not better accounted for by another mental disorder (e.g. Adjustment Disorder 
with Depressed Mood in response to the stress of having a general medical condition).
D.   The disorder does not occur exclusively during the course of a Delirium.
E.   The symptoms cause clinically significant distress or impairment in social, occupational, or other  
important areas of functioning.
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Abstract
Background
Depression in the elderly was found to be associated with a variety of risk-factors
in cross sectional designs. Based on the vulnerability-stress model, etiologic
pathways for depression have been suggested, with vulnerability modifying the
effect of stress factors. The current prospective study tests an etiologic model for
depression incidence, by assessing modifying effects of three types of vulner-
ability: genetic/familial vulnerability, organic vulnerability, and environmental
vulnerability.
Methods
1940 non-depressed community-living elderly were interviewed at baseline, and
at follow-up three years later. Bivariate and multivariate relationships between
risk factors and incident depression (GMS-AGECAT) were studied.
Results
Higher age, personal history of depression, death of spouse, health related fac-
tors and comorbid organic or anxiety syndrome showed significant bivariate
associations with depression incidence. In multivariate analysis, the effect of
stress factors on incident depression was not modified by a genetic/familial vul-
nerability, nor by an organic vulnerability. Effect modification by environmental
factors was however evident; having a marital partner, and if unmarried having
social support, significantly reduced the impact of functional disabilities on the
incidence of depression.
Limitations
The study consisted of two measurements with a three years interval, depressive
episodes with a short duration may be underrepresented. 
Conclusions
In the elderly, the effect of stress on incident depression is modified by environ-
mental vulnerability. No evidence was found of effect modification by either
genetic/familial or organic vulnerability. The results have implications for both
recognition and treatment of late-life depression.
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2.1 Introduction
Current knowledge about risk factors of late-life depression is largely derived from
either clinical populations, or from cross-sectional studies in the community. Studies
of clinical patients have the disadvantage of not being representative of the vast
majority of depressive subjects in the community. Cross-sectional studies in the
community suffer from methodological limitations such as recall and report bias in
depressed subjects (Raphael & Cloitre 1994), and contamination of the results as
risk factors are not measured independently from depression. Temporal relations
remain unclear since a characteristic found to be associated with depression may
have antedated (or caused) the disorder, but it may also be its consequence.
Likewise, cross-sectional designs cannot distinguish whether a characteristic has
prognostic value for the course of depression once depression is present, or is actu-
ally associated with its aetiology. Finally, in cross-sectional designs chronic depres-
sion is overrepresented, which may bias findings with regard to aetiology.
Prospective studies of the incidence of depression among the elderly are relative-
ly scarce and have used different sets of risk factors and research methods. Green et
al. (Green et al. 1992) found lack of satisfaction with life, feelings of loneliness and
smoking to be significantly associated with the development of depression as meas-
ured by GMS-AGECAT three years later in a cohort of community living elderly.
Multivariate analysis yielded two more factors; female gender, and bereavement of a
close person within six months of the third-year diagnosis. Phifer et al. (Phifer &
Murrell 1986) found the incidence of significant depression in a six months period to
be closely associated with changes in physical health. Kennedy et al. (Kennedy,
Kelman, & Thomas 1990) also found aspects of physical health to be closely related
to incidence of depression in a large sample of community-dwelling elderly in a two
year follow-up. In a one year follow-up study with 3-monthly assessment of depres-
sive symptomatology by Beekman et al. (Beekman et al. 1995a), depression inci-
dence was also found to be associated with health related variables. A recent publi-
cation by Prince et al. (Prince et al. 1998) revealed disablement, and more specifical-
ly handicap, to be the chief cause of onsets of depression in late-life in a one-year
follow-up of community living elderly.
According to the Brown and Harris (Brown & Harris 1978) etiologic model,
depression in adults may be the result of ‘social stress’ factors such as life events
(loss) or long term difficulties, combined with vulnerability/protective factors such
as social disadvantage, lack of intimate relationships, early traumatic life events,
lower intelligence/education, personal history of depressive illness and family histo-
ry. Earlier cross-sectional work from the Amsterdam Study of the Elderly (AMSTEL)
(van Ojen et al. 1995c;van Ojen et al. 1995a;van Ojen et al. 1995b) was inspired by
the work of Brown and Harris. The AMSTEL data suggested three different subtypes
of geriatric depression based on etiologic determinants. Early-onset depression was
found to be associated with long-standing inborn susceptibility (Kendler et al. 1993b)
and vulnerability due to previous episodes: “sensitization” or “kindling” (Post 1992).
Late-onset depression with cognitive impairment was mainly associated with the
presence of organic vulnerability factors. Late-onset depression without cognitive
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impairment was found to be associated with factors related to current life-stresses.
The primary aim of the present study was to further investigate the aetiology of late
life depression, studying incident cases in the community in a prospective longitudi-
nal design using a comprehensive set of risk factors generally believed to be associ-
ated with depression. In this way we hoped to avoid the above-mentioned methodo-
logical pitfalls and develop more insight into the temporal and causal relations
between risk factors and late-life depression. Secondly we wanted to investigate
whether the differential etiologic pathways of late-life depression suggested by earlier
cross-sectional data are confirmed using a longitudinal design.
2.2 Methods
2.2.1 Sampling and non-response
The population base for the study included all non-institutional individuals in the 65-
84 age bracket who lived in the city of Amsterdam and were registered with a general
practitioner at baseline (van Ojen, Hooijer, Jonker, Lindeboom, & Van Tilburg 1995c).
The sample was drawn from a list of 30 general practices spread throughout the city.
The mean proportion of elderly individuals (15%), and the profile of the over-65 gen-
eral practice-population in terms of age and gender, correspond to the non-institu-
tionalised Amsterdam population (Launer et al. 1993). Within each practice, respon-
dents were randomly selected from four age strata spanning five years each (65-69
to 80-84). In order to obtain equally sized age-strata at follow-up, the older old were
oversampled. Out of a sampled total of 5666, 4051 (71,5%) responded. A study of
non-response patterns (Launer, Wind, & Deeg 1994) revealed that non-response in
the younger old (<75) was associated with poor performance on cognitive tests and
with health problems. In the older old no correlates of non-response were found.
Of the 4051 subjects who initially responded 2244 (55,4%) were reinterviewed
three years later (median 38 months). Data from community death certificates were
used to cross-check our data on non-response and confirmed that 656 (16,2%) peo-
ple had died before follow-up. Another 662 (16,3%) persons refused further co-oper-
ation, 282 (7,0%) were too ill or cognitively impaired to respond, and 207 (5,1%)
were not available for interview due to a variety of other reasons. The study sample
for this study consisted of all responders at follow-up who were neither depressed
nor demented at baseline (GMS-AGECAT levels of less than three for both depres-
sion and organicity; N=1940).
2.2.2 Measures
A one hour interview was developed to gather information on psychiatric symptoms,
demographic and medical status, previous history and family history. The interview
consisted of the Dutch translation of the Mini-Mental State Examination (Folstein,
Folstein, & McHugh 1975), all Geriatric Mental State Examination-items related to
organic, affective and anxiety syndromes (Copeland, Dewey, & Griffiths-Jones
1986;Hooijer, van Ojen, & Jonker 1994), the Instrumental Activities of Daily Living
(ADL) scale (Katz et al. 1963), the Instrumental Activities of Daily Living (IADL) scale
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(Lawton & Brody 1969), and part of the CAMDEX-interview (Roth et al. 1986). The
interview was administered during home visits by lay interviewers who were specially
trained using video sessions and regularly supervised. The same GMS-AGECAT
package with an identical algorithm was used in the second wave of the study. When
re-interviewing, raters were unaware of previous data and diagnoses.
Psychiatric syndromes. Diagnoses of dementia, depression and anxiety were
made according to the GMS-AGECAT system (Copeland et al. 1988;Copeland, Dewey,
& Griffiths-Jones 1986). Diagnostic levels 3-5 correspond reliably to cases of
depression requiring clinical attention in both the community (Copeland et al.
1992;Copeland, Dewey, & Griffith-Jones 1990) and in elderly hospital patients (Ames
& Tuckwell 1994). GMS-AGECAT has proven reliability for epidemiological work in
replication studies (Copeland, Dewey, Henderson, Kay, Neal, Harrison, McWilliam,
Forshaw, & Shiwach 1988). The Dutch language version has also proved to be reli-
able (Hooijer, Jonker, & Dewey 1991). Depression caseness at baseline and follow-up
was defined as a GMS-AGECAT level 3 or higher. Subjects not depressed at baseline
who were depressed at follow-up were considered to be incident cases. GMS-AGE-
CAT generates both a non-hierarchical syndrome level and a more narrowly defined
diagnostic level. The diagnostic case level is calculated from the syndrome level
using a hierarchy from organic to depression to anxiety disorder. In order to be able
to also assess overlapping comorbidity influences, we have used syndrome levels in
our analyses since otherwise the diagnostic hierarchy would bias the results.
Vulnerability factors. As stressors may have a different impact in the older old
than in the younger old, age was conceived as a vulnerability factor. The same
applies for sex, as females have been found to be more vulnerable to depression
(Weissman & Klerman 1977). Educational status was dichotomised into lower (pri-
mary school or less) and higher (more than primary school) education. Socio-eco-
nomic status was assessed by asking respondents about the highest level of pro-
fessional occupation they had reached, and the highest level their partner had
reached. The highest level of respondent or partner was taken as the socio-economic
status. Marital status was assessed with the associated questions in GMS-AGECAT.
Social support was ascertained by the question: ‘Do you get help from children or
neighbours?’. Respondents were then asked to specify whom they received support
from. A personal history of psychiatric disorder was ascertained by the relevant
CAMDEX-question. The question was considered affirmative if treatment had been
requested and if treatment had been prescribed this was interpreted as an indicator
of the severity of the illness. Age at first onset was recorded. Onset before the age of
60 was classified as early history, onset at age 60 or after as late history. Also trans-
lated from the CAMDEX-questionnaire was a family history of mental handicaps.
Stress factors. In order to test the vulnerability-stress hypothesis ‘change’ vari-
ables were derived from differences that had occurred between baseline and follow-
up. Stressors thus defined were personal life events (partner loss, relocation),
changes in physical health (the emergence of chronic diseases), a substantial
decrease in ADL or IADL functioning (a difference of two points or more), and
cognitive decline (incident organic syndrome; GMS-AGECAT organic level three or
more at follow-up).
Genetic/familial vulnerability was defined as the presence of a personal or family
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history of mental disorders, organic vulnerability was defined as a baseline score on
the MMSE of less than 26 points, or a GMS-AGECAT organic syndrome level higher
than two at follow-up, and environmental vulnerability was defined by lack of social
support and being unmarried.
2.2.3 Data analysis
Baseline characteristics and response rate were calculated using bivariate and multi-
variate statistics. Bivariate associations of depression incidence at follow-up (T1)
with independent variables at baseline (T0) were assessed by calculating relative
risks. When the 95% confidence interval of the latter did not include one, the asso-
ciation was regarded to be statistically significant. Stepwise logistic regression mod-
elling was used to achieve independent predictive ability. 
In subjects with either a genetic/familial or environmental vulnerability, the asso-
ciation between stress factors and incident depression is expected to be stronger
than in subjects without these types of vulnerability (Brown & Harris 1978;Kendler et
al. 1993a;Post 1992). Similarly, organic vulnerability characteristics are expected to
reduce the impact of life events on incident depression (Cervilla & Prince 1997;van
Ojen, Hooijer, Jonker, Lindeboom, & Van Tilburg 1995c;van Ojen, Hooijer, Bezemer,
Jonker, Lindeboom, & Van Tilburg 1995a;van Ojen, Hooijer, Bezemer, Jonker,
Lindeboom, & Van Tilburg 1995b). In order to detect effect modification, interactions
were therefore investigated between either an environmental, a genetic/familial or an
organic vulnerability on the one hand, and stress factors that were found to be sig-
nificantly associated with incident depression on the other hand.
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2.3 Results
2.3.1 Sample characteristics and response pattern
In multivariate logistic regression, age, sex, level of education, chronic disease(s),
ADL and IADL impairment and organic syndrome differed significantly between
responders and non-responders (p<0.05). Marital status, personal history and both
anxiety and depression syndrome did not. When the deceased were excluded from
the sample, only educational level, marital status and organic syndrome remained as
significant predictors of other types of non-response. Importantly, controlling for
other factors both depression and anxiety at baseline did not significantly affect
response-rate.
At follow-up 309 subjects (15,9% of the study sample) had become depressed.
The following analyses investigate associations of risk factors with incident depres-
sion.
2.3.2 Bivariate associations with depression incidence
Vulnerability factors. In bivariate analysis [table 2A], older age (>74 yrs) showed a
significant association with depression. The level of incident depression was higher
in each consecutive five year age stratum, ranging from 12.8% in subjects aged 65-
69 to 19.5% in subjects aged 80-86 (chi-square: 8.26, p<0.05). Sex, level of educa-
tion, family history, marital status and social support did not show an effect, but
personal history of mental disorders did predict incident depression. In order to fur-
ther investigate the influence of a personal history, this variable was dichotomised in
several ways (history vs. no history, early vs. all, late vs. all, early vs. no history, late
vs. no history). All analyses showed a significant association between personal histo-
ry and incident depression, with a similar impact on incident depression of either
early or late history. Family history did not attain statistical significance as a separate
vulnerability factor.
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N 4051 2244 (55,4)
AGE 65-69              836 (20,6)               544 (65,1)             89,2/3/***               17,2/3/**
70-74                      974 (24,0)              581 (59,7
75-79                       1050 (25,9)              581 (55,3)
80-86 1191 (29,4)              538 (45,2)
SEX Male                       1523 (37,6)               817 (53,6)              3,02/1/ns               6,8/1/**
Female                    2528 (62,4) 1427 (56,4)
EDUCATION
Higher than PS        2335 (57,6)               1394 (59,7)            41,4/1/***             29,2/1/***
Primary school or less      1716 (42,4)              850 (49,5)
SOCIO-ECON STATUS 21,1/2/***              11,9/2/**
High                                182 ( 4,5)                 121 (66,5)
Middle                             1803 (44,7)              1045 (58,0)
Low 2050 (50,8)              1075 (52,4)
MARITAL STATUS 0,02/1/ns               0,2/1/ns
Married                    1970 (48,6)             1093 (55,5)
Not/no longer 2078 (51,3)              1149 (55,3)
SOCIAL SUPPORT 24,4/1/*** 4,4/1/*
No/little social support    3209 (79,2)             1841 (57,4)
Help from others 842 (20,8)               403 (47.9)
CHRONIC DISEASES 24,95/2/***           0,4/1/ns
None                               1894 (46,8)              1128 (59,6)
One or more 2157 (53,2)               1116 (51,7)
TABLE 1: ASSOCIATIONS OF PARTICIPATION AT T1 WITH SAMPLE CHARACTERISTICS AT T0
(*= p<0,05, **= p<0,01, ***= p<0,001)
VARIABLES
(Value at TO)
Resp vs Nonresp excl.
deceased   Chi-2/df/p
Resp vs Nonresp
Chi-2/df/p
T0 (%) T1 (% T0)
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VARIABLES
(Value at TO) T0 (%) T1 (% T0)
Resp vs Nonresp excl.
deceased   Chi-2/df/p
Resp vs Nonresp
Chi-2/df/p
TABLE 1: ASSOCIATIONS OF PARTICIPATION AT T1 WITH SAMPLE CHARACTERISTICS AT T0
(*= p<0,05, **= p<0,01, ***= p<0,001)
PSYCHIATRIC HISTORY 1,81/2/ns                  1,6/2/ns  
None                               
Early history                     438 (10,8)                251 (57,3)              early/other:ns        early/other:ns      
Late history                    164 ( 4,0)            84 (51,2)               late/other: ns        late/other: ns
ADL FUNCTION 40,7/1/***               5,4/1/*
Able                               3183 (78,6)               1846 (58,0) 
Disabled 868 (21,4)              398 (45,9)
IADL FUNCTION 92,3/1/***                13.9/1/***
Able                              2585 (63,8)               1578 (61,0)
Disabled 1466 (36,2)              666 (45,4)
MMSE SCORE 161,3/2/***              84.8/2/***
26-30                               3281 (81,0)             1969 (60,0)
22-25                               522 (12,9)                209 (40,0)
0-21 248 ( 6,1)                 66 (26,6)
ORGANIC                                                                                  89.7/1/***              35,5/2/***
None                       3790 (93,6)              2173 (57,3)
Case 261 ( 6,4)                 71 (27,2)
ANXIETY                                                                                      1,56/1/ns                  4,1/1/*
None                               3923 (96,8)              2180 (55,6) 
Case 128 ( 3,2)               64 (50,0)
DEPRESSION                                                                            18,2/2/***               7.3/2/*
None                               3528 (87,1)             1996 (56,6)
Neurotic                          441 (10,9)                216 (49,0)
Psychotic 82 ( 2,0)                32 (39,0)
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TABLE 2: BIVARIATE ANALYSYES OF FACTORS PREDICTING     
DEPRESSION INCIDENCE 
(N=1940; subjects with baseline organic and depression levels<Agecat level 3)
RISK FACTORS (N)                                         DEPRESSION Relative Risk (95% c.i.) 
A: VULNERABILITY 
AGE >74 yrs (941)                                           1.30 (1.06-1.60)
SEX female (1173)                                           1.20 (0.97-1.49)
EDUCATION Primary School&less (694)         1.11 (0.90-1.37)
MARITAL STATUS Unm/div/wid (950)            1.02 (0.83-1.25)
SOCIAL SUPPORT Help relat/friends (311)      1.16 (0.89-1.51)
PERSONAL HISTORY (253)                            1.61 (1.25-2.06)
FAMILY HISTORY psych (214)                        1.23 (0.92-1.66)
B: STRESS
Chronic (baseline)
CHRONIC DISEASE(S) (928)                          1.46 (1.19-1.80)
ADL DISABILITY (290)                                 1.49 (1.16-1.90)
IADL DISABILITY (493)                                   1.55 (1.26-1.92)
Changes between TO-T1
PARTNER DIED (134)                                     2.30 (1.77-2.99)
RELOCATION (233) 1.15 (0.86-1.55)
ALL ADL DECREASE >1pt (102)                       1.59 (1.11-2.27)
ALL IADL DECREASE > 1 pt (392)                  1.73 (1.39-2.14)
NEW CHRONIC DISEASE(s)  (366)                1.40 (1.11-1.77)
C: PSYCHIATRIC COMORBIDITY
Comorbidity at baseline
MMSE <26 (181)                                             1.12 (0.81-1.57)
ANXIETY SYNDROME (25)                            2.56 (1.57-4.19)
New (incident) comorbidity T0-T1
ORGANIC SYNDROME (129)                         1.57 (1.13-2.17)
ANXIETY SYNDROME (73)                            4.82 (3.96-5.87)
Stressors (table 2B). All of the stressors that were already present at baseline
(chronic disease, ADL/IADL disability) predicted depression at follow-up. New stres-
sors (changes T0-T1) that attained significance were death of spouse, a substantial
decrease in ADL or IADL function, and the occurrence of new chronic disease(s). 
Comorbidity. Assessment of psychiatric comorbidity (table 2C) showed baseline
anxiety and incident anxiety to be associated with depression at T1. Impaired cogni-
tive function at baseline (a Mini Mental State Examination of less than 26 points;
N=181, RR 1.13: 95% C.I. 0.62-2.07), did not predict depression at follow-up. We also
investigated whether enlarging the sample to include all baseline organic cases
would affect this result, but found this was not the case. There was also no signifi-
cant association between baseline organic syndrome and incident depression. In the
study sample, the development of a new organic syndrome did however show an
association with incident depression. In order to establish whether psychiatric
comorbidity would confound the results, all bivariate analyses were repeated exclu-
ding also baseline anxiety cases (baseline organic cases were already excluded). This
yielded essentially the same results.
2.3.3 Multivariate analysis
Table 3 shows the relative risks of risk factors that remained significant using step-
wise logistic regression. Loss of spouse retained the highest relative risk, followed by
personal history, IADL decrease, incident chronic disease, baseline IADL disability
and baseline chronic disease.
Interactions between either a personal or a family history and risk factors were
not found. The association between stress and incident depression was thus unaf-
fected by a difference in genetic or acquired vulnerability. Likewise, no interaction
was found between organic vulnerability and the same risk factors. When examining
effect modification by environmental vulnerability, we found a strong interaction
between marital status (not/no longer married) and baseline ADL-disability (RR
3.60; 1.79-7.20). Social support status did not show interactions with any of the
stress factors. As these variables are related, and subjects who were married had sig-
nificantly less social support (chi-square: 58.20, p<0,0001), the multivariate analysis
was repeated excluding the married subjects. A buffering effect of social support
could then be established in unmarried subjects in the presence of a substantial
decrease in ADL-functioning (RR 0.23; 0.06-0.92).
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TABLE 3: LOGISTIC REGRESSION; REMAINING SIGNIFICANT VARIABLES 
(backward stepwise logistic regression, Pout <0.05).
VARIABLE                                                   RR (95% c.i.)
Loss of spouse                                            3.11 (2.10-4.60)
Personal history                                         1.75 (1.26-2.43)
IADL decrease (>1pt)                                  1.71 (1.28-2.27)
Baseline IADL disability                               1.44 (1.10-1.90)
New chronic disease                                  1.41 (1.05-1.90)
Baseline chronic disease                             1.40 (1.08-1.80)
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2.4 Discussion
The aim of the present study was to model the aetiology of late life depression,
studying incident cases in the community in a three-year prospective design. Of the
subjects without depression at baseline, 15.9% had developed a GMS-AGECAT
depressive syndrome at follow-up. Compared to previous studies of depression inci-
dence in the elderly this is relatively high. Phifer et al. (Phifer & Murrell 1986) noted
an incidence of 10.7% after only six months, using a Center for Epidemiologic
Studies Depression Scale (CES-D) (Radloff 1977) score of 16 or higher as cut-off.
Kennedy et al. (Kennedy, Kelman, & Thomas 1990) found an incidence of 11% with
CES-D after two years, but excluded those cases who already showed subthreshold
levels of depression at baseline and only developed a mild increase in depressive
symptoms to reach the cut-off level of 16 points, thus underestimating the number
of emergent cases as compared to our definition. The Liverpool study (Copeland,
Davidson, Dewey, Gilmore, Larkin, McWilliam, Saunders, Scott, Sharma, & Sullivan
1992;Green, Copeland, Dewey, Sharma, Saunders, Davidson, Sullivan, & McWilliam
1992) revealed 44 incident cases of depression after three years in a population at
risk of 619 (7,1%), using also GMS-AGECAT, but following the diagnostic hierarchy
which does not recognise depressive syndrome levels when a comorbid organic syn-
drome is also present. The only other Dutch study (Beekman, Deeg, Smit, & Van
Tilburg 1995a) used five assessments of depressive symptomatology in a period of
one year and revealed a CES-D (16 points or more) depression incidence of in total
26%; composed of 11% incident cases that remained depressed during the study,
11% that remitted, and 4% showing a variable course. Prince et al. (Prince, Harwood,
Thomas, & Mann 1998) found a one year onset rate for pervasive depression of
12.0% using SHORT-CARE, with a one year maintenance rate of 63.2%.
These data suggest that, due to the development of chronicity, longer follow-up peri-
ods tend to show somewhat higher overall incidence rates of depression. Still, as is
the case in studies of depression prevalence (Beekman et al. 1995b), there appears
to be considerable variation in the levels of depression incidence found. This may be
partly be explained by different study intervals, but also by differences in assessment
methods and sample characteristics.
In a first, bivariate assessment of risk factors and depression, we found that all
except one of the stress factors predicted depression incidence. Only relocation,
known to be an important life-event, did not attain statistical significance. Loss of
spouse appeared to be the strongest predictor of incident depression, which is
consistent with other community-based studies of late-life depression (Beekman et
al. 1997). Physical and functional parameters also showed a relation with depression,
with both baseline measures and indicators of declining physical health predicting
new episodes of depression. These findings are concordant with those of other com-
munity based studies, and with studies comparing the relative impact of physical
health on late-life depression (Kennedy et al. 1989;Kennedy, Kelman, & Thomas
1990;Prince, Harwood, Thomas, & Mann 1998).
Among the vulnerability factors, higher age showed a statistically significant main
effect. The level of incident depression was higher in each consecutive five year age
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stratum. This would suggest that ageing itself may be a risk factor for depression in
the elderly. However, after controlling for the confounding influence of other potenti-
ally relevant factors, the effect of age disappeared. This is similar to what was found
in previous, cross-sectional studies (Beekman, Penninx, Deeg, Ormel, Braam, & Van
Tilburg 1997;Blazer & Burchett 1991).
Other vulnerability factors such as gender, level of education (and social econom-
ic status), marital status and social support did not attain significance as separate
risk factors. Many cross-sectional studies have however found women to be signifi-
cantly more at risk to be depressed than men (Wolk & Weissman 1995). This is not
replicated in our sample of incident cases, and may be due to the fact that we have
left out all baseline prevalent cases from the analyses. Among the prevalent cases at
baseline 79.9% were women, whereas among the non-depressed 59.8% were women
(chi-square 78.6, p<0.0001). A higher tendency of chronicity in women may explain
the higher prevalence in cross-sectional designs. This issue will be addressed when
studying the course of late-life depression.
Contrary to our expectation, a family history of psychiatric disorder was not sig-
nificantly associated with incident depression in our study sample. This is surprising
since others have found correlations of a family history and depression in cross-sec-
tional studies (Kendler, Kessler, Neale, Heath, & Eaves 1993a). Family history was
also associated with depression prevalence in our own baseline study (van Ojen,
Hooijer, Bezemer, Jonker, Lindeboom, & Van Tilburg 1995b), and in another
community-based study of elderly in the Netherlands (Beekman, Deeg, van Tilburg,
Smit, Hooijer, & Van Tilburg 1995b). As in the above discussion of sex-differences, it
may be that, in later life, family history acts as a prognostic factor rather than an eti-
ologic factor. Family history would then be associated with a longer duration of
episodes, increasing prevalence but not affecting incidence.
In comorbidity analyses, newly emerging organic syndromes correlated with inci-
dent depression, but baseline organic vulnerability did not. Also when enlarging the
sample to include all baseline organic cases, there was no significant association
between long-standing organic symptoms and incident depression. This finding fits
the clinical impression that the onset of cognitive decline is often accompanied or
even preceded by depressive symptoms. Our data also suggest that the effect of
cognitive decline as a risk factor for depression appears to wane with the passing of
time. Subjects may have had more time to adapt to their condition, or dementia
symptoms have progressed to a state where depressive symptomatology is less pro-
nounced. With regard to anxiety, both baseline and new anxiety syndromes predicted
depression incidence. The impressive relative risks of depression in subjects with
anxiety syndrome may very well be due to overlapping symptoms of comorbid disor-
ders, but may also be taken to indicate that depression and anxiety are different
manifestations of the same underlying condition (Tyrer 1996).
We hypothesised that three types of vulnerability would modify the effect of
stress factors: a genetic or familial vulnerability, indicated by a personal or family his-
tory of mental disorder, an organic vulnerability indicated by cognitive/organic symp-
toms at baseline or follow-up, and an environmental vulnerability defined as being
unmarried and lack of social support. Contrary to our expectations, both indicators
of a genetic/familial vulnerability did not act as effect modifiers. Although subjects
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with a personal history had a significantly higher chance of becoming depressed,
increased vulnerability when confronted with similar life-stresses could not be
shown. Both with and without stress factors, individuals with a previous history tend
to relapse. One is tempted to suggest that spontaneous relapse forms proof of the
‘kindling’ phenomenon. However, according to the kindling theory, subjects with a
previous history are expected to be more vulnerable than others, when confronted
with stress factors (Atre-Vaidya & Taylor 1997). Our data do not support this expecta-
tion. One explanation may be that the stress factors we have used in our study are
too strong to be able to detect more subtle, threshold-lowering effects that one
would expect in individuals who have become sensitised through earlier experiences.
Furthermore, in our study 80.6% of those with incident depression did not report a
personal history and were ‘true’ old-age depressions. The decrease of vulnerability in
older age samples, due to the association between personal history and excess
mortality (van Ojen, Hooijer, Jonker, Lindeboom, & Van Tilburg 1995c), may also
have influenced these findings. Younger age samples, such as formed the basis of
the Brown and Harris Studies (Brown & Harris 1978), may therefore show
significantly higher associations between stress-factors and incident depression in
subjects with a personal or family history.
The second vulnerability type, organic vulnerability, also did not modify the asso-
ciation between stress and depression. Subjects who already had mild cognitive
symptoms at baseline or who had developed an incident organic syndrome at follow-
up, were no more, and no less vulnerable to other (non-organic) stress-factors.
Although others have found some support for a differential pathway to late-life
depression mediated by cerebral deterioration in cross-sectional analysis (Cervilla &
Prince 1997), we have not been able to reproduce this in a prospective design.
With regard to environmental vulnerability, subjects without a marital partner
were more vulnerable to depression in the presence of baseline functional disabili-
ties. As marital status did not attain significance as an independent risk factor for
depression, this points to a protective modifying or buffering effect of being married.
Social support could not be shown to influence subject’s vulnerability to depression
in the study sample. Since marital status and social support are related, further
analysis in the unmarried showed that social support did have the hypothesised
buffering effect when these subjects were confronted with a decrease in functional
abilities. We need to point out that our assessment of social support has been rather
crude compared with more commonly used instruments. According to Cohen and
Wills (Cohen & Wills 1985) a detailed assessment of the availability of interpersonal
resources that are responsive to the needs elicited by specific stressful events is
required to demonstrate a stress-buffering effect. Our question of whether a person
receives ‘help from family and/or others’ points mainly to instrumental support,
which seems especially appropriate when faced with invalidating circumstances such
as a decrease in functional abilities. Although instrumental support and emotional
support are generally not mutually independent, measures of emotional support
may show more pronounced buffering effects with respect to psychological distress
(Oxman et al. 1992;Tijhuis et al. 1995). Nevertheless, both indicators of environmen-
tal vulnerability in our study do show modifying effects that fit the vulnerability-
stress model.
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Although the design of the study is an improvement over previous designs (a
prospective study, incident cases, large numbers, community based, established
measurement instruments and risk factors), there remain some limitations. There
were two measurements of symptomatology covering three years. Therefore, it is
possible that subjects without depression at baseline have been depressed between
measurements and remitted before T1. Episodes with a shorter duration may be
underrepresented in the study. We have also been unable to assess the exact tempo-
ral relations between life events and depression. Studies with more frequent
measurements are needed to explore this in more detail. 
In conclusion, we were able to investigate differential etiologic pathways to geri-
atric depression that have been put forward by other authors. Our findings partially
support the vulnerability-stress model. In the presence of changes in subject’s lives
that lead to a heightened dependency on others, being married, and if unmarried
having social support served as buffers against incident depression. Although both a
personal history of mental disorders and organic vulnerability were predictive of inci-
dent depression in bivariate analysis, we could not show a differential impact of
stress factors in subjects with or without these specific vulnerability characteristics.
Further analysis with a wider set of more detailed stress variables may still show
such effects. It is also possible that, at a later age, these vulnerability characteristics
are more influential on the course of depression than on its incidence. Further stud-
ies on both incidence and course of geriatric depression are therefore needed. If
replicated, these findings may both support and further differentiate our apprecia-
tion of etiologic pathways of depression in later life.
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Abstract
Background
This study examines whether risk factors related to incidence of depression are
also related to prognosis, and whether a vulnerability-stress model can be estab-
lished for prognosis. 
Methods
A prospective model for prognosis of depression (chronic or remitted course) in
later life was studied in 236 depressed community-living elderly. Subjects were
interviewed at baseline, and at follow-up three years later. Bivariate and multivari-
ate relationships between risk factors and chronic depression (GMS-AGECAT)
were assessed. Effect modification was studied between stressors and two types
of vulnerability: vulnerability through a personal history of depression, and gen-
der.
Results
A personal history of depression, baseline functional limitations and incident anx-
iety syndrome predicted chronic depression, whereas life-events occurring
between assessments, and changes in physical, functional or cognitive status did
not. In subjects without a previous history, functional disabilities, male gender
and receiving instrumental support correlated with a poor prognosis. The prog-
nosis for subjects with a personal history of depression was not affected by other
factors. In women, the development of chronicity was more strongly associated
with a personal history than in men, whereas in men recent psychosocial and
health related characteristics were more important than in women.
Limitations
Because the study consisted of two measurements with a three-year interval,
depressive episodes with a short duration may be underrepresented. 
Conclusions
In the elderly, the impact of risk factors on the course of depression is modified
by longstanding vulnerability characteristics, such as a personal history of
depression and gender. More recent life stresses are related to prognosis in sub-
jects without a personal history, and in men. 
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3.1 Introduction
Depression, and especially chronic depression, has a profound negative influence for
late-life physical and social adjustment (Vaillant et al. 1996), health service use
(Beekman et al. 1997;Unutzer et al. 1997) and well-being (Hays et al. 1995;Ormel et
al. 1998;Wells et al. 1989). Still, the majority of depressive elderly in primary care
remain either unrecognised or undertreated (Cole, Bellavance, & Mansour
1999;Henderson et al. 1997;Livingston et al. 1997). Both for clinical and theoretical
purposes, understanding the process that leads to chronicity is of major importance.
Identifying vulnerability factors associated with an untoward course may result in
both a better understanding of the natural history, and in more accurate therapeutic
interventions.
Findings regarding prognostic factors are mainly inconclusive (Cole, Bellavance,
& Mansour 1999). This may be due to methodological differences and limitations of
available studies. Factors potentially associated with chronicity and remittance can
be grouped as depression-related (length and severity of index episode, personal his-
tory), genetic (family history), socio-demographic (age, gender, socio-economic
status, marital status, availability of support), physical (medical illness) and cogni-
tive (mental status, neuroradiological abnormalities) (Alexopoulos & Chester 1992).
Earlier research shows that both length and severity of the index episode and an
early onset of depression are predictive of an unfavourable course, as do comorbid
cognitive symptoms and health-related variables (Beekman et al. 1995;Cole,
Bellavance, & Mansour 1999;Henderson, Korten, Jacomb, Mackinnon, Jorm,
Christensen, & Rodgers 1997;Kennedy, Kelman, & Thomas 1991). Demographic vari-
ables do not appear to influence the course of depression. Life-events and social
support show contradictory effects. 
According to the Brown and Harris etiologic model (Brown & Harris 1978),
depression may be the result of ‘social stress’ factors such as life events (loss) or
long term difficulties, in addition to vulnerability or protective factors. Earlier work
on the AMSTEL cohort (Amsterdam Study on the Elderly) confirmed a higher inci-
dence of depression in subjects with longstanding (a personal history of depression)
and more recent risk factors such as loss of spouse, higher age, untoward health
and comorbid organic and anxiety symptoms (Schoevers et al. 2000a). It was
hypothesised that three types of vulnerability would modify the effect of stressors:
genetic or familial vulnerability, indicated by a personal or family history of mental
disorder, organic vulnerability indicated by cognitive/organic symptoms at baseline
or follow-up, and environmental vulnerability defined as being unmarried and/or not
having social support. Neither a genetic/familial nor organic vulnerability acted as
effect modifiers. Effect modification was apparent only for environmental vulnerabili-
ty. Having a partner, and, if unmarried, having social support, significantly reduced
the association between functional disabilities and the emergence of depression.
The present study seeks to investigate whether similar risk patterns can be found
for the prognosis of late-life depression. A personal history of depression, a family
history, dependence on social and/or professional support, functional limitations,
chronic medical conditions, and comorbid cognitive or anxiety symptoms are there-
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fore hypothesised to predict the development of chronicity. It is also postulated that
stress factors occurring between assessments, such as life events, or changes in
physical, functional or psychiatric comorbidity status, may influence the course of
depression. Prognostic factors may have different predictive power, depending on
specific vulnerability characteristics that may modify its effects. A personal history is
a key variable in many studies on the course of depression. Depression is known to
relapse more easily after each new episode, regardless of the presence of psychoso-
cial stressors (Brown, Harris, & Hepworth 1994). We therefore postulated that
prognostic factors have a stronger impact on chronicity in depressed subjects with-
out a previous history. Likewise, women are consistently found to have higher
depression prevalence levels (Beekman, Copeland, & Prince 1999), and suggestions
have been made about a differential impact of risk factors for depression in men and
women (Sonnenberg et al. 2000;Wolk & Weissman 1995). The sample was therefore
stratified according to the presence or absence of a personal history, and according
to gender.
The present study was performed in a large representative sample of community-
dwelling elderly with a three-year follow-up, incorporating a wide set of risk factors
generally considered to be related to late-life depression.
3.2 Methods
3.2.1 Sampling and non-response
The study was designed as a part of the Amsterdam Study of the Elderly (AMSTEL)
which has been described in more detail elsewhere (Launer, Wind, & Deeg
1994;Schoevers, Beekman, Deeg, Geerlings, Jonker, & Van Tilburg 2000a;van Ojen et
al. 1995). The population base for AMSTEL included all non-institutional individuals
in the 65-84 age bracket who lived in the city of Amsterdam. Of the 4051 subjects
who initially responded 2244 (55,4%) were reinterviewed three years later (median 38
months). In total, 656 (16,2%) persons had died before follow-up, 662 (16,3%) per-
sons refused further participation, 282 (7,0%) were too ill or cognitively impaired to
respond, and 207 (5,1%) were not available for interview due to a variety of reasons.
The study sample consisted of all responders at follow-up who were depressed at
baseline (236 cases).
3.2.2 Measures
A one hour interview was conducted consisting of the Dutch translation of the Mini-
Mental State Examination (Folstein, Folstein, & McHugh 1975), all Geriatric Mental
State Examination-items related to organic, affective and anxiety syndromes
(Copeland, Dewey, & Griffiths-Jones 1986), the Activities of Daily Living (ADL) scale
(Katz et al. 1963), the Instrumental Activities of Daily Living (IADL) scale (Lawton &
Brody 1969), and the CAMDEX-interview (Roth et al. 1986). The interview was
administered during home visits by lay interviewers who were specially trained using
video sessions and regularly supervised. The same GMS-AGECAT package with an
identical algorithm was used in the second wave of the study. When re-interviewing,
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raters were unaware of previous data and diagnoses.
Psychiatric syndromes. Diagnoses of depression, organic caseness and anxiety
were reached using the GMS-AGECAT system (Copeland et al. 1988;Copeland,
Dewey, & Griffiths-Jones 1986). Diagnostic levels 1 and 2 are classified as subcases.
Diagnostic levels 3-5 have been proven valid to detect cases of depression requiring
clinical attention in both the community (Copeland et al. 1992;Copeland, Dewey, &
Griffith-Jones 1990) and in elderly hospital patients (Ames & Tuckwell 1994). AGE-
CAT has proven reliability for epidemiological work (Copeland, Dewey, Henderson,
Kay, Neal, Harrison, McWilliam, Forshaw, & Shiwach 1988). The Dutch language ver-
sion has been proven reliable (Hooijer, Jonker, & Dewey 1991). In the analyses the
diagnostic level depressive disorder was used, with a distinction between neurotic
and psychotic depression. When assessing the impact of comorbidity, syndrome lev-
els were used, as the diagnostic hierarchy in GMS-AGECAT would otherwise bias the
results. Depression caseness at baseline (T0) and follow-up (T1) was defined as a
GMS-AGECAT level 3 or higher. Subjects who were depressed at both T0 and T1 were
classified as having ‘chronic or relapsing depression’. Subjects who were depressed
at T0 but not at T1 were considered remitted.
Prognostic factors. Educational status was dichotomised as lower (primary school
or less) and higher (more than primary school) education. Socio-economic status
was assessed by asking respondents about the highest level of professional occupa-
tion they had reached, and the highest level their partner had reached. The highest
level reached by either the respondent or the partner was taken as the socio-econo-
mic status. Marital status was assessed using the appropriate questions in GMS-
AGECAT. Instrumental support was ascertained by the question: ‘Do you get help
from your children, neighbours or other aquintances?’ If so, respondents were asked
to specify whom they received support from. Professional support was ascertained
by the question: ‘Do you get help from home-care institutions (such as Humanitas,
home-care), or do you get day-care (outpatient care) in a nursing home on a regular
basis?’. Subjects where then asked to specify the kind of home-care or day-care they
received. A personal history of depression was ascertained by the relevant CAMDEX-
question. Onset before the age of 60 was classified as early onset, at age 60 or after
as late onset. For functional disability a cut-off was used of 1 (ADL), or 3 (IADL)
points below the maximum score (ADL 12 and IADL 16 points), following the stan-
dard deviations of 0.98 and 2.77, respectively.
Change variables Changes that occurred between baseline and follow-up were
included separately in the analyses. Change variables were made for social status
(partner loss, relocation), physical health (one or more new chronic diseases) and
functional status (impairment or improvement in ADL/IADL functioning with one
S.D.) or psychiatric comorbidity (incident organic syndrome, incident anxiety syn-
drome).
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3.2.3 Data analysis
Response pattern was analysed using chi-square tests, with depression or no depres-
sion at baseline. To assess stability of diagnostic subcategories over time, wave 1 val-
ues were cross-tabulated against wave 2 values. Bivariate associations of chronicity
with independent variables were assessed calculating relative risks. When the 95%
confidence interval did not include 1, the association was regarded to be statistically
significant. Subjects were then stratified according to the presence of a personal his-
tory of depression and according to gender. A statistically significant difference
between two opposite strata was concluded when the confidence intervals of both
strata mutually excluded the opposite relative risk value. Logistic regression model-
ling was used to assess the effect of comorbidity. Backward stepwise analysis was
used to reach the most parsimonious model. Interaction terms were included for
variables that remained after this procedure, and for variables that were believed to
be of key importance based on a priori notions.
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3.3 Results
3.3.1 Sample characteristics, response pattern
The total non-response has been described earlier (Launer, Wind, & Deeg 1994). At
baseline, 487 subjects had a depression diagnosis (12.0% of the total sample). Of
these, 236 participated in the follow-up study. Attrition consisted of  99 subjects who
had died at follow-up (20.3%), 80 who refused further participation (16,4%), 46 sub-
jects who were ineligible due to illness (9,5%), and 26 who were otherwise unavail-
able (5,3%). Mortality was significantly higher in depressed subjects (Schoevers et al.
2000b), and depressed subjects were also more likely to be ineligible for follow-up
interview due to illness. This pattern remained when excluding subjects with comor-
bid organic syndromes at baseline. There were no significant differences between
depressed and non-depressed subjects with respect to refusal and lack of availability
for other reasons. More detailed bivariate analyses of non-response showed that,
among depressed subjects, nonresponse was associated with higher age, male sex,
ADL and IADL disability, and both lower MMSE and organic syndrome at baseline.
When non-response due to death was excluded from the analysis, only initial IADL
disability and cognitive impairment retained a statistically significant relationship
with response-rate: depressed subjects with these characteristics were at increased
risk to be ineligible at follow-up.
3.3.2 Course of depression
Of the 236 subjects who participated in the follow-up study, 114 (48,3%) had remit-
ted and 122 (51,7%) were again found to be depressed [Table 1]. The prognosis of
neurotic depression (51% chronic or relapsing course) and psychotic depression
(56.3% chronic or relapsing course) was very similar (chi2=0.31, df=1, p=0.58). 
Well                    Subcase            Neurotic          Psychotic
No depression      Well (1589)             1026 (64,6)     380 (23,9)           150 (9,4)         33 (2,1)
Subcase (419)       172 (41,1)               35 (32,2)            86 (20,5)    26 (6,2)
Depressed            Neurotic (204)     60 (29,4) 40 (19,6) 16 (7,8)           88 (43,1)   
Psychotic (32)       9 (28,1) 5 (15,6) )             12 (37,5) 6 (18,8
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TABLE 1: CHRONICITY AND REMITTANCE; STABILITY OF DIAGNOSTIC  
CATEGORIES (all responders, N=2244, % of baseline category)
DIAGNOSIS                            T1:
at baseline:                              No depression                    Depressed
3.3.3 Prognostic factors
Bivariate associations. [Table 2] shows relative risks derived from bivariate analyses
of chronicity with prognostic factors. A personal history of depression, and baseline
functional (ADL) limitations predicted chronicity of depression. Among the changes
occurring between assessments (change variables), only incident comorbid anxiety
syndrome was associated with chronicity of depression.
Stratification according to personal history of depression. In subjects with a per-
sonal history, only incident anxiety was associated with chronicity [Table 3], first col-
umn). In subjects without a personal history of depression, chronicity was associat-
ed with male gender, with receiving instrumental support, with baseline ADL or IADL
disabilities and with incident anxiety (Table 3, second column). A statistically signifi-
cant difference between the opposite strata was found for two variables: a family his-
tory of psychiatric disorder and gender. Both a family history and male gender
showed significantly higher relative risks for developing chronic or relapsing depres-
sion in subjects without a personal history.
Stratification according to gender. Stratification for gender revealed that a person-
al history of depression, baseline functional (ADL) limitations, and incident anxiety
syndrome had a significant impact in women (Table 3, third column), whereas
receiving instrumental support, IADL disability, loss of spouse, new IADL disabilities
and both incident organic and anxiety syndrome were predictive of chronicity in men
(Table 3, fourth column). Statistically significant differences between these two strata
were found for a number of variables. A personal history of depression was a signifi-
cantly stronger predictor of chronicity in women than in men, whereas higher age,
less education, being unmarried, IADL disabilities, loss of spouse, IADL impairment
between assessments, and incident organic syndrome were stronger predictors in
men than in women.
Logistic regression. Logistic regression analysis of chronicity was performed on
the following baseline variables; age, gender, educational status, marital status, func-
tional limitations (ADL/IADL), instrumental support, professional support, personal
history of depression, family history, chronic diseases, organic syndrome and anxiety
syndrome. Three variables were significantly associated with chronic or relapsing
depression (p<0.05). Stepwise logistic regression revealed the same variables: per-
sonal history (OR 1.86; p=0.037), ADL disability (OR 2.20; p=0.007) and lower edu-
cation (OR 0.56; p=0.030). Since we also expected gender to be significantly associ-
ated with the course of depression, this factor was added to the model to determine
whether there were any significant interactions that influenced these findings. This
yielded an interaction between personal history and gender (p=0.046), and none
between any of the other variables (personal history, gender, ADL impairment, edu-
cational status). These results confirm the earlier stratification along these lines that
was based on a priori notions.
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PROGNOSTIC FACTORS                       N (exposed)      CHRONIC / RELAPSING 
DEPRESSION (122)  
1: VULNERABILITY
Personal  history of depression              75 1.35 (1.06-1.71)
Family history of psych disorder             44 1.07 (0.79-1.45)
2. DEMOGRAPHIC VARIABLES
Age >74 yrs                                           126 0.96 (0.75-1.23)
Sex: Female                                           200                  0.92 (0.67-1.27)
Education; Primary School & less           111 0.84 (0.65-1.08)
Socio-economic status: Low                  131 1.04 (0.81-1.34)
Unmarried/divorced/widowed               152                    0.90 (0.70-1.16)
Instrumental Support                            65 1.24 (0.96-1.59)
Profess. Support                                   67 1.23 (0.96-1.58)
3: PHYSICAL/FUNCTIONAL STRESS 
Chronic (baseline)
Chronic diseases                                  147 1.07 (0.83-1.39)
ADL disability                                       82 1.44 (1.14-1.83)
IADL disability                                       60 1.28 (0.99-1.64)
4: CHANGES TO-T1; LIFE EVENTS
Partner died                                          21 0.91 (0.57-1.46)
Relocation                                             47 0.93 (0.68-1.29)
New ADL disability                               69 0.94 (0.71-1.24)
New IADL disability                               35 1.06 (0.76-1.48)
New chronic diseases                            56 1.14 (0.87-1.50)
Positive changes T0-T1
ADL functional improvement                 26 1.30 (0.96-1.78)
IADL functional improvement                11 0.87 (0.45-1.69)
5: PSYCHIATRIC COMORBIDITY
Comorbidity at baseline
Organic syndrome                                 15 1.02 (0.67-1.56)
Low MMSE (<24)                                  18 1.04 (0.71-1.53)
Anxiety syndrome                                  35 1.20 (0.93-1.54)
New (emergent) comorbidity
New Organic syndrome                         29 1.13 (0.85-1.51)
New Anxiety syndrome                         35 1.64 (1.38-1.95)
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TABLE 2: FACTORS PREDICTING CHRONICITY 
bivariate analyses with Relative Risks (95% c.i.) (N=236) 
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1: VULNERABILITY
Personal  history 1.55 (1.20-2.00 )        0.57 (0.25-1.31 )
Family history            0.75 (0.46-1.23)  1.30(0.89-1.90 )    1.01 (0.71-1.44 )        1.29(0.71-2.31 )
2: DEMOGRAPHICS
Age >74 yrs 1.01  (0.71-1.43 ) 0.98(0.70-1.37 )        0.85(0.65-1.12 )        1.86 (0.97-3.54)
Sex: Female 1.85  (0.83-4.11 ) 0.68(0.48-0.96)
Lower Education           0.75 (0.51-1.09 )       0.91(0.65-1.26 )         0.77(0.59-1.02 )      1.40 (0.80-2.45)
S.E.S.Low    0.90(0.64-1.27) 1.11 (0.79-1.55 )        0.96(0.73-1.26 )    1.66 (0.84-2.71)
Unmarried 0.99(0.70-1.41 ) 0.91 (0.64-1.29)    0.81(0.62-1.07 )     1.53 (0.85-2.75)
Instrumental Support  0.97(0.64-1.47) 1.44 (1.05-1.99 )     1.13 (0.84-1.51 )       1.86 (1.10-3.14)
Professional Support 1.09 (0.75-1.58) 1.33 (0.95-1.85 )         1.19 (0.91-1.58 )        1.50 (0.87-2.59)
3: PHYSICAL/ FUNCTIONAL STRESS  
Chronic diseases 1.03 (0.71-1.49) 1.08 (0.76-1.52 )        1.05 (0.79-1.40)    1.17 (0.60-2.26)
ADL disability 1.28 (0.91-1.79) 1.56 (1.13-2.14 )        1.41 (1.08-1.83 )     1.64(0.95-2.82)
IADL disability 1.13 (0.76-1.66) 1.41 (1.02-1.95 )       1.16 (0.87-1.55 )     2.00 (1.24-3.23)
4: CHANGES TO-T1
Partner died 1.07 (0.65-1.77) 0.70 (0.31-1.58)         0.81(0.47-1.40)     1.89 (1.38-2.60)
Relocation 1.04 (0.70-1.56) 0.83 (0.52-1.33)        0.89(0.63-1.27)       1.25 (0.65-2.41 )
New ADL disability 0.97 (0.67-1.41) 0.87 (0.58-1.29)   0.90(0.66-1.24)    1.08 (0.59-1.97)
New IADL disability 0.85 (0.48-1.50) 1.20 (0.79-1.81)        0.94(0.64-1.39)    2.00 (1.41-2.83)
New chronic diseases   0.94 (0.63-1.42) 1.26 (0.89-1.80)    0.89(0.63-1.27 )       0.88 (0.41-1.88)
Positive changes T0-T1
ADL improvement 1.30 (0.81-2.10) 1.40 (0.95-2.05)    1.29(0.91-1.82 )    1.41 (0.74-2.71 )
IADL improvement 0.62 (0.21-1.85 ) 1.08 (0.48-2.44)   0.87(0.41-1.82 )    0.89 (0.22-3.70)
5: PSYCHIATRC COMORBIDITY
Comorbidity at baseline
Organic 
syndrome 0.47 (0.10-2.37) 1.25 (0.82-1.91 )        1.01 (0.62-1.65 )       1.03 (0.45-2.38)
Low MMSE (<24) 0.56 (0.19-1.67) 1.30 (0.88-1.93 )         0.99(0.62-1.58)  1.18 (0.63-2.19)
Anxiety syndrome 1.10 (0.79-1.51) 1.17 (0.78-1.75 )     1.21(0.92-1.59)      1.18 (0.63-2.19)
New  comorbidity
Organic                      0.96 (0.59-1.57 ) 1.23 (0.86-1.75 )         1.07(0.77-1.49)       1.62 (1.24-2.11 )
Anxiety                        1.62 (1.33-1.96) 1.60 (1.23-2.07 )    1.67 (1.38-2.02)      1.49 (1.00-2.2
TABLE 3: STRATIFIED ANALYSES OF CHRONICITY Relative risks (95% c.i.)
RISK FACTORS  (n) Chronic / relapsing
depression
with personal his-
tory (47)
Chronic / relapsing
depression        
no personal history
(75)
Chronic / relapsing
depression 
women (102)
Chronic / relaps.
depression
men (20)
3.4 Discussion
In this study of a large sample of community-dwelling elderly, depression was found
to have an unfavourable, chronic or relapsing course in approximately half of the
cases. 
Only a limited number of variables shown to be relevant for the incidence of
depression were found to predict a chronic course. Stratified analysis showed impor-
tant differences in the likelihood to develop chronic depression between men and
women, and between subjects with or without a personal history of depression.
Different risk patterns for incident and chronic depression
In our earlier study on the emergence of depression, a substantial influence was
demonstrated not only of a personal history, but also of baseline health related fac-
tors, negative life events and a decline of physical health and functional status prior
to the onset of depression (Schoevers, Beekman, Deeg, Geerlings, Jonker, & Van
Tilburg 2000a). The current study shows that, once a depression is present, such
recent life events and changes in health appear to have less influence with regard to
prognosis, which is mainly depending on long-standing vulnerability. Kraepelin
(Kraepelin 1913) already described the phenomenon of sensitisation and kindling-
effects in mental disorders. Depression is considered to be a recurrent disease, that
after each new episode tends to relapse more easily regardless of the presence of
psychosocial stressors (Brown, Harris, & Hepworth 1994;Dolan et al. 1985;Ezquiaga,
Ayuso Gutierrez, & Garcia 1987;Zis & Goodwin 1979). In this study, depressed sub-
jects were stratified according to the presence or absence of a personal history, and
it was expected that prognostic factors would have a stronger impact on chronicity
in subjects without a previous history. This proved to be the case. In subjects with a
previous history, none of the prognostic factors showed a statistically significant pre-
dictive effect, except for incident anxiety, which was associated with chronicity in all
strata. In subjects without a previous history however, baseline functional (ADL and
IADL) disabilities, male gender and receiving instrumental support correlated with
chronicity. As having instrumental support was associated with IADL disabilities
(P<0.001), it may be fair to conclude that, in the elderly, a first onset depression is
more likely to become chronic in the context of circumstances that make people
more dependent on others. Depressed subjects with longstanding vulnerability how-
ever develop chronic depression regardless of co-occurring risk-factors. 
Gender differences
Women are consistently found to have higher prevalence levels of depression than
men. As we did not find a higher incidence of depression in elderly women in an ear-
lier study on this subject (Schoevers, Beekman, Deeg, Geerlings, Jonker, & Van
Tilburg 2000a), the prognosis of depression was expected to be worse in females. In
the current study, this was not confirmed. Women with a depression at baseline did
not develop a chronic course more often than depressed men. Stratification for gen-
der however did show differences between the sexes. In men, the development of
chronicity is associated with a number of demographic (higher age, lower educa-
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tion), social (without marital partner, receiving instrumental support) and health
related characteristics (functional disability, cognitive decline) or loss events (of
spouse). These characteristics appear to undermine their ability to cope, and may be
of a recent origin. In women, only a personal history of depression and functional
disabilities were associated with chronicity. This suggests that the risk profile in
females is more longstanding and possibly endogenous, with a much lower impact
of recent psychosocial stressors or changes in health. Gender differences are also
apparent in the consequences of late-life depression, such as excess mortality.
Depressed men are more likely to die, even when experiencing relatively mild levels
of depression (Penninx et al. 1999;Schoevers, Geerlings, Beekman, Penninx, Deeg,
Jonker, & Van Tilburg 2000b). The higher prevalence levels of depression in women
may therefore be the result of both an interaction between personal history of
depression and gender, and of the fact that depressed elderly women are more likely
to survive than depressed elderly men.
Depression and anxiety
The only risk factor that showed a stable and statistically significant association with
chronicity in all strata was incident anxiety syndrome. This is of interest, as it has
been suggested that anxiety and depression may both be manifestations of a com-
munal underlying condition (Tyrer 1996). Earlier studies in adults have shown high
correlations between anxiety and depression (Goldberg & Huxley 1992;Kessler et al.
1994;van Balkom et al. 2000), and recent cross-sectional research in the elderly con-
firmed such symptom overlap in the age group under study (Beekman et al. 2000).
Our prospective data show that co-occurring anxiety symptoms are also associated
with an untoward course of depression. More detailed analysis of the exact symp-
toms of anxiety that are associated with chronic depression may further our insight
into this relatively new area of research.
Severity of depression and chronicity
Interestingly, the development of chronicity did not depend on the severity of the
index episode. In our study, more severe psychotic depressions had a chronic or
relapsing course a little more often than neurotic depressions (56% vs. 51%), but
this difference was not statistically significant. This finding once more underlines the
clinical importance of so-called minor levels of depression identified in community
based studies, which often do not meet the criteria for major depressive disorder
(Pincus, Davis, & McQueen 1999).
Limitations
A limitation of the current study is the fact that levels of symptomatology were
assessed with a three-year interval. An unknown number of subjects may have expe-
rienced both remittance and relapse in the meantime. This may influence our results
and lead to an overestimation of the importance of chronic depression. Hoewever,
an extensive review and meta-analysis by Cole et al. (Cole, Bellavance, & Mansour
1999) also showed the level of chronicity at 24 months follow-up to be almost 50%
of those still alive. Recent studies with more frequent measurements (Geerlings et
al. 2000;Sharma et al. 1998) suggest that the majority of these subjects indeed has a
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chronic course. 
Another potential limitation is the fact that this study is a naturalistic follow-up in
the community, not controlling for ongoing treatment that may have affected the
results. Literature shows that recognition of depression in comparable samples of
community living elderly is generally poor, with the majority of depressed subjects
not receiving any specific treatment for their depressive complaints (Beekman,
Copeland, & Prince 1999;German et al. 1987). The current study is no exception to
this. Only 12% of the depressed subjects were using any ‘medication for nervous
complaints’, and the majority of these subjects no doubt were not using antidepres-
sant medication but other pharmacological agents such as benzodiazepines. There
was no relationship between such medication use and the outcome measure of this
study. According to this study it appears fair to conclude that in community dwelling
elderly treatment for depression is usually not given at all, and if given, it is often
inadequate.  
Thirdly, selective attrition to the follow-up assessment of the study has probably
occurred among the very frail. Depressed subjects were more likely to die, and
depressed subjects with functional disabilities or cognitive impairment were more
likely to be too ill to respond at follow-up. Most probably, the prognosis of depres-
sion in these subjects is worse than in those that were included in the study.   
Conclusions
The main finding of the current study is that risk profiles for emerging depressive
syndromes and for the development of chronicity are distinctly different and consid-
erably affected by both longstanding vulnerability and gender. In women, a personal
history of depression, which probably is largely biologically determined, is most
influential when predicting chronicity. In men however, chronicity may also be the
consequence of a number of demographic, social and physical circumstances that
can be of a more recent origin. This interaction between gender and longstanding
vulnerability has not previously been described in a community based study such as
ours, and may, if replicated, further our insight into the natural history of late-life
depression.
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Abstract
Background
Depression and generalised anxiety disorder frequently overlap. The question
remains unresolved whether these are specific disorders, or that they represent
different dimensions of a single disorder. Although both are highly prevalent dis-
orders in this age group, studies on this issue in the elderly are scarce. Research
is needed that investigates patterns of comorbidity and possibly different risk
profiles for pure depression, pure generalised anxiety and mixed anxiety-depres-
sion in older people.   
Methods
GMS-AGECAT diagnoses were obtained from 4051 community living older per-
sons. Comorbidity was studied along a severity gradient for men and women sep-
arately. Multivariate analysis of risk factors included demographic variables, envi-
ronmental vulnerability, longstanding vulnerability, physical/functional stresses
and gender.
Results
The prevalence of pure depression was 12.2%, pure generalised anxiety 2.9%,
mixed anxiety-depression 1.8%. Comorbidity increased with higher severity levels
of both depression and generalised anxiety. Comorbidity was twice as likely in
women than in men. Different risk profiles for diagnostic categories were not
demonstrated for concurrent risk factors. Longstanding vulnerability was associ-
ated significantly stronger with mixed anxiety-depression than with pure anxiety
and pure depression. Mixed anxiety-depression was overrepresented in women.
Conclusions
Both lines of investigation suggest that, in the elderly, a dimensional classifica-
tion is more appropriate than a categorical classification of depression and gen-
eralised anxiety. Mixed anxiety-depression is a more severe form of psychopathol-
ogy that is almost specific to women in this age group. 
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4.1 Introduction
Co-occurrence of depression and anxiety is a consistent finding across the life cycle,
and is associated with a poorer prognosis (Regier et al. 1998). Patients suffering
from both depression and anxiety disorders experience greater functional disability
(Bijl & Ravelli 2000) and utilise services more heavily than persons with a single
disorder (Kessler et al. 1994). Comorbidity is also associated with a more persistent
illness course, in adults (Liebowitz et al. 1990) as well as in the elderly (Schoevers et
al. 2003).
Classification of depression and anxiety as distinct forms of psychopathology has
been disputed (Tyrer 1996). Generalised anxiety disorder in particular may lie on a
continuum with depression (Liebowitz, Hollander, Schneier, Campeas, Fallon,
Welkowitz, Cloitre, & Davies 1990). Diagnostic thresholds may differentiate cate-
gories of ‘pure’ depression, ‘pure’ generalised anxiety or mixed anxiety-depression
that represent the same disorder but at a different level of severity or at a different
stage of development.
A second possibility is that depression and anxiety are different entities, associat-
ed with different sets of risk factors. Earlier research in adults confirmed shared
genetic factors associated with both depression and generalised anxiety disorder, but
suggested that environmental experiences determine the actual development of
either condition (Kendler 1996).
Although generalised anxiety appears to be the most prevalent anxiety disorder in
the elderly (Beekman et al. 1998;Flint 1994), studies comparing severity levels and
risk factors with geriatric depression are scarce (Beekman et al. 2000). The current
study first investigates the diagnostic threshold hypothesis, and then assesses whe-
ther ‘pure’ depression, ‘pure’ generalised anxiety disorder, and mixed anxiety-depres-
sion have similar or different risk profiles. A distinction was made between long-
term vulnerability factors, concurrent environmental vulnerability and stress. As gen-
der differences have been described with regard to both depression and anxiety
disorders in the elderly (Schaub & Linden 2000;Schoevers et al. 2000b;Sonnenberg
et al. 2000), gender specific patterns were assessed.
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4.2 Methods
4.2.1 Sampling and non-response
The Amsterdam Study of the Elderly (AMSTEL) is a longitudinal study of a large and
representative sample of non-institutionalised community living older persons on
mental health problems, medical diagnoses and demographic characteristics. The
sampling and data collection procedures have been described elsewhere (Launer et
al. 1993;Schoevers et al. 2000a). In short, the population base for AMSTEL included
all non-institutional individuals in the 65-84 age bracket who lived in the city of
Amsterdam. The profile of the study sample corresponded to the non-institution-
alised Amsterdam population in terms of age and gender. An age-stratified sample
was drawn. All 4051 subjects (71.5%) who responded and gave their informed con-
sent were interviewed at baseline. Non-response in the younger old (<75) was asso-
ciated with poor performance on cognitive tests and with health problems. In the
older old no correlates of non-response were found (Launer, Wind, & Deeg 1994).
The study sample for this study consisted of all subjects not meeting criteria for
organic caseness.
4.2.2 Measures
A one hour interview was conducted consisting of the Dutch translation of the Mini-
Mental State Examination (Folstein, Folstein, & McHugh 1975), Geriatric Mental
State Examination (GMS) items related to organic, affective and anxiety syndromes
(Copeland, Dewey, & Griffiths-Jones 1986), the Activities of Daily Living (ADL) scale
(Katz et al. 1963), the Instrumental Activities of Daily Living (IADL) scale (Lawton &
Brody 1969), and the CAMDEX-interview (Roth et al. 1986). The interview was
administered during home visits by lay interviewers who were specially trained using
video sessions and regularly supervised.
Psychiatric syndromes. Diagnoses of depression, organic caseness and gener-
alised anxiety were reached using the GMS-AGECAT system (Copeland et al.
1988;Copeland, Dewey, & Griffiths-Jones 1986). GMS-AGECAT generates both syn-
drome levels and hierarchically defined diagnostic levels. In the analyses syndrome
levels were used, as comorbidity was the specific interest of this study. GMS-AGE-
CAT case levels represent levels of increasing severity of the disorder, with case level
5 indicating the most severe end of the spectrum (Copeland et al. 1987;Copeland et
al. 1992;Copeland, Dewey, & Griffith-Jones 1990). Case levels 1 and 2 are classified
as subcases. Levels 3-5 have been proven valid to detect cases requiring clinical
attention in the community. AGECAT has proven reliability for epidemiological work
(Copeland, Dewey, Henderson, Kay, Neal, Harrison, McWilliam, Forshaw, & Shiwach
1988), as has its Dutch language version (Hooijer, Jonker, & Dewey 1991).
Depression and generalised anxiety caseness were defined as a GMS-AGECAT level 3
or higher. Subjects meeting GMS criteria for depression and not meeting GMS crite-
ria for generalised anxiety were classified as ‘pure depression’ (DEP). Subjects with
GMS generalised anxiety without depression caseness were classified as ‘pure gener-
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alised anxiety’ (ANX). Subjects meeting GMS criteria for both depression and anxiety
(with GMS-AGECAT levels higher than 2 for both conditions) were labelled ‘mixed
anxiety-depression’ (ANXDEP). 
Demographic variables. Potentially confounding covariates were age, level of edu-
cation and socio-economic status. Educational status was dichotomised as lower
(primary school or less) and higher (more than primary school) education. 
Vulnerability factors. Marital status was assessed using the appropriate questions
in GMS-AGECAT. Social support was ascertained by the question: ‘Do you get help
from your children, neighbours or other acquaintances?’ If so, respondents were
asked to specify whom they received support from. Professional support was ascer-
tained by the question: ‘Do you get help from home-care institutions, or do you get
day-care (outpatient care) in a nursing home on a regular basis?’ Subjects where
then asked to specify the kind of home-care or day-care they received. A personal
history of depression and/or generalised anxiety disorder was ascertained by the rel-
evant CAMDEX-question. The question was considered affirmative if treatment had
been requested. Age at first onset was recorded. A personal history of depression or
anxiety was treated as longstanding vulnerability with possible biological origins,
whereas marital status, social support and professional support were considered as
more concurrent, environmental vulnerability characteristics. 
Stress factors. The presence of chronic diseases was assessed with the pertinent
Camdex questions on cardiovascular diseases, cancer, lung disease, diabetes,
Parkinson’s disease, arthritis and epilepsy. Cognitive status was assessed by MMSE-
score. Subjects were considered to have functional disability if their ADL or IADL
scores were two or more points below the maximum score on the respective scales
(ADL 12 and IADL 16 points). This signifies that subjects were ‘in need of help’ to
perform at least two of the tasks in the respective domains.
4.2.3 Data analysis
Baseline sample characteristics were assessed, including prevalence levels of depres-
sion, generalised anxiety and organic caseness. In the study sample, excluding
organic cases, comorbidity of depression and generalised anxiety was directly calcu-
lated form GMS data using the Mantel-Haenszel chi-square test for linear associa-
tion, with specification of GMS-AGECAT severity levels. This procedure was then
repeated after stratification for gender, in order to determine whether comorbidity
patterns differed in men and women. Bivariate associations of DEP, ANX and
ANXDEP with independent variables were assessed calculating relative risks (results
not shown). In order to control for confounding due to associations among risk fac-
tors, multivariate analyses, using logistic regression modelling, were carried out in
each of the diagnostic categories using the same set of risk factors. The control
group for these analyses was composed of all subjects without either depression or
anxiety. Backward stepwise analysis was used to reach the most parsimonious model
for each diagnostic category.
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TABLE 1: SAMPLE CHARACTERISTICS
VARIABLES N (%) Mean Standard deviation
Full sample 4051
AGE 65-69                         836 (20,6)        74.35 5.73
70-74                         974 (24,0)
75-79                        1050 (25,9) 
80-86                         1191 (29,4)
SEX Male                         1523 (37,6)                     
Female 2528 (62,4)
EDUCATION             Higher than PS          2335 (57,6)
P.S. or less 1716 (42,4)
MARITAL STATUS Married                    1970 (48,6)
Not/no longer           2078 (51,3)
SOCIAL SUPPORT No/little                     3209 (79,2)
Help from others 842 (20,8)
PROFESSIONAL  None                         3351 (82.7) 
SUPPORT Receiving P.S. 700 (17.3)  
PERSONAL                None                         3449 (85,1)
HISTORY Yes 602 (14.9)
CHRONIC                 One                        1894 (46,8)
DISEASES None                         1390 (34.3)
Two or more 767 (18.9)
ADL FUNCTION Able                         3726 (92.0)       11.63               0.98
Disabled 325  (8.0)
IADL FUNCTION Able 3012 (74.4)       14.60              2.77
Disabled 1039 (25.6)
MMSE SCORE 26-30                         3281 (81,0)       26.94             3.81
22-25                         522 (12,9)
0-21                           248  (6,1)         
ORGANIC None                        3790 (93,6)
SYNDROME Case                          261   (6,4)
DEPRESSION None                         3528 (87,1)
Case                          523  (12,9)
GENERALISED None                       3923 (96,8)
ANXIETY Case                          128  (3,2)
MIXED ANXIETY- None                         3975 (98.1) 
DEPRESSION Case 76 (1.9) 
4.3 Results
4.3.1 Sample characteristics
The demographic and functional profiles of the full sample are presented in [Table 1].
Depression was present in 523 subjects (12.9%), generalised anxiety in 128 (3.2%)
subjects, and 261 (6.4%) were organic cases. For this study, subjects with organic
disorder were omitted, yielding a study sample size of 3790. Cross tabulation of
depression with generalised anxiety in the study sample showed that 14.5% of the
depressed subjects also met criteria for generalised anxiety, as opposed to 1.3% in
non-depressed subjects. Subjects with generalised anxiety were concurrently
depressed in 60.4%, whereas depression prevalence was 10.8% in subjects not
meeting criteria for generalised anxiety (chi-square 247.2, df 1, p<0.0001). 463 sub-
jects were classified as DEP (12.2%), 111 had ANX (2.9%), and 67 (1.8%) had
ANXDEP. 
4.3.2 Comorbidity associated with 
severity of psychopathology
Cross tabulation of overlapping symptoms and severity levels [table 2] shows that
comorbidity levels of generalised anxiety in depression at D1 and D2 (subcase levels)
are low, and then steeply increase across severity levels from 11.1% in DN3 (neurotic
depression) to 40% in DP4 (psychotic depression). Conversely, depression is a
comorbid condition in 25% and 17.6% of anxiety subcases, but rises from 56% to a
100% with increasing severity levels in generalised anxiety cases. Thus, a parallel and
highly statistically significant increase in comorbidity is found along a gradient of
severity in both depression and generalised anxiety (Mantel-Haenszel test for linear
association 577.7, p<0.0001). 
Repeating the analysis after stratification for gender showed that this pattern of
increasing severity in both disorders was reproduced and remained statistically high-
ly significant in both men and women. However, women showed levels of comorbid-
ity that were 50 to 100% higher than those in men at all severity levels of both
depression and generalised anxiety.
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Depression  diagnostic levels (n)    Percentage with comorbid generalised anxiety
All                    Men Women
D0; no depression(2537)                0.4 %                 0.1 % 0.7 %
D1; subcase level (410)                   3.2 %                       
D2; subcase level (380) 5.3 %
DN3; neurotic depression (349) 11.1 %             
DN4; neurotic depression (62) 23 %
DP3; psychotic depression (37) 22 %                       
DP4; psychotic depression (15) 40 %
Depression in generalised anxiety disorder
Generalised anxiety                        Percentage with comorbid depression
diagnostic levels (n)
All Men Women
A0 no anxiety (1916) 2.5 %              1.4 % 3.6 %
A1 subcase level (513) 25 %              
A2 subcase (1250) 17.6 %
A3 case (70) 56 %              
A4 case (36) 64 %
A5 case (5) 100 %
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TABLE 2: COMORBIDITY OF DEPRESSION AND 
GENERALISED ANXIETY DISORDER
(GMS caselevels with increasing severity of disorder, n=3790)
Generalised anxiety in depression
30 % 4.7 %
14.1 %
33.3 %
7.7 %
} —
}
}
}
}
}
14.1 %
42.9 %
21.9 %
62.9 %
}
}
}
}
4.3.3 Risk factor analyses
Logistic regression modelling, with backward stepwise analysis, was used to reach
the most parsimonious model in each diagnostic category using the same set of risk
factors. The control group consisted of all subjects without either depression or anxi-
ety [Table 3]. Odds ratios were calculated for the remaining variables in the best fit-
ting model for each of the diagnoses.         
Overall, there was a trend towards higher odds ratios in ANX and ANXDEP than
in DEP. Among the demographic variables, higher age was negatively associated
with ANXDEP. Being unmarried was associated with the presence of DEP, but was
inversely related to ANX. As being unmarried has been suggested to affect men and
women differently (Wolk & Weissman 1995), we have also assessed whether stratifi-
cation for gender and repeating the multivariate analyses in men and women sepa-
rately would yield differences in this domain. Being unmarried remained associated
with pure depression in both men and women, but the negative association of being
unmarried with pure anxiety was no longer apparent in either sex. Of the other envi-
ronmental vulnerability characteristics, having professional support was associated
with ANXDEP. Social support was not associated with any of the diagnostic cate-
gories.
Longstanding vulnerability effects, as indicated by a personal history of depres-
sion or anxiety disorder, was highly statistically significant, with a steep increase of
the impact of this type of vulnerability going from DEP to ANX to ANXDEP. The con-
fidence intervals of the odds ratios for a personal history and gender in ANXDEP and
DEP mutually excluded the opposite value, indicating a statistically significant differ-
ence between strata on these domains.
Stress factors were significantly and similarly associated with all three diagnostic
categories. Although chronic diseases were not related to ANXDEP, and IADL dis-
ability was not associated with ANX, a clear pattern of differences between strata
could not be demonstrated. Physical and functional stresses thus appeared to have a
similar impact in all three diagnostic categories.
Gender differences were rather pronounced, and the pattern of increasing odds
ratios across categories paralleled that of a personal history. The association
between being female and the presence of ANXDEP was the strongest, and signifi-
cantly different from the odds ratio of gender with DEP. The value in ANX was exact-
ly between these extremes, suggesting a stepwise increase in the impact of this fac-
tor across categories.   
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RF Depression         Anxiety                  Mix
Age > 74                                                                                  0.53 (0.30-0.91)
Ed; Primary or less
Unmarried 1.47 (1.16-1.87)      0.51 (0.27-0.97)
Social support
Professional support                                                                 1.84 (1.03-3.28)
Personal history 2.47 (1.91-3.19)    4.11 (2.16-7.81)      5.94 (3.54-9.96)
Chronic diseases 1.51 (1.20-1.89)   2.39 (1.18-4.83)
ADL disability 2.27 (1.62-3.18)     3.50 (1.64-7.48)       2.48 (1.27-4.87)
IADL disability 1.74 (1.36-2.23)                                   2.67 (1.49-4.81)
MMSE < 26 1.49 (1.13-1.96)    2.66 (1.34-5.26)      2.26 (1.24-4.11)
Sex: female 2.06 (1.57-2.72)     3.73 (1.65-8.46)        5.53 (2.36-13.00)
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TABLE 3: MULTIVARIATE ANALYSIS; BEST FITTING MODEL FOR EACH DIAGNOSTIC CATEGORY
Control group without depression and anxiety (O.R. with 95 % C.I.,
stepwise logistic regression, backstep, P out < 0.05)
4.4 Discussion
The present study sought to investigate whether, in a large epidemiological sample
of community living elderly, generalised anxiety disorder and depression are best
described as distinct diagnostic entities or whether a dimensional classification is
more appropriate. To do so, two hypotheses were studied. The first hypothesis was
that depression and generalised anxiety are on a continuum, with diagnostic thresh-
olds differentiating categories of ‘pure’ depression, ‘pure’ generalised anxiety or
mixed anxiety-depression that essentially represent the same disorder. Different lev-
els of severity, or different stages of development, may thereby be responsible for
classification as different nosological entities. The second hypothesis was, that
depression and anxiety are in effect different entities, likely to be associated with dif-
ferent sets of risk factors that for both clinical and theoretical reasons should be dis-
cerned form each other. Lastly, gender differences were studied, as a large body of
research suggests not only different prevalence levels but also distinct risk profiles
for men and women.  
The current study is the first community based study among the elderly that we
know of that uses GMS-AGECAT data on prevalence of depression and generalised
anxiety disorder to compare both severity levels and risk profiles for these condi-
tions. It is important to note that case finding of elderly subjects with depression
and/or anxiety disorders by the health services is generally poor. Notwithstanding
the considerable amount of suffering that is associated with these conditions, the
majority do not receive any treatment at all (German et al. 1987). Previous research
has shown that a substantial number of primary care patients have a non-specific
pattern of both anxious and depressed symptoms not meeting current definitional
thresholds, but associated with significant distress or impairment (Zinbarg et al.
1994). These ‘subthreshold mental disorders’ (Pincus, Davis, & McQueen 1999) as
they are found in the community are identified with instruments such as GMS-AGE-
CAT. 
In contrast with other diagnostic instruments, GMS-AGECAT not only allows to
validly diagnose large numbers of community living elderly, but it also attributes lev-
els of caseness signifying increasing severity levels of psychopathology with a clear
distinction between cases and subcases. Screening instruments that measure symp-
toms allow comparisons of severity, but do not make valid diagnoses. Diagnostic cri-
terion instruments are often more time and personnel consuming, and do not usual-
ly attribute severity- or caselevels to subjects with valid diagnoses. These rather
unique diagnostic properties of GMS-AGECAT are well tailored to compare severity
levels of comorbid psychiatric conditions in large samples such as ours.
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Severity levels of depression and generalised anxiety disorder in mixed anxiety-depres-
sion
The first hypothesis, on a dimensional classification of depression and generalised
anxiety, appears to be largely supported by the data of this study. In this sample of
community living elderly, higher severity levels of both disorders were associated
with higher co-occurrence of the comorbid condition. More severely depressed sub-
jects are more liable to have more severe generalised anxiety symptoms and vice
versa. This parallel trend suggests a solid common ground for the two conditions,
and can be seen a strong argument favouring a dimensional instead of a categorical
diagnostic classification. As mixed anxiety-depression is on the most severe end of
both the depression and the generalised anxiety spectrum, this underlines the
importance of including both symptom clusters when studying late life psychiatric
disorders. Most studies so far have not done this (Beekman, de Beurs, van Balkom,
Deeg, Van Dyck, & Van Tilburg 2000), and data on overlap between generalised anxi-
ety disorder and depression in the elderly are relatively scarce (Flint 1994). A study
by Lindesay et al. (Lindesay, Briggs, & Murphy 1989) found that 91% of persons with
generalised anxiety disorder also had ‘depressive symptoms’, whereas a community
study by Beekman et al. (Beekman, de Beurs, van Balkom, Deeg, Van Dyck, & Van
Tilburg 2000) showed that among elderly subjects with anxiety disorders 26.5% also
met stricter criteria for major depression. The current study underlines the high co-
occurrence of these disorders also in the elderly, as 60.4% of subjects with clinically
relevant generalised anxiety symptoms were also having a depression diagnosis.
The prevalence rate of 12.9% for GMS depression found in the current study, is well
within what has been found in a larger number of community based studies on
depression in the elderly. Prevalence levels of depressive syndromes requiring clini-
cal attention generally range around 13.5% (Beekman, Copeland, & Prince 1999).
Prevalence rates of generalised anxiety in the same age group are much less fre-
quently described, and vary from 0.7% to 7.1%, (Flint 1994). The percentage of 3.2%
in the current study thus appears to be well within the range of earlier findings also.
Although more studies in the age group are needed to confirm the patterns of
increasing comorbidity along severity lines found in this study, the prevalence levels
found for depression and generalised anxiety suggest that these findings may very
well be reproduced in future work.
Risk profiles in different diagnostic categories
Our second research question was to determine whether pure depression, pure gen-
eralised anxiety disorder, and mixed anxiety-depression may have different risk pro-
files. If differential risk patterns are found this could be important for clinical rea-
sons, but it may also further our understanding of the nosology of both conditions.
Following the findings by Kendler et al (1996), it was hypothesised that long-term
vulnerability factors would be associated with both depression and anxiety symp-
toms, whereas more recent stress and vulnerability characteristics would be specifi-
cally associated with either category of psychopathology.
In this study longstanding vulnerability, exemplified by a personal history, was
found to be associated with both depression and generalised anxiety. As may be
expected in more severe psychopathology, the associations were much stronger in
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mixed anxiety-depression than in pure depression. However, also in pure generalised
anxiety disorder longstanding vulnerability was considerably higher than in pure
depression. Longitudinal research is needed to assess whether generalised anxiety
indeed has a more chronic course than pure depression in the elderly, or whether
subjects with this diagnosis have a higher change of developing mixed anxiety-
depression.
Differences in concurrent risk profiles for each of the diagnostic categories were
rather limited in the current study. Pure depression was significantly associated with
being unmarried. Environmental vulnerability has been described to be related to
depression in both adults (Brown & Harris 1978) and in older persons (Beekman et
al. 1995). The current data suggest that this type of vulnerability is specific for pure
depression in the elderly when compared with the other diagnostic categories.
Professional support was also analysed as environmental vulnerability, and was
associated with mixed anxiety-depression specifically. In our view, this factor can also
be taken as an indication of severity of both psychiatric and other handicaps in these
subjects. This is in line with the trend towards higher odds-ratios for both functional
disabilities and cognitive decline in mixed anxiety-depression. Also specific to mixed
anxiety-depression was its predominant occurrence in the younger old. With long-
standing vulnerability being very high in mixed anxiety-depression, this finding fits
the idea of a decrease of this type of vulnerability at a higher age, as the most vulner-
able subjects selectively leave the population (van Ojen et al. 1995).
No differences between strata were demonstrated for physical and/or functional
stress factors, which were largely associated to the three categories in a similar man-
ner. We therefore conclude that our second hypothesis, suggesting different risk pro-
files in ‘pure’ depression, ‘pure’ anxiety and mixed anxiety-depression, is not sup-
ported by the data. Although environmental vulnerability was apparent in pure
depression and not in the other categories, there were much more similarities than
differences in the overall risk profile of the three diagnostic categories. The rather
steep increase in longstanding vulnerability across diagnoses and the trend towards
higher odds ratios very well fits the idea of increasing severity of psychopathology
that was also apparent in the assessment of comorbidity. This is another argument
favouring dimensional rather than categorical classification of depression and gener-
alised anxiety in this age group.
Gender differences
The distribution of both pure generalised anxiety disorder and mixed anxiety-depres-
sion was very skewed, with women being 6 times as liable to have the combined dis-
order than men. Although higher prevalence of anxiety disorders in women has pre-
viously been described in the same age group (Schaub & Linden 2000), the overrep-
resentation of women in mixed anxiety-depression is striking for several reasons.
Firstly, earlier research in the AMSTEL study has shown that among all depressive
subjects, regardless of comorbid anxiety, the gender distribution becomes more
equal when higher severity levels are assessed. Women have 2.7 times more neurotic
depression than men, but only 1.4 times more psychotic depression (Schoevers,
Geerlings, Beekman, Penninx, Deeg, Jonker, & Van Tilburg 2000b). The gender dis-
tribution of mixed anxiety depression does not follow this pattern, as the overrepre-
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sentation of women in this specific type of severe psychopathology became more
pronounced rather than less. Secondly, the current data not only show that levels of
comorbidity increase along severity lines in both depression and generalised anxiety,
but also underline that this association of severity with comorbidity is twice as
strong in women than in men.
One may therefore conclude that mixed anxiety-depression is a subtype of severe
psychopathology that is strongly associated with longstanding, possibly biologically
determined vulnerability, and almost specific to women.
Limitations
The current study was performed among a large and representative sample of com-
munity living elderly using a well-established diagnostic instrument, including a large
set of risk factors generally believed to be associated with late-life psychiatric disor-
ders. However, there are several limitations. 
First of all, the cross-sectional design does not allow a distinction between risk
factors associated with aetiology and with prognosis of the disorders under study.
Similarly, temporal associations between depression and generalised anxiety can not
be addressed in cross-sectional analysis. Prospective designs are needed to clarify
the issue of possible temporal sequencing, as depression and generalised anxiety
may occur in the same person at different times and different stages of the develop-
ment of the disorder. If this is found to be the case, it is another argument favouring
a dimensional classification of depression and generalised anxiety. A second limita-
tion is the fact that cross-sectional studies tend to overrepresent subjects with
chronic disorders and longstanding vulnerability. Thirdly, the current study did not
assess other types of anxiety disorders. Although generalised anxiety is the most
prevalent anxiety disorder at a later age, and probably most closely related to depres-
sion, studies are needed that also investigate the associations between depression
and other types of anxiety disorder in the age group under study.
Conclusions
The present study shows that in the elderly, mixed anxiety-depression is on the most
severe end of both the depression and generalised anxiety spectrum. High co-occur-
rence and parallel increase in severity suggest a continuum rather than distinct diag-
nostic categories. Pure depression, pure anxiety and mixed anxiety-depression were
significantly associated with longstanding vulnerability, with a stepwise increase in
strength of the association across categories. Searching for possible differential risk
profiles demonstrated that these were very similar in the different diagnostic cate-
gories, and higher odds ratios in mixed anxiety depression most probably also reflect
more severe psychopathology. Comorbidity was markedly higher in women and in
men, and mixed anxiety-depression appears to be a form of severe psychopathology
that is almost specific for women in this age group.
The findings have implications for clinical work, as comorbidity of generalised
anxiety or depression may often indicate a more severe form of psychopathology.
Longitudinal studies are needed to assess natural course and treatment response of
pure depression, pure generalised anxiety and mixed anxiety-depression in the elder-
ly.
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Abstract
Objective
To establish the natural course and risk profile of pure depression, pure general-
ized anxiety disorder and depression with co-existing generalized anxiety disorder
in later life. 
Method
2173 community living elderly were interviewed at baseline, and at 3-year follow-
up. The course of pure depression, pure generalized anxiety disorder and depres-
sion with co-existing generalized anxiety disorder (GMS-AGECAT) was studied in
258 subjects with baseline psychopathology. Bivariate and multivariate relation-
ships between risk factors and course types were assessed. The risk profile for
onset of pure depression, pure generalized anxiety disorder and the mixed condi-
tion at follow-up was studied in 1915 subjects without baseline psychopathology. 
Results
Remission rate at follow up was 41% for subjects with pure depression, 48% in
pure generalized anxiety, and significantly lower (27%) in depression with coexist-
ing generalized anxiety disorder. A pattern of temporal sequencing was estab-
lished, with anxiety often progressing to depression or depression with general-
ized anxiety disorder. Onset of pure depression and depression with co-existing
generalized anxiety disorder was predicted by loss events, ill health and function-
al disability. Onset of pure generalized anxiety disorder, and more strongly that of
depression with co-existing generalized anxiety disorder, was associated with
longstanding, possibly genetic vulnerability. 
Conclusions
In comparison with either pure depression or pure anxiety, the co-occurrence of
these represents more severe and more chronic psychopathology, associated
with longstanding vulnerability. In the elderly, generalized anxiety disorder often
progresses to depression or to the mixed condition. These findings mostly favor
a dimensional versus a categorical classification of anxiety and depression. 
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5.1 Introduction
Co-occurrence of depression and generalized anxiety disorder is a consistent finding
across different age groups (Beekman et al. 2000;Kessler et al. 1996;Regier et al.
1998). In adults, comorbidity is associated with a poorer prognosis (Liebowitz et al.
1990;Regier, Rae, Narrow, Kaelber, & Schatzberg 1998), greater functional disability
(Bijl & Ravelli 2000) and higher service utilization than in persons with a single
disorder (Kessler et al. 1994). In the elderly, much less is known about the course
and consequences of depression with co-existing generalized anxiety disorder (Flint
1994). Available data however suggest that also in the elderly, comorbidity of depres-
sion and generalized anxiety disorder may represent a group with unfavorable cha-
racteristics in terms of severity and prognosis of psychopathology (Lenze et al.
2001). Cross-sectional findings from the Amsterdam Study of the Elderly (AMSTEL)
showed that the combined condition differs from both single disorder conditions in
the sense that comorbidity increases with higher severity levels of both depression
and generalized anxiety (Schoevers et al. 2003). Given the high prevalence and
potential adverse consequences of this type of comorbidity in the elderly, there is an
urgent need for longitudinal research in this domain (Charney et al. 2003). 
Apart from its clinical implications, the frequent co-occurrence of depression and
anxiety has also fuelled the discussion concerning the validity of current categorical
classifications of mental disorders, with critics suggesting a dimensional approach is
more appropriate (Goldberg & Huxley 1992;Tyrer 1996;Zinbarg et al. 1994).
Generalized anxiety disorder in particular may be on a continuum with depression
(Liebowitz, Hollander, Schneier, Campeas, Fallon, Welkowitz, Cloitre, & Davies
1990). It has also been suggested that, although the same genetic factors appear to
predispose to both generalized anxiety and depression, specific environmental fac-
tors may be differentially associated with the development of either anxiety or
depression (Kendler et al. 1987;Kendler 1996). Studies on the association of risk fac-
tors with each of these disorders in the elderly are however sparse and showed
contradictory results in cross-sectional analyses (Beekman, de Beurs, van Balkom,
Deeg, Van Dyck, & Van Tilburg 2000;Lenze, Mulsant, Shear, Alexopoulos, Frank, &
Reynolds, III 2001;Schoevers, Beekman, Deeg, Jonker, & Van Tilburg 2003). This may
be a result of differences in study designs. It may also be due to the fact that a cross-
sectional design is unsuited to differentiate between factors that co-occur with or
result from psychopathology, and factors that actually antedate and may be etiologi-
cally related to the occurrence of a condition. Thirdly, anxiety, depression and the
mixed condition may also represent subsequent stages of disorder. Although tempo-
ral sequencing has been described in younger adults, with anxiety often occurring
prior to the onset of depression, very little is known about longitudinal patterns in
the elderly (Kessler, Nelson, McGonagle, Liu, Swartz, & Blazer 1996;Merikangas et
al. 1996). 
The current study describes the natural course and risk profile of pure depres-
sion, pure generalized anxiety disorder and depression with co-existing generalized
anxiety disorder in later life. It seeks to establish patterns of temporal sequencing,
and investigates whether comorbidity in fact represents a more severe and more
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chronic condition in comparison with ‘single’ disorders. It also investigates the
hypotheses on the specificity of risk factors for onset of these disorders, in light of
the debate on dimensional versus categorical classification of depression and
anxiety. The study was performed in a large cohort of community living elderly using
a prospective design with a three-year interval.
5.2 Methods
5.2.1 Sampling and non-response
The Amsterdam Study of the Elderly (AMSTEL) is a longitudinal study of a large and
representative sample of community dwelling elderly concerning mental health prob-
lems, medical diagnoses and demographic characteristics. The sampling and data
collection procedures have been described elsewhere (Launer et al. 1993;Schoevers
et al. 2000a). In short, the population base for AMSTEL included all non-institutio-
nal individuals in the 65-84 age bracket who lived in the city of Amsterdam. The pro-
file of the study sample corresponded to the non-institutionalized Amsterdam popu-
lation in terms of age and gender. An age-stratified sample was drawn. All 4051 sub-
jects (71.5%) who responded and gave their informed consent were interviewed at
baseline. Non-response in the younger old (<75) was associated with poor perform-
ance on cognitive tests and with health problems. In the older old no correlates of
non-response were found (Launer, Wind, & Deeg 1994).
Of the 4051 subjects who initially responded, 2244 (55,4%) were reinterviewed
three years later (median 38 months). Nonresponse consisted of 656 (16,2%) sub-
jects who had died, 662 (16,3%) persons who refused further co-operation, 282
(7,0%) who were too ill or cognitively impaired to respond, and 207 (5,1%) who were
not available for interview due to other reasons. Subjects with an organic diagnosis
at baseline (GMS-AGECAT case levels for organicity higher than two, N=71) were
excluded, yielding a total sample of 2173 subjects.  
The study sample for the investigation of course types of psychopathology con-
sisted of subjects with baseline GMS-AGECAT case levels of depression, anxiety or
both, who attended follow-up assessment. The sample for these assessments thus
consisted of 258 subjects. 
The analyses on the association between risk factors and incidence of depres-
sion, anxiety and depression with co-existing generalized anxiety disorder at follow-
up, were performed in a sample consisting of all responders who did not have
depression, generalized anxiety disorder or dementia at baseline (GMS-AGECAT lev-
els of less than three for depression, anxiety and organicity; N=1915). 
5.2.2 Measures
A one hour interview was conducted consisting of the Dutch translation of the Mini-
Mental State Examination (Folstein, Folstein, & McHugh 1975), Geriatric Mental
State Examination (GMS) items related to organic, affective and generalized anxiety
syndromes (Copeland, Dewey, & Griffiths-Jones 1986), the Activities of Daily Living
(ADL) scale (Katz et al. 1963), the Instrumental Activities of Daily Living (IADL) scale
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(Lawton & Brody 1969), and the CAMDEX-interview (Roth et al. 1986). The interview
was administered during home visits by lay interviewers who were specially trained
using video sessions and regularly supervised.
Psychiatric syndromes. Diagnoses of depression, organic caseness and general-
ized anxiety were reached using the GMS-AGECAT system (Copeland et al.
1988;Copeland, Dewey, & Griffiths-Jones 1986). AGECAT has proven reliability for
epidemiological work (Copeland, Dewey, Henderson, Kay, Neal, Harrison,
McWilliam, Forshaw, & Shiwach 1988). The Dutch language version has been vali-
dated (Hooijer, Jonker, & Dewey 1991). In the analyses syndrome levels were used
for psychopathology, as the diagnostic hierarchy in GMS-AGECAT would otherwise
bias the results. Diagnostic levels 1 and 2 are classified as subcases. Levels 3-5 have
been proven valid to detect cases requiring clinical attention in the community
(Copeland et al. 1987;Copeland et al. 1992;Copeland, Dewey, & Griffith-Jones 1990).
Depression, generalized anxiety and organic caseness were defined as a GMS-AGE-
CAT level 3 or higher. Subjects meeting GMS criteria for depression and not meeting
GMS criteria for anxiety were classified as ‘pure depression’ (DEP). Subjects with
GMS generalized anxiety disorder without depression caseness were classified as
‘pure generalized anxiety disorder’ (GAD). Subjects meeting GMS criteria for both
depression and anxiety were labeled ‘depression with co-existing generalized anxiety
disorder’ (DEPGAD). GMS-AGECAT case levels also represent levels of increasing
severity of the disorder, with case level 5 indicating the most severe end of the spec-
trum. To determine the prognostic value of different severity levels at baseline, a
dichotomous variable was constructed for severity of psychopathology. GAD case
levels 4 and 5 were classified as higher severity, and level 3 as less severe illness.
Depressed subjects are subdivided into neurotic and psychotic depression. Psychotic
depression was classified as more severe than neurotic depression. In subjects with
any of these three types of psychopathology at baseline, remission was defined as no
longer having any of these diagnoses at follow-up.
Risk factors. Educational status was dichotomized as lower (primary school or
less) and higher (more than primary school) education. Marital status was assessed
using the appropriate questions in GMS-AGECAT. Social support was ascertained by
the question: ‘Do you get help from your children, neighbors or other acquaintanc-
es?’ A personal history was ascertained by the relevant CAMDEX-question, asking
subjects whether they had ever experienced depression and/or anxiety of such sever-
ity that treatment had been sought. Age at first onset was recorded. Also translated
from the CAMDEX-questionnaire was a family history of psychiatric illnesses. The
presence of chronic diseases was assessed with the pertinent Camdex questions on
cardiovascular diseases, cancer, lung disease, diabetes, Parkinson’s disease, arthritis
and epilepsy. A dichotomous variable indicates whether or not subjects had any
chronic illnesses. Cognitive status was assessed by MMSE-score. Subjects were con-
sidered to have functional disability if their ADL or IADL scores were two or more
points below the maximum score on the respective scales (ADL 12 and IADL 16
points). This means that subjects were ‘in need of help’ to perform at least two of
the tasks in the respective domains. 
Differences that had occurred between baseline and follow-up were also noted.
Stressors thus defined were personal life events (partner loss), changes in physical
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health (the emergence of one or more chronic diseases), a substantial decrease in
ADL or IADL functioning (two scale points or more), and cognitive decline (incident
organic syndrome; GMS-AGECAT organic level three or more at follow-up).
5.2.3 Data analysis
Characteristics at baseline and follow-up were described, and response rate accord-
ing to baseline characteristics were calculated using bivariate and multivariate statis-
tics.
In the baseline case sample, possible patterns of temporal sequencing across
both assessments of DEP, GAD and DEPGAD were calculated in cross-tabulation
with chi-square analysis. The probability of different course types was tested by
dichotomizing outcome as ‘remission vs. persistence’, and ‘developing DEPGAD vs.
not’ and drawing up two by two cross tabulations. In this way the courses of base-
line GAD and DEP were compared, as were the courses of subjects with either DEP
or GAD and subjects who had DEPGAD. 
In the non-case baseline sample, associations of independent variables with the
incidence of either DEP, GAD and DEPGAD at follow-up were assessed calculating
odds ratios, using the subjects without depression and anxiety at follow-up as refer-
ence category. When the 95% confidence interval did not include 1, the association
was regarded to be statistically significant. Multinominal logistic regression analysis
was used to achieve independent predictive ability for each diagnostic category using
the full model of potential risk factors. Differences between strata were considered
statistically significant according to the criterion that the confidence intervals of a
risk factor mutually exclude the point estimates in one or both of the other diagnos-
tic categories (Gardner & Altman 1986). Backward stepwise analysis was subse-
quently used to reach the most parsimonious model for each diagnostic category. 
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5.3 Results
5.3.1 Sample characteristics and response pattern
Non-response at the follow-up assessment was predicted by higher age, male gen-
der, lower education, chronic disease(s), ADL and IADL impairment and organic
caseness (Schoevers, Beekman, Deeg, Geerlings, Jonker, & Van Tilburg 2000a). After
subjects with dementia at baseline and those who died between measurements were
excluded from the sample, only lower education, not having a marital partner and
baseline cognitive deficits (MMSE < 26) remained as significant predictors of non-
response. Importantly, controlling for other factors in multivariate logistic regression
analysis, neither DEP (RR 0.87, 95% c.i. 0.68-1.12), GAD (RR 0.97, 59% c.i. 0.50-
1.88), nor DEPGAD (RR 0.85, 95% c.i. 0.48-1.48) were significantly associated with
the risk of attrition (overall likelihood Chi2 test for full model 85.29, df 16, P<0.001).
[Table 1] shows the sample characteristics and the associations with GAD, DEP and
DEPGAD at follow-up.
91Chapter 5 |  Depression and generalized anxiety disorder; co-occurrence and 
longitudinal patterns in elderly patients
92 Epidemiology of late life depression
TABLE 1: SAMPLE CHARACTERISTICS 
(baseline sample excluding subjects with dementia, dichotomised variables, 
N=2173, with psychopathology at follow-up, Chisq= Pearson
chi-square test with two sided p-value; *= p<0.05, **=p<0.01, ***=p<0.001) 
Age >74 yrs at baseline   1066(49.1)     808 (47.7)      13 (40.6)       202 (57.5)    43 (45.3)     12.9 / 3 / **
Sex: female                     1372(63.1)     1033(60.9)    24 (75.0)       244 (69.5)    71 (74.7)     17.1 / 3 / **
Lower education             803(37.0)       612 (36.1)       16 (50.0)      137 (39.0)    38 (40.0)    3.9 / 3 / 0.27
Unmarried                     1100(50.6)     848 (50.1)     13 (40.6)     192 (54.7)    47 (49.5)    3.8 / 3/ 0.28
Social Support                373(17.2)         273 (16.1)      4 (12.5)        78 (22.2)      18 (18.9)     8.4 / 3 / *
Pers.  hist. dep.            327(15.0)         207 (12.2)      8 (25.0)        72 (20.5)      40 (42.1)     75.7 / 3 / ***
Family history               258(11.9)         185 (10.9)       3 (9.4)        50 (14.2)      20 (21.1)     11.2 / 3 / *
Baseline chron. dis.       1073(49.4)     792 (46.7)     18 (56.3)      205 (58.4)    58 (61.1)       22.0 / 3 /***
Baseline ADL disability  103(4.7)         61 (3.6)          3 (9.4)          27 (7.7)        12 (12.6)      26.3 / 3 / ***
Baseline IADL disability  393(18.1)        255 (15.0)       7 (21.9)       104 (29.6)   27 (28.4)      49.3 / 3 / ***
Low MMSE (<26)           217(10.0)        158 (9.3)        6 (18.8)         39 (11.1)       14 (14.7)     6.5 / 3 / 0.09
CHANGES TO-T1; 
LIFE EVENTS
Partner died                  155(7.1)           97 (5.7)         1 (3.1)           43 (12.3)      14 (14.7)      28.0 / 3 /***
New ADL disability        128(5.9)         86 (5.1)          2 (6.3)           29 (8.3)       11 (11.6)       11.1 / 3 / *
New IADL disability        448(20.6)       308 (18.2)      10 (31.3)        98 (27.9)    32 (33.7)      29.8 / 3 / ***
New chronic diseases     422(19.4)       300 (17.7)     8 (25.0)        82 (23.4)      32 (33.7)      19.7 / 3 / ***
FOLLOW-UP: 
NO DEP  
OR GAD
(1695)
GAD 
(32)
DEP
(351 )
DEP 
GAD 
(95)
RISK FACTORS
BASELINE
(%)
Chisq/df/p
5.3.2 Temporal sequencing 
Pure generalized anxiety disorder Table 2 shows that the 25 subjects with GAD had
the highest remittance rate (48%). 3 subjects (12%) remained in the same category,
but 6 (24%) subjects developed DEP. DEPGAD emerged in 4 persons (16%).
Pure depression Of the 199 subjects with DEP at baseline, 82 (41.2%) no longer
had DEP or GAD at follow-up. 86 subjects (43.2%) remained in the same category at
both assessments. Only 4 subjects (2%) of those with DEP at baseline developed
GAD, whereas 27 (13.6%) developed DEPGAD. 
Mixed anxiety depression Among the 34 subjects with DEPGAD at baseline,
remission rates were low (27%). A relatively high proportion of subjects remained
within the same diagnostic category (44%). DEP appeared in 27%. Only 1 person
developed GAD (3%). 
Cross tabulation of all course types proved statistically significant (Pearson Chi-
Square test 28.14, df 6, p<0.001). Dichotomizing course types showed that there was
no statistically significant difference in the probability of remission between DEP and
GAD. Subjects with DEPGAD showed significantly lower remission rates than sub-
jects with DEP or GAD (Pearson chi2 2.96, df 1, one sided p=0.043). Comparing
baseline categories on the outcome of DEPGAD or ‘not DEPGAD’ did not show a
statistically significant difference between GAD and DEP, but showed that subjects
with baseline DEPGAD were more likely to keep the combined disorder than change
into either of the pure forms (Pearson chi2 18.47, df 1, p<0.001).
93Chapter 5 |  Depression and generalized anxiety disorder; co-occurrence and 
longitudinal patterns in elderly patients
Diagnosis
at follow-up:
at baseline:       
Pure generalised anxiety            (25) 12 (48.0)            3 (12.0) 6 (24.0)            4 (16.0)
Pure depression                        (199) 82 (41.2)            4 (2.0)          86 (43.2)          27 (13.6)
Depression with GAD               (34)                 9 (26.5)              1 (2.9)         9 (26.5)            15 (44.1)
TABLE 2: STABILITY OF DIAGNOSTIC CATEGORIES ACROSS ASSESSMENTS
(all responders with baseline generalised anxiety disorder and/or depression, excluding baseline organic 
cases,N=258, % of responders per baseline category)
GAD DEPGADDEPNo DEP/ GAD 
5.3.3 Associations of risk factors with course of illness
Stable vs. worsened Bivariate analyses showed that in subjects with either GAD or
DEP, developing DEPGAD was associated with the occurrence of chronic diseases
between assessments (RR 2.68, 95% c.i. 1.32-5.42, overall Chi2 test 8.16, df 1,
p=0.0043)(data not shown). Severity of DEP and/or GAD was not associated with
course type, nor was the presence of a personal history. In the multivariate model
(backward stepwise logistic regression modelling) the association with new chronic
illness remained (RR 2.90, 95% c.i. 1.43-5.89), and mixed anxiety depression was
also inversely associated with an age above 74 years (RR 0.45, 95% c.i. 0.22-0.95,
overall Chi2 test at last step 12.8, df 2, p=0.0017) (data not shown).
Stable vs. remitted. None of the risk factors showed significant differences
between strata of subjects with a single disorder at baseline who had remitted at fol-
low-up. In subjects with depression with co-existing generalized anxiety disorder at
baseline, partial or complete remission was not associated with any of the risk fac-
tors either.
5.3.4 Predictors of incidence at follow-up
In the sample without depression, anxiety or dementia at baseline (n=1915), 24 sub-
jects (1.3 %) had developed GAD at follow-up. 250 (13.1%) had DEP and in 49 per-
sons (3.6%) DEPGAD had occurred.
[Table 3A] shows the multinominal logistic regression models for each diagnostic
category. Only having a personal history of depression or anxiety was significantly
associated with the onset of GAD. As the numbers were relatively small, these asso-
ciations were also tested in bivariate analyses yielded no other statistically significant
associations with GAD at follow-up. The occurrence of DEP was associated with hav-
ing chronic diseases at baseline and baseline IADL disability, with loss of spouse and
with a decrease in functional abilities (IADL) between assessments. DEPGAD was
predicted by having a personal history, and by a decrease in IADL functioning. 
There were three significant differences between pure depression and depression
with co-existing GAD; the mixed category shows significantly higher odds ratios for
age (65-74 vs. 75-84 years), a personal history of depression and/or anxiety disorder,
and decreases in both ADL and IADL functioning.
The most parsimonious models (table 3B) showed similar results for GAD and
DEP, with a personal history just failing to reach statistical significance in DEP.
Having a personal history was more strongly associated with the occurrence of DEP-
GAD. DEPGAD was also predicted by baseline (ADL) and newly occurring functional
disabilities (ADL and IADL) and loss of spouse. Risk ratios of baseline and newly
occurring functional limitations were generally higher in DEPGAD. Loss of spouse
showed similar associations with the occurrence of both categories.
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TABLE 3A: ASSOCIATIONS OF RISK FACTORS WITH INCIDENCE OF GENERALISED ANXIETY, 
DEPRESSION AND DEPRESSION WITH COEXISTING GAD (N=1915, 
multinominal logistic regression model, Odds Ratios, italics: difference between 
strata according to the criterium of mutually exclusive c.i.) 
Diagnosis at follow up:
Risk factors:
Age > 74                          1.33 (0.53-3.32)         1.27 (0.94-1.72)        0.61 (0.32-1.18)
Female                                                2.62 (0.95-7.22)      1.03 (0.75-1.42)        1.32 (0.68-2.57)
Only basic education                           1.16 (0.49-2.74)       0.96 (0.72-1.29)        1.27 (0.68-2.34)
Not / no longer married                    0.56 (0.22-1.42)      1.19 (0.85-1.66)        0.78 (0.39-1.57)
Social support                                     0.53 (0.14-1.93)       0.83 (0.56-1.21)         0.58 (0.25-1.38)
Personal history depression/anxiety     2.79 (1.06-7.35)        1.42 (0.96-2.09)      4.27 (2.25-8.13)
Family history mental illnesses  0.96 (0.27-3.39)       1.39 (0.92-2.09)        0.89 (0.35-2.22)
Chronic ilnesses at baseline                1.37 (0.60-3.14)       1.47 (1.11-1.95)          1.06 (0.58-1.95)
ADL disability at baseline                   0.78 (0.00-6.29)      1.25 (0.65-2.39)         2.62 (0.90-7.61)
IADL disability at baseline                  1.31 (0.44-3.92)      1.80 (1.26-2.57)        1.50 (0.71-3.17)
MMSE < 26                                        2.02 (0.63-6.44)      0.67 (0.40-1.12)       1.45 (0.62-3.40)
Loss of spouse                                                   -              3.36 (2.09-5.38)         2.54 (0.96-6.68)
New medical illness                           1.71 (0.66-4.44)       1.31 (0.94-1.83)         1.74 (0.90-3.35)
Recent decrease ADL functioning       0.60 (0.00-4.79)      1.02 (0.57-1.81)        2.41 (0.99-5.86)
Recent decrease IADL functioning       1.56 (0.60-4.09)       1.43 (1.02-1.99)         3.04 (1.58-5.86)
Overall likelihood Chi-square test: 135.5, df: 45, p<0.001
GAD (34)                   DEP (250)                                          DEP GAD (49)
Personal history       Personal history 1.44 (0.99-2.11)                  Personal history 4.48 (2.38-8.38)
2.58 (1.01-6.58) Chron dis (baseline) 1.45 (1.10-1.91)              ADL disability(baseline)2.84(1.04-7.77)
IADL disability (baseline)  1.78 (1.28-2.48)    Loss of spouse  2.90 (1.22-6.93)
Loss of spouse  2.93 (1.93-4.47)                    Recent ADL decrease 2.39 (1.01-5.65)
Recent IADL decrease 1.53 (1.12-2.10)             Recent IADL decrease 2.91(1.56-5.44) 
TABLE 3B: Multivariate logistic regression (Odds Ratios in parsimonuous model with Pin<0.05, P 
out<0.10, backstep procedure).
GAD (24) DEP  (250) DEPGAD (49)
5.4 Discussion
The aim of the current study was to describe the natural course of pure depression,
pure generalized anxiety disorder and depression with co-existing generalized anxiety
disorder in a large and representative sample of community living elderly, and to
investigate whether different risk profiles were associated with occurrence and prog-
nosis of each of these types of psychopathology. 
Main findings
Assessment of the natural course of three diagnostic categories showed that, first of
all, the prognosis of either category in the elderly is poor, with remission rates under
50% after a three-year interval. When comparing categories, GAD was the least sta-
ble category with only 12% of anxious subjects remaining within that category at fol-
low-up. A significantly larger number of subjects with baseline GAD developed either
DEP or DEPGAD at follow-up. DEP and DEPGAD appeared to be much more stable
diagnostic categories, and these subjects were highly unlikely to develop GAD at fol-
low-up. Although, due to relatively small numbers, not al of these transitions could
be statistically tested, these data clearly suggest a fixed pattern of temporal sequenc-
ing. GAD in elderly subjects either remits or progresses into depression or mixed
anxiety depression, whereas subjects with DEP or DEPGAD are highly unlikely to
develop GAD at follow-up. Although this is in line with findings in younger adults
(de Graaf et al. 2003), such sequential patterns have not systematically been
described in this age group before. 
Studying the course of DEPGAD showed that, with only 27% remission at follow-
up, the prognosis of this mixed category is significantly worse than that of either of
the single conditions. This confirms findings of earlier, mostly cross-sectional
research showing that also in the elderly, higher levels of comorbidity indicate more
severe psychopathology (Lenze, Mulsant, Shear, Alexopoulos, Frank, & Reynolds, III
2001;Schoevers, Beekman, Deeg, Jonker, & Van Tilburg 2003). This may have impor-
tant implications. Recent data suggest that DEPGAD can effectively be treated in the
elderly (Lenze et al. 2003). Early intervention in depressed subjects with comorbid
anxiety may significantly reduce chronicity and all of its negative consequences, both
for the individual patient and for the use of health services (Katon et al. 2003). 
Studying whether specific risk factors were associated with either persistence or
remission of baseline psychopathology, or with the development of DEPGAD, yielded
a limited number of statistically significant associations. The finding that the pro-
gression to mixed anxiety depression in subjects with GAD or DEP was predicted by
comorbid medical illness, supports earlier research showing that medical comorbidi-
ty carries a higher risk for chronicity and worsening of affective disorder (Cole,
Bellavance, & Mansour 1999). The finding that the progression from a single disor-
der to depression with co-existing generalized anxiety disorder was also associated
with age below 74, fits the concept of a decrease of this type of vulnerability at a
higher age, with the most vulnerable subjects selectively leaving the population at an
earlier stage (Penninx et al. 1999;Schoevers et al. 2000b;van Ojen et al. 1995).
Apart from studying prognosis, we also attempted to study the risk profile for onset
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of any of the three subtypes of psychopathology at follow-up in subjects without
baseline psychopathology. GAD was only predicted by a personal history of depres-
sion and/or anxiety, but this may have been due to relatively low numbers. Onset of
both DEP and DEPGAD was associated with functional limitations, chronic illnesses
and loss events. This is in line with findings from earlier studies on depression inci-
dence (Cole & Dendukuri 2003) that did not make a distinction between depression
with or without coexisting anxiety. According to the criterion that the confidence lim-
its should mutually exclude the point estimates of the relative risk in the opposite
stratum, we found three risk factors that showed statistically significant differences
between DEP and DEPGAD.  Again, the younger old were more likely to have the
mixed condition, in line with the idea of more severe pathology. Decreases in func-
tional abilities also showed significantly stronger associations with DEPGAD than
with GAD. The strongest predictor of DEPGAD was the presence of longstanding,
and possibly genetically defined vulnerability, exemplified by a personal history of
depression and/or anxiety. 
Limitations
The current study is an improvement over existing studies on depression and gener-
alized anxiety in the elderly in the sense that it uses a prospective design in a
community sample using established measurement instruments and comprehensive
set of risk factors associated with late-life psychiatric disorders. 
The principal limitation is the fact that symptomatology has been assessed two
times with a three-year interval. Subjects may have seen both relapse and remittance
during the study interval and not all of this variation is accounted for in the data.
Likewise, episodes of both depression and anxiety with a shorter duration are gener-
ally underrepresented in studies with a limited number of assessments. This would
suggest that overall, the actual course of depression and generalized anxiety disor-
der in the population may be somewhat less gloomy than this study shows. Still, the
level of chronicity is comparable to what is generally found in studies on late-life
depression (Cole, Bellavance, & Mansour 1999), even when studies were able to use
more frequent measurements (Beekman et al. 2002). 
A second limitation is the fact that this study is a naturalistic follow-up in the
community, not controlling for ongoing treatment that may have affected the results. 
Comparable samples of community living elderly have demonstrated that case find-
ing is generally poor, with the majority of subjects with depression and/or anxiety
not receiving any treatment at all for their complaints (Beekman, Copeland, & Prince
1999;German et al. 1987). Our study is no exception to this. It is however fair to con-
clude that, if treatment had actually affected prognosis in some subjects, this would
have lead to an underestimation of the level of chronicity and other adverse conse-
quences in our study.
Thirdly, although the total number of subjects included in this study was relative-
ly large, and the prevalence of generalised anxiety (4.7%) was well within the range
suggested by earlier findings (Beekman et al. 1998;Beekman, de Beurs, van Balkom,
Deeg, Van Dyck, & Van Tilburg 2000;Flint 1994), stratification of the sample some-
times resulted in low numbers of subjects in the different cells. Especially when
analysing pure generalised anxiety disorder, this may have limited the possibility to
97Chapter 5 |  Depression and generalized anxiety disorder; co-occurrence and 
longitudinal patterns in elderly patients
find statistically significant differences with the risk profile of the other categories of
psychopathology. A conclusion on specificity of risk factors for generalised anxiety
disorder can therefore only be tentative. Still, both the temporal patterns and the dif-
ferences between depression and depression with co-existing generalised anxiety dis-
order were rather pronounced and statistically significant, also in more detailed
analyses. It should however be noted that reduction of the alpha level, e.g. by using
Bonferroni correction because of multiple comparisons, was not performed in this
study. This would be warranted if a conclusion were based on a single outcome with-
in a larger set of calculations. However, when assessing multiple risk factors and
searching for risk profiles with an a-priori hypothesis, this method may actually mask
valid results, especially when numbers are limited. 
A fourth limitation is that selective attrition to the follow-up assessment of the
study has occurred among the very frail. Subjects with cognitive impairment and
subjects with lower educational level were more likely to be nonresponders at follow-
up. This a normal pattern in epidemiological studies. If this has affected the results,
it again would lead to an underestimation of the actual situation in the community
with regard to prevalence and prognosis of the disorders under study.
The current study provides arguments that may be relevant to the debate on a
dimensional versus a categorical interpretation of GAD and DEP. The pattern of
temporal sequencing, with GAD often progressing to DEP or DEPGAD, can be taken
as an indication favoring a communal concept of anxiety and depression. Studying
the specificity of risk factors for onset of either category, reflective of the “same
genes, different environments” hypothesis put forward by Kendler et al (Kendler,
Heath, Martin, & Eaves 1987;Kendler et al. 1992;Kendler 1996), however did not
show that the risk profile for DEP differed from that for GAD. Although this may in
part be explained by smaller numbers of GAD cases, our data do not provide sup-
port for the idea that anxiety and depression may be associated with different risk
profiles. Further study is however needed to confirm this. 
The finding that a longstanding, possibly genetic vulnerability is most strongly
associated with DEPGAD does appear to be congruent with the findings of Kendler
et al. (Kendler 1996) in twin studies. They suggested a strong and identical contribu-
tion to both GAD and DEP by genetic factors. As previous research showed that
comorbidity indicates higher severity levels of both DEP and GAD, it is in line with
this view that these associations were more prominent in subjects with the mixed
condition. 
Overall, our data show that in the elderly, both DEP and GAD often have a chron-
ic course, in which GAD often progresses to DEP or DEPGAD. Comorbidity is asso-
ciated with longstanding vulnerability, ill health and functional decline, and has a
gloomy prognosis. These findings may be of considerable relevance for both our the-
oretical understanding of these commonly occurring disorders in later life, and for
preventative purposes. 
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Abstract
Background 
Previous studies suggest that depression is associated with subsequent cognitive
decline in elders with impaired cognition.
Aims To investigate whether depressed elders with normal cognition are at
increased risk of cognitive decline and Alzheimer’s disease (AD).
Methods
Two independent samples of older people with normal cognition were selected
from the community-based Amsterdam Study of the Elderly (AMSTEL) and the
Longitudinal Aging Study Amsterdam (LASA). In AMSTEL, depression was
assessed with the Geriatric Mental State. Clinical diagnoses of incident AD were
made using a two-step procedure. In LASA, depression was assessed with the
CES-D. Cognitive decline was defined as a drop of 3 or more points on the
MMSE at follow-up.
Results
Multiple logistic regression analyses showed that both in the AMSTEL and the
LASA sample, depression was associated with an increased risk of AD and cogni-
tive decline, respectively, but only among subjects with higher levels of education.
Conclusions
Although differential loss to follow-up may have influenced the results to some
extent, the findings suggest that in a subgroup of more highly educated elderly
people depression may be an early manifestation of AD before cognitive symp-
toms become apparent.
Declaration of interest 
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6.1 Introduction
Recent studies (Bassuk et al, 1998; Chen et al, 1999; Yaffe et al, 1999) demonstrate
the growing interest in the question whether depression in dementia may be a cause
or a consequence of the dementia process. In 1996, Devanand et al reported that
depressed mood increased the risk of Alzheimer’s disease (AD). In this study,
depressed mood was more common in subjects with greater baseline cognitive
impairment, giving them a greater probability to develop AD. Other prospective
studies were inconsistent. Dufouil et al (1996) and Henderson et al (1997) did not
find a relation between depression and subsequent cognitive decline, while Bassuk
et al (1998) and Chen et al (1999) did find such a relation, but only among subjects
in whom cognitive impairment was already apparent. To further study the nature of
the relationship between depression and cognitive decline/dementia, we investigat-
ed whether depressed elderly individuals with normal baseline cognition were at
increased risk of cognitive decline and AD. We used data from two cohorts of elderly
people living in the community.
6.2 Methods
6.2.1 Baseline samples
Data on incident AD were obtained from the Amsterdam Study of the Elderly (AMS-
TEL), whereas data on cognitive decline were obtained from the Longitudinal Aging
Study Amsterdam (LASA). For both studies, Medical Ethics Committee approval was
obtained. The sampling procedures of both studies have been described elsewhere
(Launer et al, 1993; Deeg et al, 1993; Beekman et al, 1995). In brief, for the AMSTEL
study 5,666 noninstitutionalized elderly people, aged 65 to 84 years, were selected
from 30 general practices spread across the city of Amsterdam. Within each practice
a fixed proportion of people was randomly selected from each of four 5-year age stra-
ta (65-69 years to 80-84 years) to obtain equal-sized strata. 4,051 (71.5%) people
gave their written consent and participated in the study. The LASA cohort is based
on random, sex and age stratified (six 5-year age strata from 55 to 84 years), samples
drawn from 11 municipal population registries (both urban and rural) in three
regions of the Netherlands. The baseline sample of the LASA cohort consists of
3,107 people.
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6.2.2 Baseline measurements and study samples
AMSTEL
In 1990-1991 trained lay people interviewed all 4,051 participants at home. The inter-
view comprised the Dutch version of the Geriatric Mental State Schedule (GMSS)
(Copeland et al, 1976; Gurland et al, 1976; Hooijer et al, 1991), questions on sociode-
mographic characteristics, current health status, medical history, and four mental
status tests, among which the Mini-Mental State Examination (MMSE) (Folstein et
al, 1975). Depression was measured using the GMSS, in conjunction with its com-
puterized diagnostic system AGECAT (Dewey & Copeland, 1986). The GMSS is a
structured interview to identify various psychiatric disorders, specifically designed for
use with elderly individuals. AGECAT consists of the application of hierarchical rules
to the items of the GMSS in order to reach a diagnosis for various psychiatric disor-
ders (e.g., depression and dementia syndromes) with different levels of confidence.
The presence and absence of depression was indicated by GMS-AGECAT depression
syndrome levels 3-6 and 0-2, respectively.
To select a study sample with normal cognition, a cohort without dementia was
firstly selected by excluding from the baseline sample all subjects (N=273) with a
DSM-III-R dementia diagnosis (APA, 1987) (for a more detailed description see
Jonker et al, 1998) or a GMS-AGECAT dementia diagnosis (i.e., organic illness syn-
drome levels of 3-5). Second, from this cohort without dementia all subjects with
subthreshold levels of dementia were excluded, i.e., with GMS-AGECAT dementia
levels of 1-2 or MMSE scores of 25 and less (N=631). In all, 904 subjects were
excluded, resulting in a study sample of 3,147 nondemented subjects with normal
cognition (i.e. MMSE scores of 26-30 and GMS-AGECAT organic illness score 0).
LASA
In 1992-1993, trained lay people interviewed all 3,107 participants at home. Cognitive
functioning was measured with the MMSE. Depressive symptomatology was meas-
ured with the Dutch version of the Center for Epidemiologic Studies Depression
Scale (CES-D) (Beekman et al, 1997). This is a twenty item self-report scale devel-
oped to measure current depressive symptomatology in the community. The CES-D
generates a total score which can range from 0 to 60. In order to identify respon-
dents with clinically relevant levels of depression, the generally used cut-off score of
≥16 was also used. To minimize overlap between affective symptoms and symptoms
possibly due to physical illness, analyses were also performed using a subscale con-
structed of seven items of the CES-D reflecting negative affect (bothered, blues,
depressed, fearful, lonely, cried and sad) (Radloff & Teri 1986). The negative affect
subscale ranged from 0 to 20 points with higher scores indicating greater severity.
For the present study, a sample with normal cognition was selected by excluding
all subjects of the baseline sample with MMSE scores <26, resulting in a study sam-
ple of N=2,399 people.
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6.2.3 Follow-up measurements
AMSTEL
At follow-up in 1994, all subjects who were available were interviewed again by
trained lay people using the same interview procedure as in 1990/91. A subsample
of subjects who were suspected of having developed dementia were invited for diag-
nostic evaluation. The screening procedure and diagnostic evaluation have been
described elsewhere (Geerlings et al, 1999). In brief, all subjects with MMSE scores
of 23 or less or with impairment in orientation in time, recent memory or learning
were invited for diagnostic evaluation. During home visits, physicians specifically
trained for this purpose administered the Cambridge examination for mental disor-
ders in the elderly (including a structured psychiatric interview, the Cambridge
Cognitive Examination, and a physical examination) (Roth et al, 1988). Clinical diag-
noses of AD were made according to DSM-IV criteria (APA, 1994). Diagnoses were
determined during weekly meetings with the senior neurologist (C.J.) and the neu-
ropsychologist (M.I.G.).
LASA
At follow-up in 1995-1996, all respondents who were available were interviewed again
during home visits using the same interview procedure as was used at baseline.
6.2.4 Statistical analyses
AMSTEL
Multiple logistic regression analyses were performed to assess the effect of depres-
sion on incident AD. Covariates used in the analyses were age, sex, level of educa-
tion, memory complaints and psychiatric history. Level of education was expressed
in full-time years of education needed to obtain the highest grade of education com-
pleted. In the analyses, it was used both as a continuous and as a dichotomous vari-
able (dichotomized at the median of the study sample into £8 years versus >8 years
of education; 8 years of education is comparable with two years of secondary educa-
tion after having completed primary school). Memory complaints were assessed
with the question: “Do you have complaints about your memory?” Answers were
coded yes or no. Psychiatric history was assessed with the question: “Have you ever
had emotional or nervous illness requiring treatment?”. If answered positively, age of
onset was assessed. Psychiatric history was categorized as no history or first onset
at age 60 or above versus psychiatric history before age 60.
First, the analyses were performed with adjustments for the potential con-
founders. Second, since the strength of the association between depression and inci-
dent AD may be different for people with different demographic characteristics and
for those with or without memory complaints or psychiatric history, we also tested
possible interactions between depression and age, sex, education, memory com-
plaints and psychiatric history, respectively.
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LASA
Multiple logistic regression analyses were performed to assess the effect of depres-
sive symptomatology on cognitive decline. Cognitive decline was defined as a drop
of 3 or more points (>1 standard deviation) on the MMSE at follow-up. Depressive
symptomatology was used in the analyses as a continuous variable (total CES-D
score, and negative affect score), as a dichotomized variable (CES-D ≥16 versus
<16), and as a categorical variable (the core depression item from the CES-D [during
the past week I felt depressed] was used to examine the association between mild
depressed mood (some of the time versus no) and incident cognitive decline and a
severe depressed mood (often/always versus no) and incident cognitive decline,
respectively. The same covariates as in the AMSTEL sample were used. However, in
LASA data on psychiatric history were not collected and were therefore not used in
the analyses of the LASA data. Interactions between the different depression defini-
tions and the covariates were also tested. Finally, to correct for possible differences
in baseline MMSE scores between the two education groups, we also performed the
analyses with additional adjustments for baseline MMSE score (range 26-30).
6.3 Results
AMSTEL
Table 1 shows the baseline characteristics of the AMSTEL study sample (N=3,147),
according to the presence or absence of depression. 
Depression               No depression
(N=329)                   (N=2,818)
Mean age (SD) 73.6 (5.7) 73.7 (5.7) p=0.821
Sex
Male                                  62 (18.8%)                1156 (41.0%)
Female                               267 (81.2%)              1662 (59.0%)           p=0.0002
Mean yrs of  education (SD) 8.0 (2.3)                    8.5 (2.6)                  p=0.0003
Memory complaints
No                                    263 (80.2%)            2563 (91.0%)
Yes                                     65 (19.8%)               253 (9.0%)               p=0.0002
Psychiatric history
No / late onset                   261 (79.6%)              2527 (89.8%)
Early onset                        67 (20.4%)              286 (10.2%)              p=0.0002
Note: the numbers do not always add up to 3,147 persons because of missing values on some variables. 
1 t-test; 2 Chi-square test; 3 Mann-Whitney U test.
The follow-up duration was 3.2 years, on average. Figure 1 shows the number of 
people who were available for follow-up and who were lost to follow-up. At follow-up, 
53 people received a diagnosis AD.
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Table 1. Baseline characteristics of the AMSTEL study sample (N=3,147), 
according to the presence or absence of depression
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N=414
died
N=4.051
baseline sample
N= 904
DSM-R-III dementia or
MMSE<26 or GMS
organic 1-5 excluded
N= 449      
unwilling to participate
N=202
too ill   
N=171    
not contacted
N=1,911
follow-up
N=3,147 
study sample
N=287
selected for diagnostics
N=42
died
N=16
too ill
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diagnostic evaluation
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N=29
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not contacted
Figure 1: Sample discription AMSTEL
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Table 2 shows the baseline characteristics for those who were and were not available
for follow-up.
Interview                Lost to follow-up
(N=1,911)                (N=1,236)
Mean age (SD)                      73.1 (5.5)                 74.6 (5.7)              p=0.0001
Sex 
Male                               721 (37.7%)             497 (40.2%)    
Female                            1190 (62.3%)          739 (59.8%)           p=0.162
Mean yrs of education (SD) 8.6 (2.6)                8.2 (2.4)                p=0.0003
Memory complaints
No                                  1699 (89.0%)          1127 (91.3%)   
Yes                                  210 (11.0%)            108 (8.7%)            p=0.042
Psychiatric history
No/Late onset                 1692 (88.7%)          1069 (88.9%)     
Early onset                     216 (11.3%)            137 (11.1%)             p=0.862
Depression
Absent                            1725 (90.3%)          1093 (88.4%)    
Present                           186 (9.7%)             143 (11.6%)            p=0.102
Note: the numbers do not always add up to 3,147 persons because of missing values on some 
variables. 1 t-test; 2 Chi-square test; 3 Mann-Whitney U test
Table 2. Baseline characteristics of the AMSTEL study sample (N=3,147)for
subjects who were and were not avaible for follow-up in 1994
Table 3 shows the crude and adjusted odds ratios of incident AD associated with
depression, age, sex, education, memory complaints and psychiatric history.
Depression moderately increased the risk of AD. In the multivariate model, with
adjustments for all other variables, the odds ratio of AD associated with depression
decreased towards a statistically nonsignificant level.[Table 3]
Crude OR (95% CI) Adjusted1 OR (95% CI)
Depression (yes vs no) 2.21 (1.09-4.48) 1.67 (0.76-3.63)
Age (per year increase) 1.19 (1.12-1.26) 1.18 (1.11-1.25)
Sex (women vs men) 2.10 (1.10-4.03) 1.44 (0.73-2.84)
Education (per year increase) 0.81 (0.71-0.93) 0.86 (0.75-0.99)
Memory complaints (yes vs no) 2.79 (1.47-5.30) 2.79 (1.39-5.59)
Psychiatric history
(no/late onset vs early onset) 0.31 (0.08-1.29) 0.30 (0.07-1.26)
1 Adjusted for all other variables mentioned in the Table.
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Table 3. Crude and adjusted odds ratios with corresponding 95% confidence 
inter vals for the association between depression, age, sex, education, memory 
complaints, psychiatric history and incident Alzheimer disease (AMSTEL)
Interaction terms added to the model containing all covariates showed that the asso-
ciation between depression and AD was modified by education (centered variable)
(likelihood ratio test, p=0.023). The interaction term was also statistically significant
when education was used as a dichotomous variable (p=0.004). There were no sta-
tistically significant interactions between depression and memory complaints or
between depression and psychiatric history, nor were there between depression and
age or gender.
To interpret the modifying effect of education on the association between depres-
sion and incident AD, we performed logistic regression analyses within two educa-
tion groups (dichotomized at the median value of the study sample). Depression
highly increased the risk of AD among subjects with >8 years of education, but not
among subjects with ≤8 years of education [Table 4].
≤8 years of education    >8 years of education 
N=871                          N=1,036
OR (95% CI)1 OR (95% CI)1
Depression (yes vs no) 0.63 (0.18-2.19) 5.31 (1.88-15.00)
Age (per year increase) 1.17 (1.08-1.27) 1.19 (1.09-1.29)
Sex (women vs men) 2.52 (0.86-7.38) 0.96 (0.38-2.46)
Memory complaints (yes vs no) 2.15 (0.77-5.97) 3.27 (1.26-8.49)
Psychiatric history
(no/late onset vs early onset) (-) 2 0.72 (0.15-3.46)
1 Adjusted for all other variables mentioned in the Table.
2 Not enough observations
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Table 4. Odds ratios (95% confidence interval) adjusted for all other variables of the
association between depression, age, sex, memory complaints and psychiatric 
history and incident Alzheimer’s disease, for subjects ≤8 years of education and 
>8 years of education, respectively (AMSTEL)
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LASA
Table 5 shows the baseline characteristics of the LASA study sample (N=2,399)
according to the presence or absence of depression.
The duration of follow-up averaged 3.1 years. Figure 2 shows the number of people
who were available for follow-up and who were lost to follow-up. 
Table 5. Baseline characteristics of the LASA study sample (N=2,399), according 
to the presence or absence of depressive symptomatology
CES-D 16+               CES-D <16
(N=296)                    (N=2,092)
Mean age (SD) 70.7 (8.7) 69.2 (8.5) p=0.0041
Sex
• Male                        104 (35.1%)               1060 (50.7%)       
• Female                    192 (64.9%)               1032 (49.3%) p=0.0002
Education
• ≤8 years                   186 (63.1%)               1194 (57.3%)
• >8 years                   109 (36.9%)              891 (42.7%) p=0.0542
Memory complaints
• No                          187 (63.2%)               1657 (79.2%)
• Yes                          109 (36.8%)               434 (20.8%)              p=0.0002
Note: the numbers do not always add up to 2,399 persons because of missing values on some variables
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cognitive decline
Figure 2: Sample description LASA
Table 6 shows the baseline characteristics for subjects who were and were not 
available for follow-up. 
At follow-up, 251 people showed a drop of 3 or more points on the  MMSE. 
Table 6. Baseline characteristics of the LASA study sample (N=2,399) for subjects 
who were and were not available for follow-up
Interview                    Lost to follow-up       p-value
(N=1,894) (N=505)                    
Mean CES-D score (SD) 7.1 (7.1) 8.2 (7.7) p=0.0051
CES-D score
< 16                                            1669 (88.4%)             423 (84.4%)          
16 and higher                              218 (11.6%) 78 (15.6%) p=0.0152
Mean negative affect (SD) 1.8 (2.7) 2.2 (3.1) p=0.0591
Felt depressed
Rarely or never                            1571 (83.0%)               401 (79.9%)
Some of the time                        253 (13.4%)                 65 (12.9%)
Often/always                               68 (3.6%) 36 (7.2%) p=0.0022
Mean age (SD) 68.5 (8.3) 72.8 (8.4) p=0.0003
Sex
Male                                           892 (47.1%)              278 (55.0%) 
Female 1002 (52.9%)              227 (45.0%)            p=0.0012
Mean baseline MMSE (SD) 28.2 (1.3) 27.8 (1.3) p=0.0001
Memory complaints
No                                              1463 (77.3%)              387 (76.6%)
Yes 430 (22.7%)              118 (23.4%)              p=0.7572
Education
≤ 8 years                                     1054 (55.7%)             334 (66.3%)
> 8 years 838 (44.3%)                170 (33.7%)             p=0.0002
Note: Not all numbers add up to 2,339 persons because of missing values on some variables.
1 Mann-Whitney U test
2 Chi-square test
3 t-test
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Multiple regression analyses adjusting for age, sex, education and memory com-
plaints showed that neither higher scores on the continuous CES-D nor CES-D
scores of 16+ were associated with subsequent cognitive decline (adjusted OR=1.01;
95% CI=0.99-1.03 and OR=1.07; 95% CI=0.70-1.62, respectively). However, negative
affect increased the risk of cognitive decline (adjusted OR per point increase=1.05;
95% CI=1.00-1.09). A severe depressed mood was also associated with subsequent
cognitive decline (adjusted OR=1.97; 95% CI=1.09-3.56), but a mild depressed mood
was not (OR=1.05; 95% CI=0.71-1.57).
When the interaction between CES-D (centered variable) and education (dichoto-
mous variable) was entered into the model containing CES-D (as a continuous vari-
able), age, sex, education and memory complaints, the association between depres-
sive symptoms and cognitive decline was modified by education (p=0.012). A similar
result was found when the dichotomized variable was used in the interaction term
(p=0.047) and when negative affect was used in the interaction term (p=0.017).
Finally, the interaction between a severe depressed mood and education was border-
line significant (p=0.076), but the interaction between mild depressed mood and
education was not (p=0.74). No significant interactions between depressive sympto-
matology and one of the other covariates were found.
Logistic regression analyses stratified by level of education showed that depres-
sive symptoms were associated with cognitive decline among subjects with more
than 8 years of education, but not among those with ≤8 years of education (Table 7).
Although the association between CES-D scores of 16+ and cognitive decline was
attenuated after adjusting for the possible confounders, higher scores on the contin-
uous CES-D, higher negative affect scores and a severe depressed mood remained
predictive of subsequent cognitive decline (Table 7). Among less educated subjects,
no association between depressive symptomatology and cognitive decline was
found, regardless of the definition of depressive symptomatology. When the multi-
variate analyses were performed with additional adjustments for baseline MMSE
score, the results were highly similar [Table 7].
 
Table 7. Associations (odds ratios with 95% confidence intervals) between four 
definitions of depressive symptomatology and subsequent cognitive decline, 
according to level of education (LASA)
Education*
> 8 years                   ≤ 8 years
(N=838) (N=1,054)
OR (95% CI) OR (95% CI)
CES-D score (per point increase)                 1.05 (1.02-1.08)†       1.00 (0.98-1.02)†   
1.04 (1.01-1.08)‡       1.00 (0.98-1.02)‡
1.05 (1.01-1.08)§         1.00 (0.98-1.02)§
CES-D score (16+ vs <16) 2.00 (1.05-3.81)†      0.83 (0.50-1.40)†
1.79 (0.91-3.51)‡      0.83 (0.49-1.41)‡
1.83 (0.93-3.60)§      0.84 (0.49-1.43)§
Negative affect score 
(per point increase)                                    1.14 (1.06-1.24)†        1.02 (0.96-1.07)†
1.13 (1.04-1.22)‡       1.01 (0.96-1.07)‡
1.13 (1.04-1.23)§         1.02 (0.96-1.08)§
Felt depressed 
(reference: rarely or never)
Some of the time                                       1.15 (0.57-2.31)† 1.06 (0.67-1.69)†
1.11 (0.54-2.29)‡        1.04 (0.65-1.68)‡
1.15 (0.56-2.38)§        1.03 (0.64-1.67)§
Often/always                                              4.39 (1.75-10.99)†     1.55 (0.75-3.21)†
3.92 (1.47-10.41)‡      1.44 (0.68-3.05)‡
4.10 (1.54-10.90)§     1.49 (0.70-3.16)§
The numbers do not add up to 1,894 persons because of some missing values on the variable education. 
† Crude associations
‡ adjusted for age, sex and memory complaints
§ adjusted for age, sex, memory complaints and baseline MMSE score.
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6.4 Discussion
We investigated whether depression in older people with normal cognition was asso-
ciated with subsequent cognitive decline and incident AD. Both the findings in AMS-
TEL and in LASA showed that depression increased the risk of AD and cognitive
decline, respectively, but only among people with higher levels of education.
Depression as a psychological reaction
Most commonly, two explanations have been suggested for the frequent occurrence
of depression in AD patients. First, depression may be a psychological reaction to
perceived cognitive decline (Migliorelli et al, 1995) that may play a role particularly in
mild stages of AD when patients may still be aware of their failing cognitive capaci-
ties (Ott et al, 1992). Although this explanation implies that depression is a conse-
quence of the dementia process, depressive symptoms may become apparent before
the diagnosis of AD is made. The development of AD is a gradual process that may
start long before the diagnostic criteria are met. Patients may notice these changes
in cognition at an early stage of the disease, and develop depressive symptoms as a
reaction. However, although the prevalence of depression has been found to be
inversely related to the severity of dementia (Fischer et al, 1990), others found no
association between depression and insight into cognitive deficits (Verhey et al,
1993; Cummings et al, 1995), suggesting that the association is not purely a psycho-
logical one. Moreover, if a psychological explanation were true, the association
between depression and incident AD would be modified by memory complaints,
since these may reflect realistic self-observation of cognitive decline (Geerlings et al,
1999). Although memory complaints were more prevalent among depressed sub-
jects than among nondepressed subjects, we did not find that the association
between depression and incident AD was stronger among those with memory com-
plaints. Finally, a psychological mechanism does not explain the observed interaction
between depression and education.
Depression as an early symptom of AD
Our data may be more in concordance with the second explanation that hypothe-
sizes that depression is an early symptom of the neuropathological process of AD.
Studies on neurochemical and neuropathological changes in the brain of AD
patients suggest that they may have lower thresholds for depressive disorders, or
that the dementia process contributes to the development of depression (Zubenko
& Moossy, 1988; Zweig et al, 1988; Förstl et al, 1992). It could be hypothesized that
depression as an early symptom or a subclinical expression of AD may have become
more overt in more highly educated subjects. More highly educated people may have
greater ‘reserve capacity’. This may be a ‘brain reserve’, reflected in a greater number
of large neurons, greater brain weight or increased neocortical synaptic density
(Katzman 1993), or a ‘cognitive reserve’, reflected in greater intellectual capacity or
more adequate coping skills to deal with the dementia process (Stern et al, 1994).
Several studies suggest the neuropathologic process of AD may be more advanced
in elderly people with higher educational and occupational attainment (EOA) com-
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pared with those with lower EOA (Stern et al, 1995a; 1995b) despite similar clinical
severity. Thus, it is possible that in people with greater (cognitive) reserve the cogni-
tive symptoms of AD may be delayed but not the depressive symptoms of the dis-
ease.
In the LASA sample, the association between depressive symptoms and cognitive
decline became stronger when the analyses were restricted to affective symptoms
and to a more severe form of these symptoms. The observation that a severe
depressed mood was strongly associated with subsequent cognitive decline may
also be supportive of the hypothesis that depression may be an early manifestation
of a dementia process. A severe depressed mood is a more specific indicator of
major depression (Meyers & Bruce, 1998) and this could be suggestive of some bio-
logical relationship rather than a purely psychological one (Migliorelli et al, 1995).
Psychiatric history
In the AMSTEL sample, no modifying effect of psychiatric history on the association
between depression and AD was observed as might have been expected if late onset
depression were associated with organic illness (Alexopoulos et al, 1988). However,
there may not have been enough observations in the subgroups to find the interac-
tion term to be statistically significant, since the majority (80%) of depressed people
at baseline reported no psychiatric history or a late onset history. This finding in
itself suggests that the depression that we observed in our study sample is indicative
of a dementia process.
LASA and AMSTEL
The most notable strength of this study was that we were able to analyze data from
two independent samples. Both the AMSTEL and the LASA study are prospective
community-based studies in the Netherlands; both cohorts contain elderly people
who were interviewed at home, and the follow-up interval between the first and the
second assessment of both studies was highly similar. An important difference is
that the samples were drawn independently of one another and for different purpos-
es. Moreover, depression and cognitive decline or dementia were assessed using dif-
ferent instruments. In the AMSTEL study depression was assessed with the GMSS,
which is an instrument based on the British tradition, while the CES-D, used in the
LASA study, is more widely used in the United States. Furthermore, although both
instruments measure a broad spectrum of depressive symptoms, the CES-D con-
tains fewer items than the GMSS and does not rely on clinical judgement of the
interviewer. With respect to the outcome variable, the differences between a clinical
diagnosis of AD and cognitive decline based on a subtraction score on the MMSE
may be even greater. In view of these differences in both determinant and outcome,
it is striking that the results of both the LASA and the AMSTEL study demonstrated
that depression increased the risk of cognitive decline and AD, only among subjects
with higher levels of education.
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Loss to follow-up
We have to consider that our findings may be biased due to differential loss to fol-
low-up. Particularly in the AMSTEL sample, the proportion of subjects lost to follow-
up was considerable. Although depressed people were not more likely to be lost to
follow-up in this sample, in the LASA sample depressed subjects did become lost
more often. However, we consider it unlikely that in the LASA sample the great dif-
ference in odds ratios between the two education groups for those with a severe
depressed mood is explained by differential loss to follow-up alone.
Summary
We observed in two independent community-based samples that depressed elderly
people with normal cognition and higher levels of education were at increased risk of
incident cognitive decline and AD. The data do not support the hypothesis that
depression is primarily a psychological reaction to deteriorating cognitive capacities.
Instead, they are supportive of the hypothesis that depression is a subclinical expres-
sion or an early symptom of an underlying dementia process, which may become
apparent in a subgroup of more highly educated older people in whom commonly
used mental status tests do not yet detect a decline from a previous level of cogni-
tive functioning. The data do not provide proof of possible pathogenetic mecha-
nisms, however, and it remains to be determined whether treatment of depression
would result in a delay of the clinical expression of cognitive decline and dementia.
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6.5.1 Clinical implications
1 Depression, and in particular a severe depressed mood, may be an early or 
suclinical manifestation of cognitive decline and AD in elderly people with higher
levels of education.
2 In these people, commonly used mental status tests, such as the MMSE, are 
inadequate to detect subtle cognitive decline.
3 The subclinical expression of cognitive decline or dementia may be different for 
different subgroups of elderly people, according to their educational level.
6.5.2 Limitations
1  Although our data confirm the clinical impression that late-onset depression is 
associated with organic illness, it is uncertain whether the question about 
psychiatric history in the AMSTEL study indeed assessed a history of depression.
2 The nature of this study does not allow any inferences on possible pathogenetic
mechanisms that may underlie the observed association between depression and 
incident AD.
3 Based on the findings of this study no suggestions can be made as to whether 
treatment of depression would result in a delay of the clinical expression of 
cognitive decline and dementia.
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Abstract
Background
The association between depression and increased mortality risk in older persons
may depend on severity of depressive disorder and gender.
Aims:
To investigate the association between major and ‘mild’ depressive syndromes
and excess mortality in community-living elderly men and women.
Method 
Depression (GMS-AGECAT) was assessed in 4051 older persons, with a six-year
follow-up of community death registers. The mortality risk of neurotic and psy-
chotic depression was calculated after adjustment for demographic variables,
physical illness, cognitive decline and functional disabilities.
Results
75% of men and 41% of women with psychotic depression had died at follow-up.
Psychotic depression was associated with significant excess mortality in both
sexes. Neurotic depression was associated with a 1.67-fold higher mortality risk
in men only.
Conclusions
In the elderly, major depressive syndromes increase the risk of death in both
sexes, mild depression only in men.
Declaration of interest
Grants detailed in Acknowledgements. No conflict of interest.
7.1 Introduction
The association between depression and an increased risk of death has been estab-
lished for major depressive disorder (Tsuang & Woolson, 1977), but remains incon-
clusive for more prevalent minor, or ‘mild’ depressive syndromes. Earlier studies in
the elderly differed in their assessment of depression, in controlling for physical
health, functional impairments and organic disorder, and in follow-up time
(Davidson et al, 1988, Fredman et al, 1989, Thomas et al, 1992, Sharma et al, 1998,
Pulska et al, 1998). Although the association between depression and mortality may
be gender-related (Zheng et al, 1997), this possible effect modifier has rarely been
examined. In order to establish the relationship between depression and mortality in
the elderly, studies are needed that include a range of potential risk factors, with a
sufficient sample size and follow-up time, and specific attention to gender differ-
ences and to different depression severity levels. The current study has these charac-
teristics.
7.2 Methods
7.2.1 Sample
The study is part of the Amsterdam Study of the Elderly (AMSTEL), a longitudinal
study designed to screen a large and representative sample of  non-institutionalised
community living older persons on mental health problems, medical diagnoses and
demographic characteristics. The sampling and data collection procedures and non-
response have been described in depth elsewhere (Launer et al, 1993, 1994). In
short, a random sample was drawn from the registers of 30 general practices in the
city Amsterdam. These registers include almost all of the non-institutionalised popu-
lation, who have to consult their general practitioner to gain access to the health
care system. The mean proportion of elderly individuals (15%), and the profile of the
over-65 general practice-population in terms of age and gender, corresponded to the
non-institutionalised Amsterdam population. An age-stratified sample was drawn in
the 65 to 84 age bracket, and all those who responded and gave their informed con-
sent were interviewed (71.5%). In total, 4051 subjects were enrolled for the baseline
interviews, which were conducted between May 1990 and November 1991.
7.2.2 Baseline measures
A one-hour interview was developed to gather information on psychiatric symptoms,
demographic and medical status, previous history and family history. The interview
consisted of the Dutch translation of the Mini-Mental State Examination (Folstein et
al, 1975), all Geriatric Mental State Examination-items related to organic, affective
and anxiety syndromes (Copeland et al, 1986), the Activities of Daily Living (ADL)
scale (Katz et al, 1963), the Instrumental Activities of Daily Living (IADL) scale
(Lawton and Brody, 1969), and the CAMDEX-interview (Roth et al, 1986). The inter-
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view was administered during home visits by lay interviewers who were specially
trained using video sessions and were regularly supervised.
Depression and dementia. Diagnoses of dementia and depression were made
according to the GMS-AGECAT system (Copeland et al, 1986, 1988).  The Dutch lan-
guage version has proven reliability for epidemiological work in replication studies
(Hooijer et al, 1991). Depression caseness was defined as a GMS-AGECAT level 3 or
higher. A distinction is made between neurotic and psychotic depression, indicating
increasing severity levels of depression.
Sociodemographic factors. Potentially confounding covariates were age, sex and
level of education. Educational status was dichotomised into lower (primary school
or less) and higher (more than primary school) education. 
Environmental vulnerability factors. Marital status was assessed based on the
questions in GMS-AGECAT.
Physical health. The presence of chronic diseases was assessed with the perti-
nent Camdex questions on cardiovascular diseases, cancer, lung disease, diabetes,
Parkinson’s disease, arthritis and epilepsy. Cognitive status was assessed by MMSE-
score. Subjects were considered to have functional disability if their ADL or IADL
scores were two or more points below the maximum score on the respective scales.
7.2.3 Mortality
The follow-up for recording deaths extended from the date of the clinical examina-
tion until the first of July 1996. The dates of death were ascertained through the reg-
isters of the municipality of Amsterdam, or the municipalities where subjects had
moved to during the study period. The follow-up period was 6 years, with an average
of 55.5 months (sd 16.7) ranging from 1 to 73 months. Data were missing on 6 sub-
jects (0.1%).
7.2.4 Data analysis
Baseline sample characteristics were compared between men and women, using chi-
square statistics. Mortality rates per 1000 person-years were calculated according to
depressed mood status. Bivariate associations of mortality at follow-up (deceased or
alive on 01-07-1996) with independent variables at baseline were assessed by calcu-
lating relative risks. When the 95% confidence interval of the latter did not include
one, the association was regarded to be statistically significant. 
Kaplan-Meyer curves and Cox proportional hazard regression models were used to
further examine the association between depression and time to mortality in men
and women separately. The mortality risk was expressed as the mortality rate ratio
(R.R.). In multivariate analysis, the effect of depression on mortality was studied for
the two levels of depression (neurotic/psychotic), with successive adjustment for
potential confounding factors: sociodemographic factors, environmental factors, car-
diovascular and other chronic diseases, cognitive decline and functional disability. As
disability may be a consequence of depression (Penninx et al, 1998) and therefore
may cause overcorrection for the effect of depression on mortality, this variable was
entered as a last, separate step. The difference between two mortality rate ratios was
considered to be statistically significant if the confidence intervals of either variable
did not overlap with the value of the opposing variable.
7.3 Results
7.3.1 Sample characteristics
Depression prevalence at baseline was 12.9% overall (neurotic 10.9 %, psychotic 2.0
%), with 6.9 % depression in men and 16.5 % in women. The demographic and
functional profiles of the study sample are presented in [Table 1]. In bivariate analysis
men and women differed on most disease variables: men had more myocardial
infarction and lung disease, women had more arthritis and diabetes. Functional dis-
abilities were more common in women. The majority of men (72.6 %) were married,
whereas women were more often not or no longer married (65.8 %).
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TABLE 1: BASELINE SAMPLE CHARACTERISTICS FOR MEN AND WOMEN
(*= p<0.05, **= p<0.01, ***= p<0.001, ns= not significant; p>0.05)
VARIABLES MEN(%) WOMEN(%) STATISTICS
Chisq/df/p
N 1523 2528 
Depression                                                                                                                    82.1/1/***
None                                                         1418 (93.1)                 2110 (83.5)
Neurotic                                                      81 (5.3)                      360 (14.2)
Psychotic 24 (1.6)                     58 (2.3)
Age                                                                                                                              23.3/3/***
65-69                                                         350 (23.0)                  486 (19.2)
70-74                                                          396 (26.0)                 578 (22.9)
75-79                                                           389 (25.5)                  661 (26.1)
80-86                                                          388 (25.5)                 803 (31.8)
Education                                                                                                                      79.9/1/***
More than Primary School                           1014 (66.6)                1321 (52.3)
Primary School or less 509 (33.4)                  1207 (47.7)
Myocard.infarction: 
No/never                                                    1298 (85.2)                 2337 (92.4)                53.7/1/***
Yes 225 (14.8)                191 (7.6)
Stroke: 
No/never                                                    1428 (93.8)                 2392 (94.7)               Ns
Yes                                                             95 (6.2)                    135 (5.3)
Cancer: 
No/never                                                    1369 (89.9)                2233 (89.9)                Ns
Yes 154 (10.1)                   295 (11.7)
Lung disease:                                                                                                                26.5/1/***
No/never                                                    1215 (79.8)                 2173 (86.0)                
Yes 308 (20.2) 355 (14.0)
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VARIABLES MEN(%) WOMEN(%) STATISTICS
Chisq/df/p
Arthritis: No                                               1378 (90.5)                1979 (78.3)                 99.6/1/***
Yes 145 (9.5)                   549 (21.7)
Diabetes: No                                               1405 (92.3)                2286 (90.4)               3.9/1/*
Yes 118 (7.7)                     242 (9.6)
Epilepsy: No/never                                    1497 (98.3)                 2484 (98.3)                Ns
Yes                                                             26 (1.7)                      44 (1.7)                      
Parkinson’s: No                                          1493 (98.0)                2499 (98.9)               4.5/1/*
Yes 30 (2.0)                     29 (1.1)
MMSE                                                                                                                        12.06/2/**
26-30                                                         1274 (83.7)                 2007 (79.4)
22-25                                                          163 (10.7)                359 (14.2)
0-21 86 (5.6)                     162 (6.4)
ADL disability                                                                                                              10.5/1/**
None                                                          1425 (93.8)                 2293 (90.9)
Yes                                                            95 (6.3) 230 (9.1)
IADL disability                                                                                                            33.1/1/***
None                                                          1205 (79.4)               1796 (71.2)
Yes 313 (20.6)                 726 (28.8)
Marital status                                                                                                               560/1/***
Married                                                    1105 (72.6)               865 (34.2)
Unmarried 417 (27.4)                 1661 (65.8)
Social support                                                                                                              58.3/1/***
None                                                          1302 (85.5)                 1907 (75.4)
Yes                                                            221 (14.5)                  621 (24.6)
134 Epidemiology of late life depression
135Chapter 7  |  The association of depression and gender with mortality in old age
7.3.2 Associations of risk factors with mortality
The total follow-up time of the sample was 18726 person years. 1035 (25.6 %) sub-
jects had died during the study period. The crude mortality rate was 55.3 deaths per
1000 person-years. Bivariate analysis of baseline characteristics with mortality
showed that all risk factors, except arthritis, were associated with mortality in both
men and women [Table 2]. 75% of men with psychotic depression had died at follow-
up, whereas in women this was ‘only’ 41.4%. The presence of neurotic depression
doubled the mortality in men, from 30.3% (without depression) to 59.3%. In women
the presence of neurotic depression only slightly raised the mortality from 20.5% to
23.1% (mortality risk not statistically significant).
In Kaplan-Meyer analysis, depression was found to have a significant negative effect
on survival. This effect was more pronounced in men than in women. In men, both
neurotic and psychotic depression were associated with higher mortality, in women
this was only the case for psychotic depression [Figures 1 and 2]. 
Stepwise hierarchical regression using the Cox proportional hazards model, with
successive adjustment for potential confounding and explanatory variables, also
showed different results for men and women [Table 3]. In women, the mortality risk
for ‘all depression’ was significantly lower than in men, and was reduced to a statis-
tically non-significant level when adjusting for other variables. The unadjusted mor-
tality risk for neurotic depression was not statistically significant in women (R.R.
1.14, 95% C.I. 0.90-1.45), and less than half of the associated mortality risk in men
(R.R. 2.67, 95% C.I. 1.98-3.60), yielding a statistically significant difference between
the sexes. In men, the higher initial mortality risks for both all depression and for
neurotic depression still showed a statistically significant impact of depression after
adjustment for all other possible explanatory factors.
Although the initial mortality rate ratio for psychotic depression was considerably
higher in men (R.R. 3.77 vs. 2.43 in women), the difference was not statistically sig-
nificant. Successive adjustment for other variables then reduced the mortality rate
ratio for psychotic depression in both men and women to a statistically non-signifi-
cant level. However, if the last step, adjustment for functional disabilities, was not
taken into account, the mortality rate ratio for psychotic depression in women
remained statistically significant (R.R. 1.66, C.I. 1.08-2.55), whereas in men it only
just failed to reach statistic significance (R.R. 1.64, C.I. 0.96-2.78). It should be noted
that, especially in men, the numbers of psychotically depressed patients were rather
small to perform statistical testing with a relatively large number of control variables
(24 psychotically depressed men, 58 psychotically depressed women). Finally, there
were no substantial interactions between depression (all, neurotic, psychotic) and
somatic or organic disorders in both men and women.
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TABLE 2: BIVARIATE ASSOCIATIONS OF RISK FACTORS WITH MORTALITY IN MEN AND WOMEN 
(Deceased or alive on 01-07-1996, % deceased of baseline category, mortality rate ratio with 95% 
confidence interval, * reference category)
MORTALITY                 MEN% (n)     Mortality risk            WOMEN)              Mortality risk
(95% c.i.) % (n                      (95% c.i.)
TOTAL 32.6 (496)                                     21.4 (539)
Depression: 
None *                         30.3                                                20.5
Neurotic                       59.3              1.95 (1.60-2.38)         23.1                        1.13 (0.92-1.39)
Psychotic                      75.0             2.47 (1.94-3.15)          41.4                       2.02 (1.47-2.77)
Age: 
65-69 *                        15.4               8.7
70-74                            21.2             1.37 (1.01-1.88)          14.6                       1.68 (1.19-2.39)
75-79                        37.8           2.45 (1.86-3.23)         22.0                     2.54 (1.84-3.50)
80-86 54.5             3.53 (2.72-4.59)         33.4                       3.86 (2.84-5.24)
Education:
More than P.S.            29.3                                               18.6 
Primary School or less 39.1            1.33 (1.15-1.54)           24.4 1.31 (1.13-1.53)
Myocard.inf.: 
No/never                    31.0                          20.2
Yes 41.8            1.35 (1.13-1.61)           35.6 1.76 (1.43-2.17)
Stroke: No/never         31.7                           20.7
Yes 45.3             1.42 (1.13-1.80)         33.3 1.61 (1.25-2.07)
Cancer: No/never        31.1                                              20.6
Yes                           46.1 1.48 (1.23-1.79)         27.2                      1.32 (1.07-1.62)
Lung disease: No          28.9                                               20.5
Yes 47.2             1.63 (1.41-1.89)        26.8                     1.31 (1.08-1.59)
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TABLE 2: BIVARIATE ASSOCIATIONS OF RISK FACTORS WITH MORTALITY IN 
MEN AND WOMEN (Deceased or alive on 01-07-1996, % deceased of baseline 
category, mortality rate ratio with 95% confidence interval, * reference category)
MORTALITY                 MEN% (n)    Mortality risk             WOMEN                Mortality risk
(95% c.i.) % (n)                   (95% c.i.)
TOTAL 32.6 (496)                                     21.4 (539)
Arthritis: No             32.2                                              21.3
Yes                            36.1 1.12 (0.89-1.41)        21.6                     1.01 (0.85-1.21)
Diabetes: No            31.3                                              20.0
Yes 47.5              1.51 (1.23-1.86)           34.3                       1.72 (1.41-2.08)
Epilepsy: No/never        32.2                                               21.1
yes                               53.8 1.67 (1.16-2.40)          38.6                       1.83 (1.25-2.68)
Parkinson’s: No          32.1                                                21.2
Yes                             58.6 1.83 (1.33-2.50)           37.9                       1.79 (1.12-2.87)
MMSE:
26-30 *                        27.3                                                17.5
22-25                        56.8              2.08 (1.77-2.44)         28.5                       1.63 (1.34-1.97)
0-21 65.1               2.38 (1.99-2.85)        53.1                       3.03 (2.55-3.60)
ADL disability
None                          29.5                                               19.3
Yes                               78.9 2.68 (2.35-3.05)         40.9                      2.12 (1.77-2.52)
IADL disability 
None                           25.7                                                 14.3
Yes                             58.5 2.27 (1.99-2.60)         38.3                       2.67 (2.31-3.09)
Marital status
Married                        30.6              17.4
Unmarried 37.7              1.23 (1.06-1.44)         23.5                       1.35 (1.14-1.60)
Social support
None                           29.6                                                18.4
Yes                              50.5 1.71 (1.46-1.99)        30.4                      1.65 (1.42-1.93)
138 Epidemiology of late life depression
Women
Survival time (months)
Log-rank test p=0.0001
C
um
ul
at
iv
e 
su
rv
iv
al
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Figure 2: Kaplan-Meyer survival curve for men
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UNADJUSTED 
RATIO                          1.30 (1.05-1.60)        1.14 (0.90-1.45)          2.43 (1.61-3.67)                                                   
ADJUSTMENT
FOR*:
+ age, education           1.28 (1.04-1.59)       1.13 (0.90-1.43) 2.43 (1.61-3.67)
+ marital status            1.28 (1.04-1.59)       1.13 (0.89-1.43)          2.43 (1.61-3.67)
+ myocard. infarction, stroke   1.26 (1.02-1.56)        1.13 (0.89-1.43) 2.26 (1.49-3.43)
+ other diseases                      1.18 (0.95-1.47)       1.05 (0.83-1.34)           2.05 (1.35-3.14)
+ MMSE                                  1.11 (0.89-1.38)        1.02 (0.80-1.30)         1.66 (1.08-2.55)
+ ADL, IADL disability             0.99 (0.79-1.23)       0.93 (0.73-1.18)         1.37 (0.88-2.10)
(* stepwise analysis, subsequently adding independent variables to the model)
MORTALITY RATE
RATIO
FOR DEPRESSION
WOMEN
All depression 
(418) Vs none
N=2528
Neurotic (360) 
Vs none
N=2470
Psychotic (58) 
Vs none
N=2168
TABLE 3: MORTALITY RATE RATIOS FOR DEPRESSION IN MEN AND WOMEN 
WITH SUCCESSIVE ADJUSTMENT FOR POTENTIAL CONFOUNDERS AND 
EXPLANATORY VARIABLES (Cox proportional hazards model, 95% C.I.) 
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Psychotic (24) 
Vs none
N=1442
MEN
All depression 
(105) Vs none
N=1523
Neurotic (81) 
Vs none
N=1499
2.90 (2.23-3.76)       2.67 (1.98-3.60)       3.77 (2.35-6.05)
2.65 (2.04-3.44)      2.47 (1.83-3.34)       3.25 (2.02-5.22)
2.68 (2.06-3.49)      2.49 (1.85-3.37)       3.27 (2.02-5.30)
2.49 (1.90-3.25)       2.35 (1.74-3.19)        2.78 (1.70-4.54)
2.05 (1.54-2.71)        1.90 (1.39-2.60)       2.26 (1.34-3.82)
1.88 (1.42-2.49)       1.90 (1.39-2.59)       1.64 (0.96-2.78)
1.60 (1.20-2.15)        1.67 (1.22-2.30)       1.26 (0.73-2.18)
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7.4 Discussion
This study sought to identify if depression may influence survival in community-liv-
ing elderly. Due to the large sample size, the relatively long follow-up time and the
incorporation of a wide range of other risk factors of mortality, the design of the
study was suitable to perform this task. Specific attention was paid to gender differ-
ences, and to differences in depression severity level, based on the hypothesis that
these two aspects may be important in understanding some of the contradictory
findings of earlier studies.
Main findings
The overall prevalence of depression (12.9%) was well within the range of what has
been found in other studies of depression in community-living elderly (Beekman et
al, 1999). The unadjusted mortality risks showed depression to be associated with
mortality, with a considerably stronger impact on survival of the more severe, psy-
chotic depression. This trend is consistent with earlier findings (Penninx et al, 1999),
and confirms that the more severe the depression is, the higher the associated mor-
tality. 
These effects, however, were modified by gender. Although, consistent with the
literature (Wolk & Weisman 1995), the total prevalence of depression was found to
be 2.4 times higher in women than in men, its negative effect on survival in women
was less pronounced. A very large proportion of psychotically depressed men (75%)
had died after a follow-up of six years, whereas in women this was clearly lower,
although still considerable (41.4%). Likewise, neurotic depression in men showed a
much higher mortality risk than in women. 
After controlling for other explanatory variables, this overall impression did not
change. The mortality risk of psychotic depression remained statistically significant
in women, and very nearly significant in men, when the last step in subsequent
adjustment was not taken into account. As functional disability has been found to be
a consequence of depression, and the numbers of psychotically depressed men were
rather small, it appears to be a reasonable conclusion that psychotic depression is
associated with a higher mortality risk in both men and women. The gender differ-
ences were however most striking when investigating the more prevalent neurotic
depression. Even unadjusted, neurotic depression in women was not found to be
significantly associated with mortality. The mortality risk in men however remained
statistically significant after controlling for all competing factors that may have
affected survival. 
Methodological considerations
A first methodological explanation for the gender differences observed may be that
there has been report bias, differentially affecting prevalence rates of depression in
men and women. One possible explanation is that women are culturally more prone
to report depressive complaints, and therefore have higher depression scores. A de-
facto broader definition of depression in women would thus conceal the real effect
that more severe, clinically relevant levels of depression may have on mortality.
There are some data that support this proposition (Angst et al, 1984), but most
studies failed to confirm it (Wolk & Weissman 1995). Symptom-patterns in men and
women are very much alike and studies in different adult age groups consistently
show a female preponderance in depression (Sonnenberg et al, 2000). If the current
study would only take into account psychotic depression, the gender distribution of
this condition would be found to be less skewed (women have 1.4 times more psy-
chotic depression than men, instead of 2.7 times that of men in neurotic depres-
sion). Still, the mortality rate ratio for psychotic depression was almost two times
higher in men, demonstrating a robust difference between the effects of depression
in men and women.
A second methodological explanation for the observed gender difference may be
that depressed subjects are more inclined to report negatively about their own health
(Raphael & Cloitre, 1994). In studies such as ours, in which every effort was made to
control for confounding, report bias may lead to overcorrection in multivariate analy-
sis. Due to the higher prevalence of depression, this effect may be stronger in
women. However, the unadjusted mortality rate ratios for depression are already
much lower or statistically insignificant in women, suggesting that a possible con-
trol-bias does not account for the difference. Report bias thus appears to be an
improbable explanation for the observed gender-differences.
A third source of bias may be selective non-response. A previous study in this
sample by Launer et al (1994) revealed that nonresponders to the baseline assess-
ment more often reported a heart attack, stroke, and diabetes, and were more likely
to be unmarried, to have a lower education, to do poorly on cognitive tests and to
have a history of psychiatric illness. There were no differences in response rate
between men and women (OR 1.0, C.I. 0,6-1,5). We therefore conclude that only the
very ill and cognitively impaired may have been underrepresented in the current
study. This appears similar to the nonresponse pattern found in other community
studies. Risk factors for mortality were however well represented in men and women
throughout the age strata of the study population. Due to the efficient functioning of
Dutch community registers, measurement of the outcome variable of this study was
99.9% complete. Thus, the results do not appear to be fundamentally affected by
this nonresponse pattern.
The conclusion is therefore justified that depression is associated with a higher
mortality in older men than in older women. This is especially true for depression
syndromes generally considered ‘milder’, which do not meet criteria for major
depressive disorder. Our findings offer an explanation for some of the contradictory
findings of earlier studies on pervasive or minor depression and mortality, most of
which did not specifically address gender as an effect modifier.
Implications
Both the theoretical and clinical implications of this finding are considerable. Earlier
research has shown that depressive symptoms are of major importance to physical,
social and role functioning (Beekman et al, 1997). Our data show that depression
also exerts an influence on mortality in men, after controlling for the effects of a vari-
ety of serious somatic conditions. Even though there is growing consensus on the
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fact that mild or ‘subthreshold’ depressive syndromes (not meeting full diagnostic
criteria for DSM-IV or ICD-10) identified by screening methods such as GMS-AGE-
CAT deserve clinical attention (Pincus et al, 1999), recognition is poor (German et al,
1987). The majority of depressed patients living in the community do not receive any
specific treatment for their depressive complaints. Treatment studies however con-
firm the gender-specific pattern, and suggest that the potential effect of depression
on mortality can be affected by treatment. Avery and Winokur (1976) showed that
treatment of clinically admitted patients with major depression significantly reduced
the number of deaths through myocardial infarctions. They found the impact of ade-
quate treatment of depression to be especially influential on the survival of older
men. A study by Craig et al (1981), comparing pre-drug era and post-drug era patient
samples, revealed that the decline in mortality associated with the introduction of
psychiatric drug treatment was also especially marked in elderly men. 
Possible explanations for the observed gender-differences
Although it has since long been pointed out that untreated depressed subjects tend
to be in worse health due to continuous agitation, malnourishment, intercurrent
infections and cardiovascular problems (Malzberg, 1937), and are also more likely to
die from accidents or suicide (Tsuang et al, 1978), a clear explanation for the sex spe-
cific pattern has not been provided. 
A first explanation may be that men have more cardiovascular pathology, the
course of which is affected more strongly by comorbid depression. A number of
studies have shown depression to be related to a less favourable course of cardio-
vascular disease (Avery and Winokur 1976, Frasure-Smith 1995). These studies how-
ever investigated the impact of major depression, and not of less severe depressive
syndromes. 
A tentative psychological explanation for the excess mortality in men, may be that
men are less equipped to deal with feelings of hopelessness and depression than
women. Women are more inclined to discuss such feelings with others (Briscoe et
al, 1982), are more open to accept support from others when experiencing them
(Longino and Lipman, 1981), and therefore are more able to sustain and overcome
feelings of depression (Grootheest et al, 1999). The male coping style is more exter-
nalising, and feelings of depression will only be experienced by men when other,
more typical forms of coping have not been successful. A depressive syndrome in
men thus signifies a more invalidating and threatening condition than such a syn-
drome in women, which is reflected in the robust differences in mortality. 
A third, possibly related mechanism explaining the gender differences we found, may
be that depressed elderly men are more inclined to commit suicide than depressed
women (Conwell et al, 1996). 
As the current data do not include the causes of death, the question on the exact
mechanism can not directly be addressed. The finding of a relation between ‘milder’
depression and mortality, especially in elderly men, is however robust in this study. If
the clinician were to focus solely on patients with DSM IV major depressive disorder
(A.P.A., 1994), a diagnostic convention imposed on a continuum of depressive
symptoms of varying severity and duration, this appears once more to be an under-
 
estimation of the actual level of morbidity. Although the majority of the community-
dwelling elderly with depressive syndromes that were investigated in this study had
not been treated for depression, earlier data suggest that they might have derived
important benefits from it. With an average total prevalence of 13.5% (Beekman et al,
1999), late-life depressive syndromes are likely to be found in all medical settings,
and may affect the course of a variety of conditions. This study lends a strong basis
to the notion that, together with patients suffering from more severe levels of
depression, especially elderly men with neurotic or ‘minor’ depression deserve to be
recognised and treated more vigorously than is currently practised.
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7.5.1 Clinical implications
1  Late-life depression is associated with excess mortality, with a higher impact 
of more severe levels of depression. 
2 Major depressive syndromes are associated with excess mortality in both sexes. 
Mild or minor depressive syndromes are related to a higher mortality risk in 
older men, but not in older women.
3 Late-life depression often remains unrecognised and untreated by the health  
services. Research however suggests that, together with other vital aspects 
of life, survival may be positively affected by adequate treatment of depression.
7.5.2 Limitations
1  The current data do not include the causes of death, the question on the exact 
mechanism linking depression and mortality can therefore not be directly 
addressed.
2  Selective attrition to the baseline assessment of the study has probably 
occurred  among the very frail.
3  The study is a naturalistic follow-up in the community, not controlling for 
(low levels of) ongoing treatment. 
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Depression and 
excess mortality; 
a bio-psycho-social 
relationship?
8
Abstract
Depression is a highly prevalent disorder at all levels of health care delivery.
Depression is associated with an untoward course of medical illnesses, and with
excess mortality. Several mechanisms may contribute to these associations. First of
all, depression affects behaviour. Depressed patients have more unhealthy living
habits, are less compliant with medical treatment, and show a higher number of
accidents and suicides. Secondly, biological aspects of depression are important in
the context of an association with excess mortality. Dysregulation of the neuro-
immune system, hyperactivity of the HPA-axis, and autonomic dysregulation may all
have a negative effect on both the prognosis of somatic illnesses and longevity. A
third aspect of interest is depression treatment. Although the beneficial effects of
pharmacotherapy for depression are uncontested, this also has side effects. It
remains unclear whether treatment may affect survival. Further research is needed to
disentangle the mutual influences of depression and somatic illnesses, to search for
possible pathogenetic mechanisms that may underlie both depression and medical
disorders, and to assess the effects of depression treatment on biological dysregula-
tions and survival. 
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8.1 Introduction
Depression is a highly prevalent psychiatric disorder in adult populations (Kessler et
al. 1994). The negative influence of depression on physical and social functioning,
subjective health, pain and the use of health care facilities is comparable with, or
even greater than that of chronic physical illnesses (Hays et al. 1995;Ormel et al.
1998;Wells et al. 1989).
Depression also affects longevity. In large community studies among both
younger adults (Zheng et al. 1997) and older persons (Penninx et al. 1999), an asso-
ciation has been found between depression and excess mortality(Schoevers et al.
2000). The same association was found in medical patients. 
Excess mortality associated with depression has been described in patients with
myocardial infarction(Frasure-Smith, Lesperance, & Talajic 1995), diabetes (Black &
Markides 1999;Honig 2000), kidney disease (Peterson et al. 1991), cancer (Pirl &
Roth 1999;Spiegel & Giese-Davis 2003), and numerous other illnesses (Herrmann-
Lingen, Klemme, & Meyer 2001;Katon 2003). In these studies, depression was asso-
ciated with an excess mortality risk of 1,5 to 5 times that of patients without comor-
bid depression (Cole & Bellavance 1997;Wulsin, Vaillant, & Wells 1999). The associa-
tion of depression with excess mortality appears to be independent of the mortality
risk that can be attributed to physical illnesses (Cuijpers & Smit 2002;Katon
2003;Penninx et al. 2001).
Findings such as the above have been described not only for major depression,
the most severe form of depression (American Psychiatric Association, American
Psychiatric Association, & Task Force on DSM-IV 1994), but also for less severe or
minor depression (Enzell 1984;Ganguli, Dodge, & Mulsant 2002;Penninx, Geerlings,
Deeg, van Eijk, Van Tilburg, & Beekman 1999). Minor or ‘subthreshold’ depression
is a term to define clinically relevant forms of depression associated with significant
social and functional impairment, although they remain below the diagnostic thresh-
old for major depression (Pincus, Davis, & McQueen 1999). In this paper, ‘depres-
sion’ includes also minor or subthreshold depression. In community studies, the
prevalence ranges from 9 to 20% (Beekman, Copeland, & Prince 1999). In medical
patients the prevalence of depression is around 25%, and even higher in patients
with more severe medical conditions (Katon & Sullivan 1990;Kessler, McGonagle,
Zhao, Nelson, Hughes, Eshleman, Wittchen, & Kendler 1994). Inversely, depressed
patients also have higher levels of physical illnesses (Wells et al. 1991), including a
higher incidence of cardiovascular pathology and myocardial infarctions (Ford et al.
1998;Wulsin & Singal 2003). 
These data underline the importance of depression for both the prognosis of the
individual patient in primary and secondary care, and for public health. Still, there is
limited consensus on the mechanisms that may explain the association between
depression and excess mortality. The current paper presents a brief overview of the
mechanisms that have been put forward in the literature (Medline search with title
words: ‘depression and mortality’, from  1977-2002). Explanations for the depres-
sion-mortality association can be divided into two domains. The first domain con-
cerns the behaviour of depressed patients and the implications this may have for
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onset and course of medical illnesses. The second domain is that of the biological,
possibly pathogenic, mechanisms that may be associated with depression, physical
illnesses and different forms of treatment.
8.2 Depression and illness behaviour
Depression is associated with unhealthy nutritional habits and life styles (Krauchi,
Reich, & Wirz-Justice 1997;Wallin & Rissanen 1994), a decrease in physical activities
(Stephens 1988), smoking and excessive alcohol use (Aneshensel & Huba 1983;van
Gool et al. 2003). Through these mechanisms, depression most probably affects
both physical health (Wells, Golding, & Burnam 1988), and mortality risk (Katon
2003).
In medical patients, treatment adherence is negatively affected by comorbid
depression (Blumenthal et al. 1982;Carney et al. 1995a;Cooper-Patrick et al.
1999;Ziegelstein et al. 2000). A recent meta-analysis covering the last 30 years,
clearly showed that the presence of depression triples the chance of non-compliance
with medical treatment in a large number of somatic illnesses (DiMatteo, Lepper, &
Croghan 2000). A separate meta-analysis on non-compliance in diabetes patients
demonstrated a significant association between hyperglycaemia and comorbid
depression, in both early and late onset diabetes patients (Lustman et al. 2000).
Also by affecting treatment adherence, depression may be associated with an unto-
ward prognosis of medical illnesses.
Another form of behaviour associated with depression is suicidality. Studies on
the prognosis of patients with psychiatric disorders consequently show higher mor-
tality levels through suicide. Still, other forms of unnatural causes of death, such as
accidents, are also found in excess in depressed patients (Black, Warrack, & Winokur
1985), especially when patients also have somatic illnesses (Brodaty et al.
1997;Hoyer, Mortensen, & Olesen 2000;Tsuang & Woolson 1978). Although it may
not be easy to determine whether death has occurred through suicide or parasuicidal
behaviour, especially in the presence of comorbid physical illnesses requiring med-
ical treatment, it has become clear that not all of the excess mortality associated
with depression can be attributed to suicide (Lindesay 1989;Maris 2002;Murphy et
al. 1988;Murphy et al. 1987;Penninx, Beekman, Honig, Deeg, Schoevers, van Eijk, &
Van Tilburg 2001).
8.3 Depression and biological dysregulation
Research in depressed patients has demonstrated dysregulations of a number of
neuro-endocrinal circuits. Examples of this are hyperactivity of the HPA
(Hypothalamic-Pituitary-Adrenocortical) axis, activation of the autonomic nervous
system, and activation of pro-inflammatory cytokines. Such dysregulations frequently
occur in combination, and may constitute a possible pathogenic basis for the associ-
ation between depression and the occurrence or untoward cause of physical illness-
es. 
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8.3.1 Pathogenic mechanisms
The association of depression with hyperactivity of the HPA-axis has often been
replicated, and is usually demonstrated by either the dexametason suppression test
or the dexametason-CRH (Corticotrofine Releasing Hormone) test. These tests show
abnormal values in 25 to 80% of depressed patients (Holsboer 2000;Pariante
2003;Raison & Miller 2003). An excess production of CRH in the hypothalamus
leads to higher release of adrenocorticotrophic hormone (ACTH) in the pituitary
gland, resulting in hypercortisolemia and hypertrofia of the adrenal cortex
(Musselman & Nemeroff 1996). Dysregulation of the HPA axis may be due to a dis-
turbed negative feedback of the glucocorticoid receptors in the hippocampus and
the paraventricular nucleus of the hypothalamus (Holsboer 2000). Through a similar
mechanism, chronic stress may also cause depression. Hypercortisolemia not only
causes depressive symptoms, but also has physical consequences such as insulin
resistance and accumulation of visceral fat (Bjorntorp & Rosmond 1999). The com-
bination of ‘upper-body obesity’, glucose intolerance, hypertension and hypertriglyc-
eridemia (the “deadly quartet”) is associated with an elevated cardiovascular risk
(Kaplan 1989). Through alterations in both behaviour (decreased physical activities)
and neuroendocrine systems (hypercortisolemia) depression also leads to a
decrease in bone density and a higher risk of fractures; women with a personal histo-
ry of depression had lower bone density than matched controls, in combination with
higher levels of urinary cortisol (Michelson et al. 1996).
Genetically determined disturbances in cerebral glucocorticoid receptor function-
ing appear to play an important role in the pathogenesis of affective disorders
(Muller, Holsboer, & Keck 2002). Hyperactivity of the HPA axis is found significantly
more often in first grade family members of patients with affective disorder (Krieg et
al. 2001). It is therefore not unlikely that genetic disturbances in the functioning of
the HPA-axis are associated with a higher prevalence of both depression and somat-
ic illnesses.
A second important pathophysiological mechanism is the association between
depression and neuro-immune dysregulation. Depression is associated with higher
levels of pro-inflammatory cytokines, such as interleukine-1 en interleukine-6 (Maes
et al. 1995;Penninx et al. 2003). An acute phase response, with elevated levels of C-
reactive protein (CRP) and alpha-1 anti chymotrypsin (alpha-1-ACT), activation of
interleukin-1 receptors in the paraventricular nuclei of the hypothalamus, and higher
release of CRH leads to higher adrenocortical production of cortisol (Maes, Meltzer,
Bosmans, Bergmans, Vandoolaeghe, Ranjan, & Desnyder 1995;Sapolsky et al. 1987).
Excess concentrations of interleukin-6 and CRP are associated with a higher risk of
myocardial infarction and stroke (Ridker et al. 1998;Ridker et al. 2000;Ridker, Glynn,
& Hennekens 1998). In line with this, an infiltration of inflammatory cells is found in
all stages of  atherosclerotic plaque formation (Shah 2000). The neuro-immune dys-
regulation associated with depression may thus be related to both onset and unto-
ward course of cardiovascular pathology (Musselman, Evans, & Nemeroff 1998).
Still, it remains unclear whether depression precedes neuro-immune dysregulation
or whether it is a consequence. The latter possibility is illustrated by the finding that
low doses of endotoxines may cause symptoms of depression, anxiety and memory
153Chapter 8  |  Depression and excess mortelity; a bio-psycho-social relationship?
complaints in healthy volunteers (Reichenberg et al. 2001). 
Thirdly, depression is also associated with sympathoadrenergic dysregulation,
with elevated levels of norepinephrine and its metabolites (Esler et al. 1982;Roy et al.
1988). Autonomic hyperactivity is associated with a decrease in heart rate variability,
which in itself is a strong predictor of ventricular arrhythmias and acute heart failure
(Carney et al. 1995b;Rechlin et al. 1994;Yeragani et al. 2002). The association
between depression and decreased heart rate variability has however not been con-
firmed in all studies, and may be found in subgroups of depression only (Volkers et
al. 2003). Autonomic dysregulation also leads to an up regulation of platelet sero-
tonin receptors and an increased intracellular calcium mobilization, yielding stronger
platelet activation and aggregation, and a higher risk of trombotic events
(Musselman, Evans, & Nemeroff 1998;Schins et al. 2003). Thus, autonomic dysregu-
lation may also play a role in the excess mortality associated with depression,
although the scale of its contribution still has to be determined. 
In conclusion, the above pathogenic mechanisms may be associated with both
onset and course of depression and physical illnesses. Still, the temporal and causal
associations between these disorders need further study. 
In elderly persons, the association between depression and excess mortality may
be based on different mechanisms than in younger adults. ‘Vascular depression’, a
syndrome specific for later life, is characterised by psychomotor retardation, loss of
interest, functional disabilities (IADL) and autonomic symptoms. This disorder is
primarily determined by cerebral (fronto-striatal) white matter hyperintensities, prob-
ably as a result of (micro)vascular lesions that may be negatively associated with
survival (Alexopoulos et al. 2002;Steffens et al. 2002).
8.3.2 Treatment
An entirely different explanation for the excess mortality associated with depression
could be found in the toxic effects of antidepressant medication. Tricyclic antidepres-
sants are considered less safe due to possible abnormalities of cardiac conduction,
arrhythmias and postural hypotension, especially in people with medical illnesses
and higher age (Glassman, Roose, & Bigger, Jr. 1993;Muskin & Glassman
1983;Roose & Dalack 1992;Warrington, Padgham, & Lader 1989). However, limitedly
available evidence suggests that adequate biological treatment of depression, either
by pharmacotherapy or Electro Convulsive Therapy (ECT) may positively affect the
survival of depressed patients (Avery & Winokur 1976;Craig & Lin 1981;Muller-
Oerlinghausen et al. 1992). It has been suggested that selective serotonin reuptake
inhibitors (SSRI) may lead to a normalization of serotonin-mediated platelet activa-
tion in depressed patients (Musselman et al. 2000), and a protective effect against
recurrence of myocardial infarction (Sauer, Berlin, & Kimmel 2001). An intriguing
placebo-controlled randomised trial showed that treatment with antidepressants for
12 weeks during the first 6 months after stroke, significantly increased the 9-year sur-
vival of both depressed and non-depressed patients (Jorge et al. 2003). 
These findings suggest that antidepressants may influence the above pathophysio-
logical mechanisms. Currently, it is unclear whether this is a direct consequence of
medication, or whether it can be attributed to the remission of depression. A meta-
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analysis showed that psychosocial interventions also have a statistically significant
positive influence on prognosis and survival in patients with coronary heart disease
(Linden, Stossel, & Maurice 1996). Recently, two placebo-controlled studies investi-
gated the influence of different treatment modalities for depression on the prognosis
of patients after myocardial infarction. Six months of cognitive therapy, if necessary
combined with an SSRI, did not reduce mortality or increase invent-free interval after
29 months follow-up (Berkman et al. 2003). In the second study, sertraline was
shown to be a safe and effective treatment for recurrent depression in patients with
recent MI or unstable angina, but it was not associated with a more beneficial
course of cardiological parameters in comparison with placebo (Glassman et al.
2002;van den Brink et al. 2002). It is clear that more research is necessary to deter-
mine the associations between treatment of depression, the prognosis of comorbid
medical illnesses and longevity. 
8.4 Discussion
From this review of mechanisms that could explain the association between depres-
sion and excess mortality, it can be concluded that these are complex interactions in
which depression and medical illnesses may have multiplicative negative effects on
survival. Underlying pathogenetic mechanisms as well as psychological factors may
be responsible for the impressive comorbidity of somatic illnesses and depression.
Suggestions for further research 
The available literature on the association between depression and mortality is main-
ly composed of studies on associations between these phenomena that do not make
causal inferences. Prospective studies with an extensive follow-up time, and the full
spectrum of explicatory and potentially confounding variables are needed to address
onset and reciprocal influences of depression and medical illnesses, and their asso-
ciation with survival. It is also of interest to determine whether the association
between depression and mortality can be attributed to specific biological symptoms
of depression, or to psychological phenomena such as depressive thoughts and sui-
cidal ideation. Research on the genetics of depression, such as dysfunctions in the
HPA-axis, may provide more clarity on possible underlying pathogenetic mecha-
nisms. RCT’s with sufficient follow-up time are needed to address the potential
effects on survival of psychotherapeutic and pharmacological treatments of depres-
sion. Such studies may also lead to a better understanding of the pathofysiological
mechanisms underlying the association between depression, somatic illnesses and
excess mortality.
Clinical relevance
Depression is a serious psychiatric condition that causes substantial individual suf-
fering. It is also associated with a higher incidence and an untoward course of a
large number of medical conditions, with significantly higher levels of health care
use (Katon et al. 2003). Although a direct effect of depression treatment on survival
has not been demonstrated, it is clear that both psychosocial interventions (Linden,
Stossel, & Maurice 1996) and pharmacotherapy (Gill & Hatcher 1999;Gill & Hatcher
155Chapter 8  |  Depression and excess mortelity; a bio-psycho-social relationship?
2000) for depression are effective in medically ill patients. Still, the recognition of
depression in both primary (German et al. 1987) and secondary care (Hansen et al.
2001) is far from adequate. Considering the above, the clinical implications of this
cannot easily be underestimated.
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Abstract
Context  
Depression is associated with an increased mortality risk. It is not known to what
extent depression characteristics such as severity, duration or specific symptoms
contribute to the association with excess mortality.
Objectives 
To investigate the association between severity, duration and symptom profiles of
depression with mortality in community-living elderly.
Design
Ten-year prospective epidemiological study. Assessment of depression at baseline
and at three-year follow-up (GMS-AGECAT). Cox proportional hazards analyses of
depression according to severity and length of exposure, adjusted for demo-
graphic variables, physical illnesses, cognitive decline and functional disabilities.
Associations between specific baseline symptoms and symptom profiles and 10-
year mortality were studied in the full cohort, and in subjects with clinical depres-
sion  
Setting and participants
Randomly selected cohort of 3746 non-demented older community-living persons
in the city of Amsterdam.
Main outcome measures
Mortality at 10 years from baseline for the full cohort, and mortality 6 years from
the follow-up assessments for non-demented subjects participating in both
assessments (N=1989). 
Results
Both moderate (MRR 1.29, 95% C.I. 1.03-1.61) and severe depression (MRR 1.34,
95% C.I. 1.07-1.68) predicted 10-year mortality after multivariate adjustment.
Chronic depression was associated with a 41% higher mortality risk in 6-year fol-
low-up compared to subjects without depression. Somatic depression items were
predictive of excess mortality in the full cohort. In subjects with depression, only
depressive thoughts, suicidal ideation and guilt, were specifically associated with
excess mortality. 
Conclusions
Severity, chronicity and specific symptom profiles of depression are associated
with a higher mortality risk. This may have important implications for both pre-
ventive and treatment strategies of late-life depression.
Declaration of interest
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9.1 Introduction
Unipolar major depression is expected to become the second leading cause of disa-
bility world-wide in 2020, with only ischemic heart disease causing higher disease
burden and economic impact (Murray & Lopez 1997). Depression is also associated
with excess mortality(Wulsin, Vaillant, & Wells 1999), both in the community
(Cuijpers & Smit 2002), in medical patients (Katon 2003) and in studies that specifi-
cally focussed on the elderly(Ganguli, Dodge, & Mulsant 2002;Penninx et al. 1999). 
Still, relatively little attention has been paid to discriminating subtypes of depres-
sion with a particularly disadvantageous prognosis. This may be of considerable
interest for the clinician, as it may guide both preventive and treatment strategies.
On a theoretical level, it may further our understanding of the processes underlying
the association between depression and excess mortality. 
The most obvious line of investigation would be to determine whether the associ-
ation between depression and mortality depends on depression severity. Although
the detrimental effects of depression with regard to physical health and various
aspects of functioning are directly related to the number of depression symptoms
(Hays et al. 1995;Ormel et al. 1998), few studies have made comparisons of mortali-
ty risk according to depression severity measures. Dichotomizing severity levels as
major and minor depression (Penninx, Geerlings, Deeg, van Eijk, Van Tilburg, &
Beekman 1999), or psychotic and neurotic depression (Schoevers et al. 2000) did
not show a statistically significant association of severity with excess mortality after
adjustment for other explanatory variables. Using more continuous measures of
severity however yielded an association with mortality in two studies (Geerlings et al.
2002;Schulz et al. 2000).     
The association of depression with mortality may also be affected by length of
exposure to depression. In depressions with a longer duration, the negative effects
of depression on both biological and psychosocial functioning have had more time
to accumulate. Although this seems plausible, again very few studies have examined
this parameter (Geerlings, Beekman, Deeg, Twisk, & Van Tilburg 2002). 
A third approach disentangling the depression concept is to study specific symp-
toms of depression in relation to excess mortality. Data on specific symptoms of
depression and mortality are scarce. Feelings of hopelessness and pessimism have
been found to be predictive of eventual suicide (Beck et al. 1985) or death from vio-
lence or injury (Everson et al. 1996). Motivational depletion was important in
explaining the depression-mortality effect in one large study of community living eld-
erly (Schulz, Beach, Ives, Martire, Ariyo, & Kop 2000). A ‘vital exhaustion syndrome’
consisting of excessive fatigue, irritability and demoralization was associated with
onset and untoward course of ischemic heart disease (Kop et al. 1994;Prescott et al.
2003). The ‘vascular depression’ concept has received considerable attention as a
depression subtype specific for the elderly population, characterized by psychomotor
retardation, reduced interest in activities, impaired instrumental activities of daily liv-
ing and limited vegetative symptoms (Alexopoulos et al. 2002). The frontostriatal
dysfunction in vascular depression is associated with cerebrovascular pathology that
may also affect mortality. Very few symptoms of depression are pathognomonic, and
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other conditions may also lead to such ‘isolated symptoms’. Studies that are cur-
rently available have often examined isolated symptoms of depression regardless of
the presence of a depression according to diagnostic criteria. It is therefore of con-
siderable interest to examine whether associations of specific depression symptoms
with mortality differ in subjects with and without a depression diagnosis.
In order to establish associations between specific depression characteristics and
survival, prospective community based studies are needed that include a compre-
hensive set of confounders, large sample sizes and a relatively long follow-up time.
The AMSTEL study is community based and started in 1990, with a follow-up three
years later, and collection of mortality data until 10 years after baseline. The research
questions for this study were first to describe the impact of depression on mortality
according to depression severity and length of exposure to depression, and second
to investigate whether specific depression symptoms or symptom profiles show
stronger associations with excess mortality.
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9.2 Methods
9.2.1 Sample
The Amsterdam Study of the Elderly (AMSTEL) is a longitudinal study in a large and
representative sample of non-institutionalized community living older persons on
mental health problems, medical diagnoses and demographic characteristics.
Informed consent was asked and obtained from each participant before starting the
study. The study was approved by the Medical Ethical Committee of the Vrije
Universiteit Amsterdam. 
Sampling, data collection procedures and response have been described in depth
elsewhere (Launer et al. 1993;Launer, Wind, & Deeg 1994). In short, a random and
representative sample was drawn from the non-institutionalized Amsterdam popula-
tion over 65 to 84 years old. An age-stratified cohort of 4051 subjects was enrolled
for the baseline interview, which was conducted between May 1990 and November
1991. GMS-AGECAT dementia was present in 261 subjects (6.4%).
The study sample for this study consisted of all 3746 subjects participating in the
baseline assessment who did not have GMS-AGECAT dementia, of whom vital status
could be ascertained. At three year follow-up (median 38 months), data were avail-
able in 2144 (57.2 %) subjects. At follow-up, 553 (14.8%) persons were deceased, 604
(16.1%) persons refused further participation, 254 (6.8%) were too ill or cognitively
impaired to respond, and 191 (5.1%) were not available for interview due to other
reasons. Of the responders, 155 subjects (7.2 %) had developed dementia between
the two assessments. These subjects were excluded from the survival analyses after
1994. The study group for the assessment of the effect of length of exposure to
depression thus consisted of 1989 subjects without GMS-AGECAT dementia.
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9.2.2 Baseline measures
A one-hour interview was developed to gather information on psychiatric symptoms,
demographic information and medical status. The interview consisted of the Dutch
translation of the Mini-Mental State Examination (Folstein, Folstein, & McHugh
1975), all Geriatric Mental State Examination-items related to organic, affective and
anxiety syndromes (Copeland, Dewey, & Griffiths-Jones 1986), the Activities of Daily
Living (ADL) scale (Katz et al. 1963), the Instrumental Activities of Daily Living
(IADL) scale (Lawton & Brody 1969), and the CAMDEX-interview (Roth et al. 1986).
The interview was administered during home visits by lay interviewers who were spe-
cially trained using video sessions and regularly supervised. The same GMS-AGECAT
package with an identical algorithm was used in the second wave of the study. When
re-interviewing, raters were unaware of previous data and diagnoses.
Depression and dementia Depression and dementia were diagnosed using GMS-
AGECAT (Copeland et al. 1988;Copeland, Dewey, & Griffiths-Jones 1986), an estab-
lished and widely used instrument that diagnoses cases of late-life depression
requiring clinical attention in the community (Copeland et al. 1992;Copeland, Dewey,
& Griffith-Jones 1990) and in hospital patients (Ames & Tuckwell 1994). GMS-AGE-
CAT has proven reliability for epidemiological work in replication studies (Copeland,
Dewey, Henderson, Kay, Neal, Harrison, McWilliam, Forshaw, & Shiwach
1988;Hooijer, Jonker, & Dewey 1991). 
Depression severity In order to study the association of different severity levels of
depression with mortality, a sum score was composed out of the total number of 31
items for depression in GMS-AGECAT (see Table 1 for items and item scores).
According to the scores of subjects with depression at baseline, a severity variable
was calculated that classified the lower tertile of the scale as ‘mild depression’ (2-12
points), the middle tertile as ‘moderate depression’ (13-19 points), and the upper ter-
tile as ‘severe depression’ (20-48 points). In a second approach, a continuously
scaled variable of the total depression item score (0-48) to was used to indicate
severity.
Length of exposure Longitudinal patterns of the exposure to depression were
assessed in the subjects that participated in both waves of the study (n=1989). To
investigate whether a longer period of exposure to depression would show a higher
mortality risk, two measurements of depression allowed four different categories.
Subjects were classified as ‘no depression’, ‘remitted depression’ (depressed at
baseline and no longer depressed at follow-up), ‘incident depression’ (newly
depressed at follow-up) and ‘chronic depression’ (depressed at both assessments).
Symptom profiles In order to study the impact of specific symptom profiles on
mortality, several approaches were used. First, the full range of geriatric depression
symptoms identified in GMS-AGECAT were investigated. Second, the nine DSM-IV
depression criteria were derived from these items and assessed separately.
Depression items were also clustered into 4 symptom dimensions: affective symp-
toms, somatic symptoms, cognitive symptoms and depressive thoughts (see Table 1
for DSM symptoms and item clustering). For each symptom dimension a continu-
ous variable was calculated by adding the sum of the constituent item scores. In
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order to verify whether the symptom clusters that were constructed on theoretical
grounds were also statistically related, a factor analysis was performed on the 31
baseline depression items. All associations with a component loading above 0.40
were considered when comparing this statistically driven model with the symptom
clusters that were chosen on a priori notions. This procedure showed considerable
agreement. The domains of depression chosen on a priori notions remained almost
completely intact, although fewer items qualified to be included in each specific fac-
tor [Table 1] shows the results of factor analysis].
Covariates Potentially confounding covariates included age, sex and level of edu-
cation. Educational status was assessed as the number of years of education (5-18
years). Marital status was assessed based on the questions in GMS-AGECAT. The
presence of chronic diseases was assessed with the pertinent Camdex questions on
cardiovascular diseases, cancer, lung disease, diabetes, Parkinson’s disease and
epilepsy. Cognitive status was assessed by MMSE-score. Subjects were considered to
have functional disability if their ADL scores were two or more points below the max-
imum score on the scale. This indicates that subjects were ‘in need of help’ to per-
form at least two of the tasks mentioned, or were unable to perform at least one
task.
TABLE 1: GMS DEPRESSION ITEMS AMSTEL STUDY WITH COMPILATION OF 
SYMPTOM CLUSTERS AND DSM SYMPTOMS 
Item     Question Answer
D1        Have you been sad / depressed recently? Yes sometimes
Often / severely  
D2        How often have you cried last month? Yes
Often (severely) / almost every day or more  
D3        Felt like crying but no tears came? Yes 
Often (severely) / almost every day  
D4    Do you worry, and if so, 
do your worries trouble you? Yes, unable to stop, keep crossing my mind
D5   Obs: appears sad / depressed                                       Definite, some of the time
Definite (excessive) & most of the time
D6      Obs: eyes moist / tearful / crying Definite, some of the time
Definite (excessive) & most of the time
D7   How is your interest in things? Less interest  
D8      How is your appetite? Diminished desire for food               
Strongly diminished desire for food
D9   Have you lost weight last 3 months? Lost weight, amount unclear
9 pounds or more 
D10 Do you have trouble falling asleep? Yes
D11  Do you wake up early? Two hours earlier than usual, > 2 times a week
D12      Difficulty in relaxing? Difficulty in relaxing  
Much difficulty in relaxing
D13 Obs: appears tense / worried Definite, some of the time  
Definite (excessive) & most of the time
D14      Do you have the feeling that you started to                                                        Subjective slowing
think slower lately?                                                                                Severe subjective slowing
D15      Obs: slowness Slow in movements  
Very slow in all movements
D16      Not enough energy (to do what you want)? Loss of energy / fatigue
D17      Do you tend to feel guilty? Is that reasonable?    Excessive guilt, not in proportion to subject
D18      Can you concentrate (radio / TV)? Untill the end?                                       Difficulty concentrating  
Much difficulty concentrating
D19      Can you concentrate (reading)? Difficulty concentrating  
Much difficulty concentrating
D20 Do you find it hard to make up mind / decisions?                                                  Feels indecisive 
Feels very indecisive   
D21 Obs: difficulty concentrating on interview? Obvious difficulty concentrating on interview
Cannot concentrate on interview
D22 Obs: indeciveness Appears indecisive
D23      Have you felt life was not worth                                                                             Yes, sometimes  
living last 3 months? Yes, clearly / severely   
D24     Have you wished you were dead                                                                                                 
(because life is a burden)?                                                                                                       Yes 
D25     Have you thought of killing yourself / quitting?  Yes, felt suicidal
D26 Have you actually tried to kill yourself? Has actually done or planned something
D27      What time of day do you feel worst? In the mornings
D28     Loss of energy; worst at what time of the day?               Mornings
D29     Have you been irritated / easily annoyed lately? Yes, a little   
Yes, very much
D30 How do you see / what expectations do you                         Pessimism justified by circumstances 
have for your future?  Pessimistic/future looks bleak/unbearable /
general feeling of hopelessness
D31 Do you get annoyed with yourself as well? Yes, a little  
Yes, very much
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2      I Depressed mood Affective  1
1
2      I Affective
1                                          Affective
2
2     Thoughts 3
1      
2      I Affective  1  
1           
2      I                                        Affective     1 
2    II Anhedonia/Loss interest Affective
1
2       III Anorexia Somatic
1          
2        III Somatic
2       IV Sleep disturbance Somatic
2      IV Somatic      3
1        
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1        
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1       
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1       
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2       VI loss of energy / fatigue  Somatic   3
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1
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Item
9.2.3 Mortality
The follow-up for recording deaths extended from the date of the baseline examina-
tion until the 31st of December 2000. Dates of death were ascertained through the
registers of the municipality of Amsterdam, or the municipalities where subjects had
moved to during the study period. Data on vital status were missing in 47 subjects
(98.8 % complete). 
9.2.4 Data analysis
Baseline sample characteristics and participation in the follow-up study were ana-
lyzed using Chi2 statistics. Cox proportional hazards regression models were used to
examine the association between depression and time to deaths. The mortality risk
was expressed as the mortality rate ratio (M.R.R.). When the 95% confidence interval
of the latter did not include one, the association was regarded to be statistically sig-
nificant.
In multivariate analysis, ten-year mortality from 1990 to 2000 according to
depression severity (mild, moderate or severe depression, each compared with ‘no
depression’, and a separate analysis using the continuous depression severity score)
was studied in a kaplan-meyer curve and Cox proportional kazard regression model,
with stepwise adjustment for potential confounding factors. In the first step,
sociodemographic factors (age, gender, years of education, marital status) were
entered. The second step adjusted for cardiovascular diseases, the third step for all
other diseases and in the fourth step the MMSE score was entered. As functional
limitations are strongly associated with depression (Penninx et al. 1998), and over-
correction for the effect of depression may result when entering this factor in a mul-
tivariate logistic regression model, this factor was adjusted for in the last step.
Results are presented for each step in the multivariate model. Differences between
strata were considered statistically significant when the confidence intervals mutually
excluded the opposite MRR value.
Mortality according to length of exposure to depression (remitted depression,
incident depression and chronic depression vs. no depression, and remitted depres-
sion vs. chronic depression) was studied in a similar Cox regression model, with sur-
vival time counted from date of 1994 interview until 2000. 
To determine possible associations between specific depression symptoms and
mortality, all of the 31 depression items were entered in a Cox regression model
together with the other explanatory or confounding variables, including also ADL
functional status and depression diagnosis. Backward stepwise analysis was used to
reach the most parsimonious model predicting 10-year mortality. A similar approach
was used for the nine DSM-IV symptoms, and subsequently for the four symptom
clusters. In order to determine whether specific depression items would be predic-
tive of excess mortality within the subsample with clinical depression, this procedure
was repeated in the depressed subjects. As the association between specific depres-
sion items and mortality may be confounded by depression severity, these analyses
were also performed controlling for severity. Risk ratios are also presented for the
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other remaining predictors of mortality in the most parsimonuous models.
9.3 Results
9.3.1 Sample characteristics
Baseline characteristics are shown in [Table 2]. At baseline, depression was present
in 455 subjects (12.1 %). 165 subjects had mild depression, 146 had depression of
moderate severity, and 144 severe depression. The total follow-up time of the sample
was 28156.5 person years. 1844 (49.2 %) subjects had died during the study period.
The crude mortality rate was 65.5 deaths per 1000 person-years. The average follow-
up period from the baseline assessment of subjects who were still alive at 1/1/2001
was 117.8 months, ranging from 109.2 to 127.2 months. The average follow-up period
of subjects participating in the 1994 assessment who were still alive at 1/1/2001 79.6
months, ranging from 72.3 to 95.9 months. 
Univariate comparison of baseline characteristics with mortality showed that all
characteristics, except arthritis and epilepsy, were associated with 10-year mortality
[Table 2]. 
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TABLE 2: BASELINE SAMPLE AND 10 YEAR MORTALITY 
(deceased at 01-01-2001, *= p<0.05, **= p<0.01, ***= p<0.001, ns= not significant with p>0.05)
VARIABLES BASELINE         DECEASED(%)   STATISTICSChisq/df/p
N 3746 1844 (49.2)
Age 
65-69                                  803                  219 (27.3)          453.3/3/***
70-74                                 929                  338 (36.4)
75-79                                 974                  533 (54.7)
80-86                                 1040                 754 (72.5)
Gender 
Men                                  1425                 831 (58.3)           76.0/1/***
Women                              2321                  1013 (43.6)
Education
More than 
Primary School          2231                 1017 (45.6)         29.3/1/***
Primary School or less       1515                 827 (54.6)
Marital status
Married                    1853                 859 (46.4)         12.0/1/**
Not / no longer 
married 1890                 983 (52.0)
Myocard.infarction:           
No/never                          3346                  1586 (47.1)          57.1/1/***
Yes                                     382                    258 (67.5)
Stroke: No/never               3545                  1709(48.2)          27.3/1/***
Yes 201                    135 (67.2)
Cancer: No/never               3332                  1609 (48.3)        10.6/1/**
Yes 414                   235 (56.8)
Lung disease: No                3136                 1480 (47.2)         31.8/1/***
Yes 610                   364 (59.7)
Diabetes: No            3417                 1624 (47.5)        44.9/1/***
Yes                           329 220 (66.9)
Epilepsy: No/never   3691                 1810 (49.0)         3.5/1/ns
Yes 55                    34 (61.8)
Parkinson’s: No                  3692                  1798 (48.7)         28.2/1/***
Yes                                     54 46 (85.2)
Arthritis: No             3107                 1517 (48.8)          0.28/1/n.s.
Yes 639                  327 (51.2)
MMSE
26-30                                  3195                  1476 (46.2)         89.9/2/***
22-25                         465                   297 (63.9)
0-21 86                    71 (82.6)
ADL disability: No               3492                 1656 (47.4)         70.0/1/***
Yes 254                   188 (74.0)
Depression 
No                            3291                  1586 (48.2)        11.6/1/**
Yes                           455 258 (56.7)
Depression severity score
No depression                    3291                 1586 (48.2)        13.8/3/**
Mild (2-12)                          165                    86 (52.1)
Moderate (13-19)                146                  88 (60.3)
Severe (20-48)                    144 84 (58.3) 
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9.3.2 Severity
Subjects with a depression of moderate or high severity showed an excess mortality
risk of 46% and 35% respectively, when compared to subjects without depression.
[figure 1] After multivariate adjustment, both moderate (MRR 1.29, 95% C.I. 1.03-
1.61) and severe depression (MRR 1.34, 95% C.I. 1.07-1.68) still showed a statistically
significant association with excess mortality. At the last step, entering functional
impairment, these risk ratios just failed to reach statistical significance, most likely
due to overcorrection of the effect of depression [Table 3]. The differences between
each of the mild, moderate and severe strata were not statistically significant, as the
95% confidence intervals were not mutually exclusive. A severity effect was con-
firmed in a similar analysis with the continuously scaled total depression item score
with an MRR of 1.02 (95% CI 1.01-1.02) per scalepoint increment after multivariate
adjustment.
MRR                                       Mild                           Moderate                  Severe 
vs no depression        vs no depression vs no depression
Unadjusted ratio                   1.13 (0.91-1.40)          1.46 (1.18-1.81)           1.35 (1.08-1.68)
Adjusted for:
Demographics 1.24 (1.00-1.55)           1.52 (1.22-1.89) 1.65 (1.32-2.06)
Cardiovascular disease           1.23 (0.98-1.53)          1.48 (1.19-1.84) 1.60 (1.28-2.00)
Other diseases 1.15 (0.92-1.43)           1.36 (1.09-1.69) 1.41 (1.12-1.77)
MMSE 1.13 (0.90-1.40)         1.29 (1.03-1.61) 1.34 (1.07-1.68)
Functional (ADL) impairment   1.09 (0.88-1.37)          1.24 (0.99-1.55) 1.24 (0.98-1.56)
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TABLE 3: DEPRESSION SEVERITY AND 10 YEAR MORTALITY
Deceased by 01-01-2001, Mortality Rate Ratio with 95% C.I. after correction for other explanatory 
variables, comparing ‘mild’ / ’moderate’ / ’severe’ depression with ‘no depression’, N=3746
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Figure 1 Survival and depression severity
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9.3.3 Length of exposure 
Of the 229 subjects with baseline depression who participated at follow-up, 95 (41.5
%) had remitted, and 134 (58.5 %) were still depressed at follow-up. Incident depres-
sion was present in 302 subjects (14.4% of subjects that participated in both waves
of the study). 
Figure 2 shows the kaplan-meyer curve. The unadjusted mortality risks of remit-
ted and incident depression were not statistically significant. Only chronic depres-
sion showed a significant association with excess mortality (MRR 1.65, 95% C.I. 1.25-
2.17) (Table 4). This association remained statistically significant in stepwise multi-
variate analysis (MRR 1.41, 95% C.I. 1.05-1.89), also at the last step, entering func-
tional limitations (MRR 1.38, 95% C.I. 1.03-1.85). 
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TABLE 4: LENGTH OF EXPOSURE FROM T0-T1 WITH MORTALITY 1994-2000
Deceased between follow-up 1994 and 01-01-2001, Mortality Rate Ratio with stepwise adjustment 
for other variables, organic cases at follow-up excluded, N=1989
MRR                                          Remitted               Incident                  Chronic 
vs no depression     vs no depression     vs no depression
Unadjusted ratio                        0.97 (0.66-1.42)       1.07(0.86-1.34)        1.65 (1.25-2.17)
Adjusted for:
Demographics 1.14 (0.77-1.67)        1.11 (0.89-1.38)        1.81 (1.36-2.39)
Cardiovascular disease 1.12 (0.76-1.64)       1.06 (0.85-1.32)        1.76 (1.33-2.33)
Other diseases 1.06 (0.72-1.56)       1.05 (0.84-1.31)        1.54 (1.15-2.07)
MMSE 1.05 (0.71-1.54)        1.04 (0.83-1.30)       1.41 (1.05-1.89)
Functional (ADL) impairment 0.98 (0.66-1.45)      1.03 (0.83-1.28)        1.38 (1.03-1.85)
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9.3.4 Specific symptoms and symptom profiles
GMS-AGECAT items: Controlling for all the other symptoms, predictors of excess
mortality in the whole cohort were (in decreasing order of effect size)(Table 5); slow-
ness (MRR 1.70, 95% C.I.1.30-2.20), loss of appetite (MRR 1.24, 95% C.I. 1.11-1.39)
and loss of energy (MRR 1.15, 95% C.I. 1.09-1.21). Indecisiveness / loss of concentra-
tion showed a protective effect relative to the other items (MRR 0.87, 95% C.I. 0.77-
0.98), and inappropriate feelings of guilt just failed to reach statistical significance in
the same direction. Repeating these analyses within the depressed subjects yielded
one new item, death wishes (MRR 1.14, 95% C.I. 1.00-1.29) (data not shown).
Adding a continuous depression severity variable to the model did not change the
results in either the full sample or the depressed sample, showing that the associa-
tion with mortality of specific depression items is not confounded by depression
severity (data not shown).
DSM-IV items: In the full cohort, loss of energy (MRR 1.35, 95% C.I. 1.22-1.50),
psychomotor agitation / retardation (MRR 1.22, 95% C.I. 1.02-1.45), and suicidal
ideation (MRR 1.21, 95% C.I. 1.04-1.40) were associated with excess mortality.
Indecisiveness / loss of concentration showed a statistically significant association
in the opposite direction (MRR 0.81, 95% C.I. 0.72-0.91) [Table 5]. In the subjects
with depression, the association of suicidal ideation with excess mortality was even
more pronounced than in the full sample (MRR, 1.35, 95% C.I. 1.05-1.73).
Interestingly, inappropriate feelings of guilt again showed an association in the
opposite direction (MRR 0.54, 95% C.I. 0.35-0.83). Controlling for depression severi-
ty did not significantly affect these results (data not shown).
Symptom clusters: In the full cohort, only somatic depression symptoms were
associated with mortality (MRR 1.11, 95% C.I. 1.06-1.16)(Table 5). Repeating these
analyses in subjects with depression showed that none of the four symptom clusters
retained statistical significance with regard to excess mortality. Controlling for
depression severity in the full sample, somatic symptoms were no longer associated
with mortality. 
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TABLE 5: PARSIMONIOUS MODELS FOR 10 YEAR MORTALITY
Cox regression analyses, Backstep modelling with P in at 0.05 and P out at 0.05
FULL COHORT (N=3746)
GMS items MRR                              DSM items
D15 slowness obs. 1.70 (1.30-2.20) VI loss of energy
D8 loss of appetite 1.24 (1.11-1.39)               V psychomotor agit/retard   
D16 loss of energy 1.15 (1.09-1.21)              IX suicidal
D20 indecis /concentr 0.87 (0.77-0.98)             VIII indecisive / concentr
D17 guilt 0.88 (0.76-1.01)
Age 1.10 (1.09-1.11)              Age
Gender 0.52 (0.48-0.58)             Gender
Myocardial infarction 1.47 (1.29-1.69)              Myocardial infarction
Stroke 1.30 (1.09-1.55)               Stroke
Cancer 1.34 (1.16-1.54)               Cancer
OPD 1.30 (1.16-1.46)             OPD
Diabetes                                                  1.56 (1.35-1.80)              Diabetes
MMSE 0.94(0.92-0.96)           MMSE
ADL disablity 1.46 (1.24-1.71)              ADL disability
DEPRESSED SUBJECTS (N=455)
GMS items MRR                              DSM items
D15 slowness obs. 1.50 (1.02-2.19)              IX suicidal
D24 death wish 1.14 (1.00-1.29)              VIII guilt
D17 guilt 0.88 (0.76-1.01)
Age 1.08 (1.05-1.10)              Age
Gender 0.33 (0.25-0.44)             Gender
Stroke 1.65 (1.08-2.51)               Stroke
Cancer 1.55 (1.12-2.14)              Cancer
OPD 1.43 (1.07-1.90)              OPD
MMSE 0.92(0.89-0.96)            MMSE
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Symptom clusters
1.35 (1.22-1.50)                  Somatic                            1.11 (1.06-1.16)
1.22 (1.02-1.45)
1.21 (1.04-1.40)
0.81 (0.72-0.91)
1.10 (1.09-1.11)                   Age                                 1.10 (1.09-1.11)
0.52 (0.47-0.57)                 Gender                             0.51 (0.46-0.56)
1.45 (1.27-1.66)                  Myocardial infarction        1.46 (1.27-1.66)
1.34 (1.12-1.60)                  Stroke                               1.35 (1.13-1.62)
1.32 (1.15-1.51)                   Cancer                             1.32 (1.15-1.51)
1.30 (1.15-1.46)                   OPD                                1.30 (1.17-1.47)
1.57 (1.36-1.81)                   Diabetes                           1.56 (1.35-1.80)
0.94 (0.92-0.95)               MMSE                             0.94 (0.92-0.96)
1.51 (1.28-1.78)                   ADL disability                   1.48 (1.26-1.74)
Parkinson’s                       1.36 (1.01-1.84)
Epilepsy                            1.41 (1.00-1.99)
Symptom clusters
1.35 (1.05-1.73)
0.54 (0.35-0.83)
1.08 (1.06-1.11)                 Age                                  1.08 (1.06-1.11)
0.32 (0.24-0.42)               Gender                             0.33 (0.25-0.44)
1.67 (1.10-2.53)                 Stroke                               1.74 (1.15-2.63)
1.49 (1.08-2.06)               Cancer                              1.47 (1.07-2.03)
1.39 (1.05-1.84)                  OPD                                1.48 (1.12-1.96)
0.91 (0.88-0.95)                MMSE                             0.91 (0.88-0.95)
9.4 Comment
This study systematically examined whether severity, duration of exposure and spe-
cific symptom profiles of depression are associated with a higher mortality risk. The
findings may have important implications for both prevention and intervention in
late life depression, and provide cues for further research on the mechanisms linking
depression and excess mortality.
Studying survival according to different levels of depression severity is based on
the hypothesis that a higher ‘dosage’ of depression would result in a higher mortality
risk for the individual patient. This would be in line with cross-sectional studies that
have demonstrated the detrimental effects of depression with regard to physical
health and various aspects of functioning to be directly related to the number of
depressive symptoms (Hays, Wells, Sherbourne, Rogers, & Spritzer 1995;Ormel,
Kempen, Deeg, Brilman, van Sonderen, & Relyveld 1998). The current study con-
firms this hypothesis, as moderate to severe levels of depression were associated
with a higher mortality risk.
Similarly, the dosage of depression can be quantified as the length of exposure to
depression. Subjects with chronic depression had a 41% higher mortality risk in 6-
year follow-up than subjects who were not depressed at either assessment. Subjects
with either incident or remitted depression did not have a higher mortality risk.
Length of exposure thus plays a vital role with respect to longevity. This once more
underlines the detrimental effects of chronic depression, that has already been
shown to have a profound negative influence for late-life physical and social adjust-
ment (Vaillant et al. 1996), health service use (Beekman et al. 1997;Unutzer et al.
1997) and well-being (Hays, Wells, Sherbourne, Rogers, & Spritzer 1995;Ormel,
Kempen, Deeg, Brilman, van Sonderen, & Relyveld 1998). With chronicity ranging
around 50% (Cole, Bellavance, & Mansour 1999), and even higher at more severe
levels of depression (Beekman et al. 2002), the clinical importance of these findings
is considerable. 
Studying the association between depressive symptoms and mortality on a popu-
lation level showed that somatic symptoms such as slowness, loss of energy and
loss of appetite predicted subsequent mortality. The majority of subjects with these
symptoms did not have a depressive disorder. Although chronic diseases were care-
fully adjusted for in this study, these somatic symptoms may be related to condi-
tions that were subclinical at the time of interview, but nevertheless affected 10-year
survival. Somatic symptoms may also be an indicator of the severity of physical ill-
nesses and likewise be associated with an untoward course. Classifying these symp-
toms as originating from either depression or medical illness is further complicated
by the fact that depression is associated with biological dysregulations such as dys-
functions in the hypothalamic-pituitary-adrenocortical (HPA) system (Holsboer
2000;Musselman & Nemeroff 1996), autonomic dysregulation (Yeragani et al. 2002)
and inflammatory processes (Penninx et al. 2003). All of these processes may also
be associated with higher levels of comorbidity and excess mortality.
When the analyses were confined to subjects with clinical depression, the specific
influence of somatic items almost disappeared. In depressed subjects, psychological
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symptoms such as suicidal ideation appear to be much more prominently associat-
ed with mortality than somatic symptoms. Although it is obvious that suicidal
ideation may affect survival, previous work suggests that suicide alone can not
account for the excess mortality of depression (Lindesay 1989;Maris 2002;Murphy et
al. 1988;Murphy et al. 1987;Penninx et al. 2001). Negative thoughts may also be
related to a wider array of counterproductive and noncompliant behavior associated
with ill health and mortality. Depression is associated with unhealthy life styles such
as smoking, alcohol use (Aneshensel & Huba 1983;Goodwin & Jamison 1990) and
physical inactivity (Stephens 1988), noncompliance with medical treatment
(DiMatteo, Lepper, & Croghan 2000) and death from accidents (Brodaty et al.
1997;Hoyer, Mortensen, & Olesen 2000;Lindesay 1989;Murphy, Smith, Lindesay, &
Slattery 1988;Murphy, Monson, Olivier, Sobol, & Leighton 1987;Wulsin, Vaillant, &
Wells 1999). Although the current study was not able to determine whether these
mechanisms have actually played a role in the mortality association, this is a plausi-
ble explanation. It also stresses the clinical relevance of assessing death wishes and
suicidal ideation, not only for the prevention of actual suicide. 
The finding that guilt had a protective effect compared with other depression
symptoms came as a surprise. One may assume inappropriate guilt to be associated
with various forms of destructive and self-punishing, possibly (para)suicidal behav-
ior. As both guilt and suicidal ideation are depressive thoughts, this finding may be
due to confounding and their association was tested. Subjects with inappropriate
guilt were more likely to have death wishes (37.2%) than subjects without guilt
(9.9%; chi2 107.7, p= 0.000) in the full sample. A similar pattern of co-occurrence
was found among the depressed. However, there was no interaction of guilt and
death wishes on the outcome measure, suggesting that these are in fact distinct and
separate associations.
In the third set of analyses, clustered somatic items were important in relation to
survival in the full sample, whereas none of the symptom clusters was predictive of
excess mortality in the depressed subsample. As Table 1 shows, the symptom cluster
‘depressive thoughts’ included both suicidal ideation, feelings of guilt and worrying.
The opposing association of guilt on the outcome measure may have neutralized
associations that were evident on a more detailed symptom level. 
Literature on mortality and specific symptom profiles of depression is both
scarce and contradictory, and often focused on suicide as cause of death
(Baumeister 1990;Schneider, Philipp, & Muller 2001;Seidlitz et al. 2001). Our study
is the first to examine these issues in a broader context of all cause mortality in a
community sample. The distinction made in this study between isolated symptoms
and symptoms as part of clinically relevant depression offers a possible explanation
for contradictory findings of earlier studies that mainly assessed isolated symptoms.
The finding that depressive thoughts are most influential with regard to mortality
suggests that a behavioral component plays an important role in the interface
between clinically relevant depression and excess mortality. However, further
research is needed to determine whether this hypothesis is correct.
The current study is a naturalistic study in the community with a 10-year follow-up of
mortality data. One limitation is, that a number of possible influences and changes
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affecting the prognosis of the almost 4000 subjects that participated in the study
were not accounted for in these analyses. Depression is a disorder with a variety of
course types. Subjects that were depressed at baseline may have recovered, remit-
ted, and/or subsequently relapsed, or may have become chronically depressed.
Likewise, subjects without depression at baseline may have experienced depressive
episodes during the study period, which may also have influenced their survival. Still,
studies with a limited number of assessments tend to overrepresent chronic depres-
sion. When comparing course types, misclassification may therefore, if anything,
have led to an underestimation of the strength of the association between length of
exposure and mortality.
A second limitation is that subjects may have had treatment for their depression,
which may have affected prognosis. Unfortunately the impact of treatment is proba-
bly very limited. Studies in comparable samples of community living elderly across
different countries have consistently shown that case-finding is poor, and adequate
treatment of depression even more so (German et al. 1987;Sonnenberg et al. 2003).
Our study is no exception to this. Although the effects of treatment were probably
very limited, this may again have lead to an underestimation of the strength of the
association between depression and mortality.
A strength of the current study is that it was able to examine both severity, dura-
tion and specific symptoms with regard to their implications for survival, using a
design that allowed to control for a large number of possibly confounding variables.
It was possible to investigate both the DSM core symptoms of depression, and the
more elaborate symptom array for elderly populations available through GMS-AGE-
CAT. 
In conclusion, the current study shows that several characteristics of depression
are of importance when assessing the risk of mortality. Severity and chronicity of
depression are directly related to an increased mortality risk. Furthermore, somatic
depression symptoms, potentially related to both concurrent physical illnesses and
to biological aspects of depression are important with regard to survival on a popu-
lation level. More interestingly, specific depressive cognitions are important with
regard to the survival of depressed subjects. Apart from indicating possible behav-
ioral pathways explaining the depression-mortality association that has frequently
been established in other studies, more active casefinding and treatment of persons
at risk may yield important benefits from a clinical perspective. 
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Abstract
Context
Depression is a highly prevalent disorder causing a large amount of non-fatal dis-
ease burden. Even optimal treatment would reduce this burden by only 1/3. In
older persons, depression has a predominantly chronic course. It is of great
interest to investigate possible strategies to prevent the onset of late-life depres-
sion in primary care.
Objective
To compare two models for selective (persons at elevated risk) and indicated pre-
vention (persons with subsyndromal symptoms of depression), and determine
which is the optimal strategy for prevention of late-life depression.
Design, setting and participants: 
Depression onset was assessed at three-year follow-up using GMS-AGECAT in a
randomly selected cohort of 1,940 non-depressed and non-demented older com-
munity-living persons in the city of Amsterdam. A comprehensive set of risk fac-
tors that can easily be identified in primary care was available. 
Main outcome measures:
The association of risk factors with depression incidence was expressed in terms
of Absolute and Relative Risk estimates, Numbers-Needed-to-be-Treated, and
Population Attributable Fraction. Prevention models are identified using
Classification And Regression Tree (CART) analyses.
Results
In the indicated prevention model, subsyndromal symptoms of depression were
associated with a risk of almost 40% of developing depression, an NNT of 5.8,
and accounted for 24.6% of new cases. Adding more risk factors raised the AR
up to 49.3%, with a lower NNT (3.2), but also lower AF values. In the selective
prevention model, loss of spouse showed the highest risk (AR 37%, NNT 5.3, AF
8.2%), a risk that became even higher if subjects also had a chronic illness.
Overall, the AF values in the indicated model were higher, identifying more per-
sons at risk.
Conclusions
Considering the costs and benefits of both models in the context of the availabili-
ty of evidence-based preventative interventions, indicated prevention aimed at
elderly persons with depressive symptoms is the preferred option. The exclusive
focus on treatment of depressive disorder should be readdressed. A new
approach in public mental health is needed, with a stronger emphasis on preven-
tive psychiatry.   
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10.1 Introduction
The adverse consequences of depression are well established. Currently, of all ill-
nesses, depressive disorder is causing the largest amount of non-fatal burden,
accounting for almost 12% of all years lived with disability worldwide (Ustun et al.
2004). Depression is also associated with excess mortality (Cuijpers & Schoevers
2004), higher demands on caregivers and higher service utilization, and has sub-
stantial economical implications (Charney et al. 2003). In community dwelling elder-
ly, the prevalence of depression requiring clinical attention is 13.5 % (Beekman,
Copeland, & Prince 1999), and more than 50% have a chronic course (Beekman et
al. 2002;Cole, Bellavance, & Mansour 1999). Although effective treatment is avail-
able, case finding and adequate treatment in primary care are generally poor
(Sonnenberg et al. 2003;Tiemens, Ormel, & Simon 1996). Still, even if all patients
with depression were optimally treated with evidence-based interventions, only 34%
of the disease burden in terms of Years Lived with Disability (YLD) could be averted
(Andrews et al. 2004). From the public health perspective, it is therefore of great
interest to consider the possibility of depression prevention (Smit et al. 2004b;Smit
et al. 2004a). However, evidence-based preventive strategies aimed at reducing the
incidence of late life depression in community living elderly are sparse.
In prevention, different strategies can be chosen according to the stages or tran-
sitions in the development of a disorder (Haggerty & Mrazek 1994) (Figure 1).
Universal prevention aims to influence the behaviour of the whole population in
order to prevent the onset of disease. Examples of universal prevention are pro-
grams informing the population about the risk of alcohol intake or the benefits of
physical exercise. Selective prevention is aimed at persons who are at risk because
they have been exposed to certain risk factors. In the case of depression, risk indica-
tors are for example loss of spouse and physical illness (Schoevers et al. 2000). The
third form, indicated prevention, targets persons who already have early or subsyn-
dromal symptoms, in whom an intervention may reduce the likelihood of becoming
a full-blown ‘case’ (Haggerty & Mrazek 1994;Munoz, Mrazek, & Haggerty 1996). An
example of indicated prevention is cognitive therapy for the prevention of psychosis
in people at ultra-high risk (McGorry et al. 2002;McGorry & Killackey 2002), or phar-
macotherapy for people with Mild Cognitive Impairment (MCI) to delay the onset of
Alzheimer’s disease (Jelic & Winblad 2003). 
The choice for a specific type of prevention depends on the ‘untreated’ prognosis
of the disorder, in combination with the costs, benefits and possible adverse conse-
quences of different types of intervention. An ethical dilemma is that, by identifying a
healthy person as a possible future case and starting some kind of intervention, this
in itself carries certain negative consequences and should only be applied if the alter-
native has a significantly higher probability of adverse consequences. In the case of
depression, evidence-based universal prevention of depression is currently non-exis-
tent. Selective prevention may focus on persons with certain risk indicators such as
exposure to loss events. Indicated prevention would be directed at persons with
depressive symptoms below the diagnostic threshold for ‘clinically relevant depres-
sion’ (Cuijpers & Smit 2004;Pincus, Davis, & McQueen 1999). For both ethical rea-
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sons and reasons of cost-effectiveness, preventative measures aimed at reducing
incidence should target subjects with high a priori risk through exposure to multiple
risk factors (Cuijpers 2003). Furthermore, for practical reasons, persons at risk
should be easily identifiable in primary care, and risk profiles have to be simple and
unambiguous. From a public health perspective, prevention should be cost-effective
and lead to a substantial reduction of total disease burden. This implies that the
selected risk indicators should be indicative of a substantial proportion of new cases.
The current study explores selective and indicated prevention models to identify
high-risk groups among older GP patients, bearing in mind the above qualifications.
It seeks to identify those combinations of exposures that predict the largest health
gains in the most cost-effective way when prevention is successful in blocking the
adverse effects of these risk factors. These risk factors could then be used in primary
care as an easy to use checklist or screener to identify patients at elevated risk of
becoming a future case of depressive disorder. For indicated prevention, the use of a
screening instrument to detect subsyndromal depression would be required. As this
is more time-consuming than recognising subjects on the basis of more straightfor-
ward risk factors needed for selective prevention, the benefits of both approaches
are compared. The study is based on data from the Amsterdam Study of the Elderly
(AMSTEL study), a large and prospective cohort study of depression in community
living elderly incorporating a comprehensive set of risk factors associated with late-
life depression (Schoevers, Beekman, Deeg, Geerlings, Jonker, & Van Tilburg 2000). 
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10.2. Methods
10.2.1 Sampling and non-response
The AMSTEL study is a prospective cohort study on the incidence of depression in a
large and representative sample of non-institutionalised older persons (65+).
Informed consent was asked and obtained from each participant before starting the
study. The study was approved by the Medical Ethics Committee of the Vrije
Universiteit Amsterdam. The population base for AMSTEL included all non-institu-
tionalised individuals in the 65-84 age bracket who lived in the city of Amsterdam
and were registered with a general practitioner at baseline. The study was actively
supported by the general practitioners, whose lists were used as the sampling frame.
In the Netherlands, general practitioners are the gatekeepers to the health care sys-
tem and almost every citizen is on the list of a general practitioner. In this role, gen-
eral practitioners in the Netherlands generally provide social support and have a
long-standing personal relationship with their patients. Thus, the source population
consisted of almost all of the non-institutionalised population. The sample was
drawn from a list of 30 general practices spread throughout the city; practices were
selected from all practices registered within the city of Amsterdam, 22 randomly and
8 by convenience from a network of general practitioners participating in medical
research. The profile of the over-65 general practice-population in terms of age and
gender, correspond to the non-institutionalised population in Amsterdam (Launer et
al. 1993;Launer, Wind, & Deeg 1994). Within each practice, respondents were ran-
domly selected from four age strata spanning five years each (65-69 to 80-84). In
order to obtain equally sized age-strata at follow-up, the older old were over sam-
pled. Out of a sampled total of 5,666, 4,051 (71.5%) responded and formed the base-
line sample. Interviews with these subjects were conducted between May 1990 and
November 1991. The profile of the over-65 general practice-population in terms of
age and gender corresponds to the non-institutionalised Amsterdam population. 
At follow-up three years later (median 38 months), 2,244 (55.4%) were reinter-
viewed, 656 (16. 2%) people were deceased, 662 persons (16.3%) refused further co-
operation, 282 (7.0%) were too ill or cognitively impaired to respond, and 207 (5.1%)
were not available for interview due to a variety of other reasons. For this study, sub-
jects with depression (523; 12.9%) or dementia (261; 6.4%) at baseline were exclud-
ed. The study cohort consisted of all respondents at follow-up who were neither
depressed nor demented at baseline, for whom complete data were available at fol-
low-up (N=1,940).
10.2.2 Measures
A one-hour interview was developed to gather information on psychiatric symptoms,
demographic and medical status, personal history of depression and family history.
The interview consisted of the Dutch translation of the Mini-Mental State
Examination (Folstein, Folstein, & McHugh 1975), all Geriatric Mental State
Examination-items related to organic, affective and anxiety syndromes (Copeland et
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al. 1988;Copeland, Dewey, & Griffiths-Jones 1986), the Instrumental Activities of
Daily Living (ADL) scale (Katz et al. 1963), the Instrumental Activities of Daily Living
(IADL) scale(Lawton & Brody 1969), and part of the CAMDEX-interview (Roth et al.
1986). The interview was administered during home visits by lay interviewers who
were trained using video sessions and regularly supervised. The same GMS-AGECAT
package with an identical algorithm was used in the second wave of the study. When
re-interviewing, raters were unaware of previous data and diagnoses.
Psychiatric diagnoses Diagnoses of dementia, depression and generalised anxiety
disorder were made according to the GMS-AGECAT system. Diagnostic levels 3-5
correspond reliably to cases of depression requiring clinical attention in both the
community (Copeland, Dewey, & Griffith-Jones 1990) and in elderly hospital patients
(Ames & Tuckwell 1994). GMS-AGECAT has a proven reliability in epidemiological
studies, as became evident through replication studies (Copeland, Dewey,
Henderson, Kay, Neal, Harrison, McWilliam, Forshaw, & Shiwach 1988). GMS-AGE-
CAT generates both a non-hierarchical syndrome level and a more narrowly defined
diagnostic level. The diagnostic case level is calculated from the syndrome level
using a hierarchy from organic to depression to anxiety disorder. In order to be able
to also assess overlapping comorbidity influences, syndrome levels were used in the
analyses as otherwise the diagnostic hierarchy would bias the results. Depression
caseness at baseline and follow-up was defined as a GMS-AGECAT level 3 or higher
(Copeland, Dewey, Henderson, Kay, Neal, Harrison, McWilliam, Forshaw, & Shiwach
1988). Subjects not depressed at baseline who had become depressed at follow-up
were considered to be incident cases. Subjects with depression case levels 1 or 2 at
baseline were classified as having ‘subsyndromal depression’. 
Risk indicators Socio-demographic variables included age, gender and educa-
tional level, the latter of which was dichotomised into lower (primary school or less)
and higher (more than primary school) education. Living situation was assessed
with the associated questions in GMS-AGECAT. A personal history of depression was
ascertained by the relevant CAMDEX-question. The question was considered affirma-
tive if treatment had previously been requested. The presence of chronic diseases
was assessed with the pertinent Camdex questions on myocardial infarction, stroke,
cancer, lung disease, diabetes, Parkinson’s disease, arthritis and epilepsy. Cognitive
status was assessed by MMSE-score. Cognitive impairment was defined as an
MMSE score below 24. Sleeping disorder was determined by two questions from the
GMS on “trouble falling asleep (yes, or ‘I would have problems if I didn’t use sleep-
ing medication) and ‘early wakening’ (at least two times per week at least two hours
earlier than usual). Disability was measured using a combined scale consisting of all
ADL and IADL items (Kempen, Myers, & Powell 1995;Kempen & Suurmeijer 1990).
Subjects were considered disabled if the total score was two or more points below
the maximum. This indicates that subjects were ‘in need of help’ to perform at least
two of the tasks mentioned, or were ‘unable to perform’ at least one task. 
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10.2.3 Data analysis
The analyses were conducted in several steps. First, standard epidemiological tech-
niques were used to analyse the risk of becoming a case in subjects with or without
being exposed to a certain risk indicator. These risks are denoted P1 and P0 for the
exposed and unexposed group respectively. The absolute risk, AR, and relative risk,
RR, were obtained by,
AR = P1,
RR = P1 / P0 ,
with the RR denoting the excess risk of becoming depressed in the exposed group
relative to the unexposed group. The RR can be interpreted as a measure of the
strength of association between exposure and disease onset. In this way, both the
relative and the absolute risk (conditional on exposure status) of depression inci-
dence are presented.
In a second step, the importance of risk indicators for onset of disorder at popu-
lation level can be quantified. It is necessary to know how many persons are exposed
to a certain risk factor, in order to determine the scale of both the problem and of
possible interventions. This can be done by taking into account the level of exposure
to a risk factor in the population, also called exposure rate (E). By combining the rel-
ative risk (RR) with the exposure to a risk factor (E) in the population, the population
attributable fraction (AF) can be computed, as,  
AF = E(RR–1) / (1+E(RR–1)).
The AF indicates by how many percentage points the incidence rate of depression in
the population will be lowered when the adverse effect of the risk factor (or combina-
tion of risk factors) can be completely blocked. Therefore, the AF can be interpreted
as the upper limit of the potential health gain in the population. 
Similarly, a measure of the efficiency of a preventive intervention can be calculat-
ed: the Number-Needed-to-be-Treated (NNT) (Cook & Sackett 1995). In the context
of an epidemiological study, the NNT can be interpreted as a measure of efficiency,
showing how many people must be protected from the adverse influence of a risk
factor in order to avoid one new case of depression. The NNT was obtained by,
NNT = 1/| P1 –  P0|.   
It should be borne in mind that the NNT values presented here, are based on the
assumption that an intervention is able to completely block the adverse influence of
a risk factor on the onset of depression. Depending on the actual efficacy of each
preventative intervention, the NNT should therefore be adapted. If an intervention
has a 50% efficacy in containing the effect of a risk factor, the actual NNT should be
multiplied by 2. Using Stata (Stata Corporation 2001) statistics like RR, AF and NNT
can be obtained in a multivariate context controlling for competing risks (Smit,
Beekman, Cuijpers, de Graaf, & Vollebergh 2004a). 
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In the third step, the RR, AF, NNT and E statistics were used to find the best values
for efficiency (i.e., low NNT values), and the best values for health gains (i.e., high-
est AF values) for combinations of exposures. The idea is that people may be
exposed to more risk factors simultaneously, and that joint exposures entail higher
RRs, lower NNTs and perhaps higher (or lower) AF values. In other words, targeting
preventative interventions on groups that have been exposed to specific combina-
tions of risk factors may yield, by implication, higher health gains (RR, AF), against
less effort (NNT). 
To trace the effect of multiple exposures in all their combinations we used a
method known as classification and regression tree (CART) analysis (Everitt B.S.
2003;Lemon et al. 2003), and adapted it for our purposes. CART analysis can graphi-
cally be represented as tree-like figures (see Figure 1, later). First, a parent node is
selected that optimises the NNT, RR and AF values in preferably the smallest (E)
groups. This parent node branches off in two directions, creating child nodes in
which people are not only exposed to the risk factor in the parent node, but also to
an additional risk factor in the child node. Therefore, the first generation of child
nodes captures the effect of double exposures, the second generation of child nodes
represents the effect of triple exposures, and so on. At each node, both branches (for
subjects with and subjects without that specific risk indicator) are followed up to
determine NNT, RR and AF values of combined exposures.  Thus, the sample is split
into smaller subgroups at each step.
In CART analysis one has to make use of explicit decision rules for selecting child
nodes and terminating branches. For identifying the best child node, the following
hierarchy of decision rules was used:
1 Chose child node with the lowest NNT (i.e. greatest efficiency)
2 Chose child node with the highest AF (i.e. greatest health gain).
3 When ties occurred, the child node was selected with the smallest exposure (E)
rate, because it was reasoned that targeting smaller groups is logistically and eco-
nomically less demanding and more feasible given equal NNT and AF values. 
The following rules were employed for the termination of branches:
1 R < 1.00 or RR not significant (i.e. no risk involved)
2 AF < 5% or AF not significant (i.e. no health gain)
3 NNT > 50 or NNT not significant (i.e. not efficient).
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Figure 1: Types of prevention and treatment according 
to transitions in disease development
(adapted from A.T.F. Beekman, 2004)
 
10.3 Results
10.3.1 Sample characteristics and response pattern
The baseline sample characteristics are shown in Table 1 and have been described in
more detail elsewhere (Schoevers, Beekman, Deeg, Geerlings, Jonker, & Van Tilburg
2000). In multivariate logistic regression analysis, non-response at follow-up was
predicted by higher age, male gender, lower education, living alone, chronic dis-
ease(s), disability, organic caseness and depression (dichotomised as depression
case level vs. no depression case level). After subjects who died between measure-
ments were excluded from the sample, only lower education, living alone and base-
line organic syndrome predicted non-response. At follow-up 309 subjects (15.9% of
the study sample) had become depressed. The following analyses investigate the
associations of risk factors with incident depression.
10.3.2 Predictors of late-life depression
Table 2 shows the predictor model and the associations with the onset of depres-
sion. Statistically significant associations between risk indicators and depression
incidence were found for the following risk factors: medical illness, disability, a per-
sonal history of depression, recent loss of spouse, sleep disturbance, generalised
anxiety disorder and subsyndromal depression. From these, the absolute risk of
developing depression when exposed to a risk factor was calculated. The NNT val-
ues for the risk factors in the model range from 242 (living alone) to 4.1 for subjects
with GAD. For each risk factor the associated AF was also calculated, ranging from
24.6 (subsyndromal depression) to 1.1 (living alone).
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TABLE 1: SAMPLE CHARACTERISTICS AND ASSOCIATIONS WITH FOLLOW-UP 
(*= p<0,05, **= p<0,01, ***= p<0,001)
VARIABLES            T0 (%)                  T1 (% T0)                Resp vs Nonresp    Resp vs Non R.
(Value at TO)                                                                             Chi-2/df/p              excl. deceased  
Chi-2/df/p 
N 4051 2244 (55,4)
AGE 65-69       836 (20,6)             544 (65,1)                89,2/3/***             17,2/3/***
70-74        974 (24,0)             581 (59,7)
75-79        1050 (25,9)            581 (55,3)
80-86 1191 (29,4)             538 (45,2)                   
SEX          Male                1523 (37,6)  817 (53,6)                 3,02/1/ns              6,8/1/**
Female             2528 (62,4)            1427 (56,4)
EDUCATION                                                                                   41,4/1/*** 29,2/1/***
Higher than PS          2335 (57,6)            1394 (59,7)
Primary school or less      1716 (42,4)             850 (49,5) 
SOCIO-ECON STATUS                                                              21,1/2/***             11,9/2/**
High                                182 ( 4,5)             121 (66,5)
Middle                              1803 (44,7)            1045 (58,0)
Low 2050 (50,8)            1075 (52,4)
LIVING SITUATION                                                                   1,03/1/ns                1,22/1/ns
With other(s)            2197 (54,2)            1201 (54,6)
Alone 1854 (45,8)           1043 (56,3)
SOCIAL SUPPORT                                                                     24,4/1/***              4,4/1/*
No/little social 
support                     3209 (79,2)            1841 (57,4)
Help from others 842 (20,8)              403 (47.9)
CHRONIC DISEASES                                                                24,9/1/***             0,4/1/ns
None                        1894 (46,8)           1128 (59,6)
One or more                     2157 (53,2) 1116 (51,7)
PSYCHIATRIC HISTORY                                                             0,02/1/ns               1,6/2/ns 
None                              3449 (85,1)            1909 (55,3)
Yes 602 (14,9) 335 (55,6)
DISABILITY                                                                                 91,6/1/*** 10,5/1/**
Able                          2931 (72,4)            1759 (60,0)
Disabled 1120 (27,6)             485 (43,3)
MMSE SCORE                                                                           161,3/2/*** 84.8/2/***
26-30                                3281 (81,0)             1969 (60,0)
22-25                       522 (12,9)              209 (40,0)
0-21                                  248 ( 6,1) 66 (26,6)
ORGANIC syndrome level                                                               89.7/1/*** 35,5/2/***
None                               3790 (93,6)            2173 (57,3)
Case 261 ( 6,4)              71 (27,2)
SLEEP DISTURBANCE                                                                     1.49/1/ns 2,48/1/ns
None                               2615 (64,6)           1467 (56,1)
Yes                            1436 (35,4)             777 (54,1)
GENERALISED ANXIETY                                                            1,56/1/ns 4,1/1/*
None                                3923 (96,8 )          2180 (55,6)
Case                          128 ( 3,2) 64 (50,0)
DEPRESSION                                                                            19,4/2/*** 10.48/2/**
None                                2667 (65,8)           1534 (57,5)
Subsyndromal           861 (21,3)               462 (53,6)
Case level 523 (12,9) 248 (47,4)
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TABLE 2: PREDICTION MODEL; BIVARIATE ASSOCIATIONS WITH 
DEPRESSION ONSET
(Subjects without depression and/or dementia at baseline, N= 1940, analyses holding constant for other 
variables, E= Exposure Rate, RR= Relative Risk, AR= absolute risk of developing depression, 
NNT= numbers needed to be treated, AF= population attributable fraction) 
RISK FACTORS E  (%)            RR (95% c.i.)        AR (%)        NNT AF (%)
Female sex 60.5             1.20 (0.97-1.49)  Ns                 35.2                10.8
Education 
(primary school or less) 35.6                1.12 (0.91-1.39)    Ns                 54.9 4.1
Living alone 44.0             1.03 (0.84-1.26)    Ns                 242 1.1
Medical illness 47.8                1.46 (1.19-1.80)     23.2               16.6                18.1
Disability 17.7               1.74 (1.39-2.17)    27.7               9.6                  11.5
Mmse < 24 2.6                1.13 (0.62-2.07)   Ns                 47.0                 3.4
Personal history dep./anx.     13.0               1.61 (1.25-2.06)    25.6               11.2 7.3
Loss of spouse 6.9                2.29 (1.77-2.99)  36.4               5.3 8.2
Trouble sleeping 30.4               1.73 (1.41-2.12)     27.5             10.5 18.2
Generalised Anxiety Disorder 1.3                 2.56 (1.57-4.19)    40.7             4.1 2.0
Subsyndromal depression 22.7              2.43 (1.99-2.97)   38.6              5.8 24.6
10.3.3 Indicated prevention model (CART analysis)
Following the algorithm described in paragraph 2.3, subsyndromal depression clearly
was the preferred primary node (figure 2). Although the NNT of 5.8 was higher than
that of GAD (4.1, see table 2), the associated AF of depression was far greater
(24.6%), and that of GAD (2.0%) was below the threshold of 5% for the termination
of branches. The prevention model was then continued for each branch, starting
with subjects who had, and those who did not have subsyndromal depressive symp-
toms. In subjects with subsyndromal depression, the next branching candidate was
having a disability. This step reduced the NNT to 3.9, but also limited the AF to
9.7%. The model was then further subdivided with living alone and female sex as fol-
lowing risk indicators. As the AF was below 5% at the next step (all →...subsyndro-
mal symptoms → disability → living alone → female sex  →..) the branch was termi-
nated here. In subjects with subsyndromal depression who were not disabled, hav-
ing a chronic illness (AR 34.2%, NNT 6.0) and living alone (AR 35.0%, NNT 5.6, AF
4.9%) were chosen as subsequent child nodes. In subjects who did not have depres-
sive symptoms, loss of spouse was the strongest predictor, with an AR of 33.1% of
developing depression, an NNT of 6.1 and AF 5.4%. Further branching was not per-
formed as the AF became too small (<5%). 
The way in which NNT, AF and E are interrelated is graphically illustrated in
figure 3. It shows how adding more risk factors to the model results in a higher AR,
a lower NNT, but also in a lower AF.
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Figure 2: Indicated prevention model
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Figure 3: Consequences of adding risk factors to the prediction model in terms of
Absolute Risk (AF, in %), Numbers Needed to be treated (NNT, in %), 
and Attributable Fraction (AF, in %).
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10.3.4 Selective prevention model (CART analysis)
Figure 4 shows the model without subsyndromal symptoms of depression. Now the
focus is on selective prevention and easy case-recognition by GPs. Following the
algorithm described above, the first branching candidate on the basis of NNT and
AF scores is loss of spouse, with NNT 5.3 and AF 8.2%.  This was chosen as the pri-
mary (or parent) node. The selective prevention model then yielded medical illness
as the next branching candidate in subjects who lost their spouse. This step reduced
the NNT to 3.7, but also limited the AF to 5.8%. Because of this, further branching
was not performed. In subjects who did not recently lose their partner, being dis-
abled was the most important risk indicator, with NNT 11.5 and AF 9.0%.  Further
risk indicators were the presence of a chronic medical illness, and female gender.
The latter step reduced the AF, but only slightly affected the NNT (from 8.6 to 8.3). 
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10.4. Discussion
In this study, high-risk groups for incident depression were identified in a large
cohort of elderly GP patients. As case finding is generally poor, and both prevalence
and persistence of late-life depression are of major concern, the goal was to identify
groups in primary care with a high vulnerability for depression according to easily
identifiable criteria. Prevention is of interest, bearing in mind that even optimal care
can only reduce the burden of depression by 34% (Andrews, Issakidis, Sanderson,
Corry, & Lapsley 2004). Since the detection of subsyndromal depressive symptoms
requires more effort than recognising other, more easily identifiable risk indicators in
primary care, two models were compared that either incorporated or excluded sub-
syndromal depression as a predictor of the future onset of a full-blown depressive
disorder. Thus, the potential health benefits of preventative measures aimed at
reducing the incidence of late-life depression could be determined, taking into
account the time that should be invested in adequate case-finding in primary care.
Although this approach, combining clinical, epidemiological and public health per-
spectives, has been strongly advocated (Munoz, Mrazek, & Haggerty 1996), it is rel-
atively new to the field of common mental disorders.
Our findings suggest that indicated prevention  — which involves identifying
subsyndromal depressive symptoms as the most important risk indicator — is the
preferred option for identifying groups at high risk of developing depression.
Subjects with depressive symptoms had a risk of almost 40%, and accounted for
24.6% of new cases at follow-up. With an NNT of 5.8 — which carries the promise
of efficient interventions in this group —  these subjects are of major interest for
preventative interventions. Further subdivision of the sample according to combina-
tions of risk factors yielded groups with an even higher risk of developing depression
and lower NNT values, but these more narrowly focussed approaches have a smaller
impact on the incidence rate of depression in the population. For example, disabled
women with subsyndromal symptoms who live alone had a 50% risk of becoming
depressed, an NNT of only 3.2, but a relatively low AF (5.9%) indicating that the inci-
dence rate would only fall by 5.9% at best. 
In a recent meta-analysis on short-term psychotherapeutic interventions aimed at
persons with subsyndromal depressive symptoms, these were found to reduce the
incidence of depression by 30% (Cuijpers, van Straten, & Smit 2005). If this were
applied to a sample such as ours, the NNT of intervention would be 19.3 (5.8 / 0.3)
for persons with subsyndromal depression. For a relatively intensive form of treat-
ment, this may be considered to be too great an effort, and it could be argued that
one should start with those subjects who have the highest vulnerability. Further sub-
division in the CART analysis then leads to smaller subgroups that were exposed to
more risk factors. In women with disability who live alone, the adjusted NNT would
be 10.7 (3.2 / 0.3). As an alternative to cognitive behavioural therapy, less costly
forms of indicated prevention should also be taken into consideration. Both biblio-
therapy (Cuijpers 1997) and the Coping With Depression course, a manualised form
of self-help with instructions on mood management, were found to be effective ther-
apies for unipolar depression, with effect sizes that are comparable to those of other
206 Epidemiology of late life depression
treatment modalities for depression (Cuijpers 1998). Very recently, minimal contact
psychotherapy along these lines has been proven effective in reducing the onset of
depression in primary care patients with subthreshold depression (Willemse et al.
2004). Also in low-cost computerised form, such interventions have proved effective
(Christensen, Griffiths, & Jorm 2004;McCrone et al. 2004).
If one considers selective prevention of late-life depression, our analyses show
that, in line with earlier findings (Cole & Dendukuri 2003), elderly persons who
recently lost their spouses are at great risk of developing depression, and even more
if they also have a chronic medical condition (AR 44%, NNT 3.7). Overall, the AF val-
ues in this model were somewhat smaller, which means that fewer cases can be pre-
vented. Examples of preventative programs directed at persons who lost their
spouse include self-help groups of fellow-sufferers that convene for emotional
exchange and support, specific courses on competences needed to cope with single
life, and ‘widow-to-widow’ programs in which women who had lost their husband
earlier visit recently widowed persons for emotional and practical support. Although
these programs have shown promising results in terms of post bereavement adapta-
tion (Vachon et al. 1980) and social functioning (Van Lammeren & Geelen 1995), the
evidence of efficacy in reducing depression onset is limited. In a meta-analysis of
eight types of such interventions, Cuijpers et al. found an effect size of 0.34 in com-
parison with controls, but the number of published studies is still limited and this
difference was not statistically significant (Cuijpers, Van Gageldonk, & Overtoom
2000). Considering the fact that these are low-cost community based interventions,
randomised controlled trials are urgently needed.
Indicated prevention thus has the best chances of detecting large groups of sub-
jects at high risk of developing depression, with NNT values that could make pre-
ventative actions cost-effective, using available evidence-based interventions. Still, in
comparison with selective prevention, indicated prevention requires the extra effort
of screening subjects for subsyndromal depression. A number of screening instru-
ments have been validated for case finding in community living elderly. These
include the CES-D, a 30-item questionnaire on depressive symptoms (Beekman,
Copeland, & Prince 1999;Prince et al. 1999;Radloff 1977), but more recently also the
15-item version of the Geriatric Depression Scale has demonstrated its effectiveness
for detecting elderly subjects with depressive symptoms in the community (Almeida
& Almeida 1999;de Craen, Heeren, & Gussekloo 2003;Osborn et al. 2002;Sheikh &
Yesavage 1986). Screening of large numbers of patients in primary care has been
shown to be both feasible and effective (Bijl et al. 2003;Bijl et al. 2004). Primary care
facilities therefore appear to be well equipped to find elderly persons with subsyn-
dromal symptoms. 
Strengths and limitations
The AMSTEL study is a large prospective cohort study with long follow-up times, and
it incorporated a wide range of risk factors for late life depression measured inde-
pendently of depression onset. The findings are representative for urban populations
of community dwelling older persons, and are highly relevant for primary care. 
Nonetheless, a number of limitations deserve mentioning. First of all, studies
with a limited number of measurements tend to overrepresent chronic forms of dis-
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order. Between assessments, subjects may have had both onset and remission of
shorter episodes of depression. At the same time it may be concluded that, even
with a three-year interval, the set of risk factors employed in this study can identify a
large number of future cases of depression. Secondly, although the risk factors cover
many domains relevant to depression, biological (genetic) risk indicators are less
well represented in the dataset. Thirdly, it should be concluded that this study does
not prove that preventative interventions are successful in community-living elderly.
Available studies on indicated prevention were mostly performed in younger adults.
However, as other forms of treatment of depression are also effective in the elderly,
there would be no reason to doubt the efficacy of preventative interventions in elder-
ly subjects. Considering the potential benefits of prevention there is an urgent need
for randomised controlled trials to address this matter. 
Conclusions
The results of this study stress the importance of preventative action for depression
as the primary common mental disorder. And to answer the question put forward in
the title of this paper: “Yes, we do know where to begin”. Indicated prevention of
depression is the preferred strategy. Still, as this involves screening patients for sub-
clinical depression, selective prevention of depression may prove to be a good alter-
native. It will only require the use of a simple checklist of the relevant risk factors,
and the expected health gains can also be substantial. Either way, primary care facili-
ties are equipped to perform adequate case-finding. Nonetheless, even though mini-
mal contact, low-cost, evidence-based interventions for persons with subsyndromal
symptoms are available, their cost-effectiveness has to be established in proper ran-
domised trials. Recent data however indicate that this may be the case (Smit,
Ederveen, Cuijpers, Deeg, & Beekman 2004b;Willemse, Smit, Cuijpers, & Tiemens
2004). It is therefore time to reconsider whether the exclusive focus on treatment of
common mental disorders should be adapted, and whether an allocation of person-
nel and resources for prevention may be more effective in reducing both individual
suffering and the overall costs of health care. 
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General discussion
11
11 General Discussion
In this chapter, the major findings of this thesis will be presented following the
research questions formulated in chapter 1. In addition, the most important limita-
tions and strengths of the design and implementation of the study will be discussed.
The last paragraph describes the relevance of these findings from a theoretical, clini-
cal and public health standpoint, leading to the formulation of recommendations for
future research. 
11.1 Brief summary of findings
1. Can different etiologic pathways for the onset of late-life depression (through
genetic/familial vulnerability, organic vulnerability or environmental vulnerability)
be demonstrated in a longitudinal study of community-living elderly?
[Chapter 2] This study sought to determine whether, in line with the vulnerability-
stress model (Brown & Harris 1978), depression is the result of ‘social stress’ factors
such as partner loss, relocation and (the occurrence of) chronic diseases or disabili-
ty, and whether the influence of these is modified by the vulnerability or protective
factors distinguished in this study. Higher age, personal history of depression, death
of spouse, health related factors and comorbid organic or anxiety syndrome showed
significant associations with depression incidence in bivariate analyses. It was
shown that genetic/familial vulnerability, defined as having a personal or family his-
tory of psychiatric illness, and organic vulnerability did not modify the association
between the investigated stress factors and incident depression. Subjects with these
types of vulnerability were not more likely than others to develop depression in
response to loss, to a decrease in physical wellbeing, or in response to deteriorating
functional abilities. Having a personal history of depression was in itself a relatively
strong predictor of depression onset. Although this may be suggestive of a ‘kindling’
effect, whereby the onset of a new episode of depression is more easily elicited by
either external or internal stressors in subjects who have become sensitised through
earlier episodes, interactions between a personal history and stress factors on the
outcome measure could not be demonstrated. The third type of vulnerability, by
environmental factors, did act as effect modifier; having a marital partner, and if
unmarried having social support, significantly reduced the association between func-
tional disability and the incidence of depression. This can be taken as modest sup-
port for the vulnerability-stress hypothesis to model the incidence of depression.
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2. Are risk factors related to incidence of late-life depression also related to prog-
nosis? Can a vulnerability-stress model also be established for prognosis of late-life
depression? 
[Chapter 3] In subjects with a depression at baseline, having a personal history of
depression, having baseline functional limitations and emerging comorbid anxiety
symptoms were associated with chronicity of depression. These risk factors also pre-
dicted depression incidence in the earlier study. Although other risk factors associat-
ed with incidence, such as recent life-events and changes in physical, functional or
cognitive status, were not associated with the development of chronicity overall, the
impact of these risk factors on the course of depression was predictive of chronicity
after stratification of the sample. Effect modification by longstanding vulnerability
characteristics was demonstrated, and the analyses were repeated in subjects with,
or without a personal history. In subjects without a previous history of depression,
functional disabilities, receiving instrumental support and also male gender were
predictive of a chronic course. In subjects with a personal history of depression how-
ever, course type was not associated with other factors. Similarly, but for theoretical
reasons, the sample was stratified according to gender. It was shown that in women
the development of chronicity was more strongly associated with longstanding, pos-
sibly genetic vulnerability than in men. In men, recent psychosocial and health relat-
ed characteristics showed stronger associations with course type than in women. It
was concluded that more recent life stresses are related to prognosis in depressed
subjects without a personal history, and in depressed men. The risk profile for
depression onset differs from that associated with the development of chronicity, in
the sense that chronicity is more strongly associated with both longstanding vulnera-
bility and gender. 
3. Depression and generalised anxiety disorder; dimensions of a single disorder, or
different and distinct disease entities?
[Chapter 4] In this cross-sectional study, it was shown that comorbidity of depres-
sion and generalised anxiety disorder increases with higher severity levels of either
category. This is suggestive of a dimensional rather than a distinctly different inter-
pretation of these phenomena. A related issue is whether pure depression, pure gen-
eralised anxiety disorder or mixed anxiety-depression may show different associa-
tions with risk factors for these disorders. This proved not to be the case for concur-
rent risk factors, but longstanding vulnerability showed significantly stronger associ-
ations with mixed anxiety-depression than with pure anxiety and pure depression.
Comorbidity was also twice as likely in women than in men. It was concluded that in
the elderly, a dimensional classification is more appropriate than a categorical classi-
fication of depression and generalised anxiety. It was also concluded that mixed anxi-
ety-depression is a more severe form of psychopathology that is almost specific to
women in this age group.
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4. Pure depression, pure generalised anxiety disorder and mixed anxiety-depres-
sion; different course types and/or fixed patterns of temporal sequencing? Can dif-
ferent risk profiles be distinguished for onset in a prospective design?
[Chapter 5] In a study of course types, remission rates at follow up were significantly
higher for subjects with pure depression or pure generalised anxiety than in subjects
with mixed anxiety-depression, of whom only 27% had remitted at three year follow-
up. A pattern of temporal sequencing was established, with anxiety often progress-
ing to depression or mixed anxiety-depression. A prospective study of risk factors
and onset of either category showed that pure depression and mixed anxiety-depres-
sion were predicted by loss events, ill health and functional disability. Onset of pure
generalised anxiety, and more strongly that of mixed anxiety-depression, was associ-
ated with longstanding, possibly genetic vulnerability. It was concluded that, in com-
parison with either pure depression or pure anxiety, mixed anxiety-depression repre-
sents more severe and more chronic psychopathology, associated with longstanding
vulnerability. These longitudinal findings were also interpreted as favouring a dimen-
sional versus a categorical classification of generalised anxiety disorder and depres-
sion.
5. Is depression indicative of subsequent cognitive decline and Alzheimer’s disease
(AD) in elderly persons with normal cognition?
[Chapter 6] In this study on the nature of the relationship between depression and
cognitive decline/dementia, the research question was investigated in two independ-
ent samples of older people with normal cognition. Similar analyses were performed
in samples without cognitive impairment from both the Amsterdam Study of the
Elderly (AMSTEL) and the Longitudinal Aging Study Amsterdam (LASA). Although
both studies used different methodology and research instruments, it was concluded
that in both studies depression was associated with an increased risk of subsequent
AD and cognitive decline respectively, but only among subjects with higher levels of
education. It was suggested that in a subgroup of more highly educated elderly peo-
ple, depression may be an early manifestation of AD before cognitive symptoms
become apparent, rather than a psychological reaction to subjective and subclinical
memory cognitive complaints.
6. Is there an association between depression in community living older persons
and an increased mortality risk? And if so, does this association depend on severi-
ty of depressive disorder and/or gender? 
[Chapter 7] Earlier community-based studies had found opposing results as to
whether depression (according to a variety of different definitions, research instru-
ments and severity levels) was associated with excess mortality. As both gender and
severity of depression may theoretically have acted as confounders, the study of
mortality was performed with a special interest in these associations. Using a six-
year follow-up of community death registers, the mortality risk of neurotic (mild) and
psychotic (severe) depression was calculated after adjustment for demographic vari-
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ables, physical illness, cognitive decline and functional disabilities. Psychotic depres-
sion was associated with significant excess mortality in both sexes. Neurotic depres-
sion was associated with a higher mortality risk in men only. It was concluded that in
the elderly, major depressive syndromes increase the risk of death in both sexes,
whereas mild depressive syndromes only show this association in men.
7. What mechanisms can be responsible for the excess mortality associated with
depression?
[Chapter 8] In a review article on this issue, it was shown that a number of different
processes may play a role in this association. First of all, depression affects behav-
iour. Depressed patients show more unhealthy living habits, less compliance with
medical treatment, and a higher number of accidents and suicides. Secondly, biolog-
ical correlates of depression such as dysregulation of the neuro-immune system;
hyperactivity of the HPA-axis, and autonomic dysregulation may all have a negative
effect on both the prognosis of somatic illnesses and longevity. Although the litera-
ture suggests that treatment of depression positively affects some biological param-
eters, it remains unclear whether successful treatment of depression may lead to
better survival.
8. Do depression characteristics such as severity, duration or specific symptoms
contribute to the association with excess mortality?
[Chapter 9] A second study of mortality data was performed at ten-year follow-up. It
was concluded that both moderate and severe depression, now defined by the num-
ber of GMS depression symptoms at baseline, predicted 10-year mortality after mul-
tivariate adjustment. Also chronic depression, defined as having a depression at
baseline and at three-year follow-up, was associated with a significantly higher mor-
tality risk compared to non-depressed subjects. Somatic depression items were pre-
dictive of excess mortality in the full cohort, regardless of the presence of clinical
depression. In subjects with depression, only depressive thoughts, suicidal ideation
and guilt, were specifically associated with excess mortality, albeit in opposing direc-
tions. Subjects with suicidal ideation were at higher risk to die, whereas guilt showed
a protective effect relative to the other depression symptoms. This was taken to indi-
cate that both severity, chronicity and specific symptom profiles of depression are
indicative of a higher mortality risk, with a differential pattern in symptoms associat-
ed with mortality depending on depression severity.
9. Is community-based prevention of late-life depression feasible?
[Chapter 10] As case finding in late-life depression is generally poor, and optimal
treatment would only partially reduce the disease burden of depression, two models
for prevention of late life depression in community living elderly were presented. For
reasons of cost-effectiveness an for ethical reasons, preventative measures should
be targeted at subjects with a high risk of developing depression through exposure
to multiple risk factors. A distinction was made between indicated prevention, in
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subjects with early or subsyndromal symptoms, and selective prevention in persons
who are at risk because they have been exposed to certain risk factors. Prediction
models for the onset of depression were calculated in terms of Absolute and Relative
Risk estimates, Numbers-Needed-to-be-Treated, and Population Attributable
Fraction. It was found that subsyndromal symptoms of depression were associated
with a risk of almost 40% to develop depression, an NNT of 5.8, and accounted for
24.6% of new cases. Adding more risk factors yielded higher AR, lower NNT, but
also lower AF values. In the selective prevention model, persons who recently lost
their spouse were at highest risk (AR 37%, NNT 5.3, AF 8.2%), a risk that became
even higher if they also had a chronic medical illness. Considering costs and benefits
of both models in the context of the availability of evidence-based preventative inter-
ventions, indicated prevention aimed at elderly persons with depressive symptoms is
the preferred option. It was concluded that the exclusive focus on treatment of
depressive disorder should be readdressed, and more attention should be given to
the possibilities of prevention in psychiatry. 
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11.2 Methodological considerations 
11.2.1 Sampling and non-response 
The AMSTEL study is a prospective cohort study with an age-stratified, random sam-
pling procedure enabling good representativeness of the community living popula-
tion and its prevailing psychopathology. The sampling procedure was independent of
the referral filters of health care (Goldberg & Huxley 1980) that introduce major bias-
es in the clinician’s impression of prevalence, clinical picture and course of major
mental disorders such as depression (Cohen & Cohen 1984). Still, a number of
potential sources of bias deserve a more careful description (Bouter & Van Dongen
2000;Sackett 1979). 
First of all, selection bias may have affected the external validity of the study pop-
ulation. The sample was drawn from an elderly population living in the city of
Amsterdam, excluding elderly persons living in institutions. Although their numbers
are rather small compared to the whole population, generalisations towards hospital
and institutionalised populations are of limited legitimacy. This can also be said for
persons who were not sufficiently fluent in Dutch to understand the questions com-
prising the GMS-AGECAT interview. Ethnic minority groups and (immigrant) popula-
tions of non-Dutch origin are probably underrepresented in this study. Although the
total number of older persons originating from these groups was rather limited at
the time this study was started (Van Zee, Brinkman, & Vermeulen Windsant 1990),
there has been a considerable increase over the last years, and recent data suggest
that prevalence levels of depression may be substantially higher among these groups
(van der Wurff et al. 2004). Generalisation is also hampered towards rural popula-
tions, who generally have lower levels of psychopathology than people living in large
cities (Peen & Dekker 2003;Peen & Dekker 2004). As the subjects in this study were
in the 65-84 age bracket, these results also have limited value for younger adults,
and for the growing group of very old elderly (above 84 years). 
Non-response patterns in the baseline sample revealed that non-response was
associated with cognitive impairment and health problems in the younger old (<75),
whereas in the older old (75-84 years) no correlates of non-response were found
(Launer, Wind, & Deeg 1994). This indicates that the very frail were underrepresent-
ed in this study. The presence of clinically relevant depression, the core variable in
this study, was however not associated with attrition to the baseline cohort. 
Overall, these patterns are similar to what is found in other community studies,
and, with the above limitations in mind, the sampling procedure resulted in a repre-
sentative sample of community-living elderly that is among the largest cohorts of
elderly individuals internationally.
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11.2.2 Loss to follow-up
As was described in chapter 2.3, the total loss to follow-up was relatively large in this
study. This was partly due to oversampling of the older old in order to obtain equally
sized strata at follow-up. Not surprisingly, attrition was associated with higher age,
male sex, lower education, chronic disease(s), disability and organic syndrome. As
can be expected from these characteristics, a relatively large number of people had
died during the first phase of the study period. Two studies in this thesis specifically
investigated the associations between risk factors and excess mortality at 6 and 10
years follow-up, and found that depression carried an excess mortality risk. As data
on vital status were almost complete, the mortality studies were not affected by any
form of attrition bias. Apart from non-response because of death, 16.3% of the base-
line sample refused further participation at 3-year follow-up. This is comparable to
later studies such as the LASA study (Deeg et al. 2002). Multivariate analyses of
non-response, excluding the deceased, revealed that only lower education, being
unmarried and having an organic syndrome remained as predictors of all other types
of attrition. Importantly, depression and generalised anxiety did not significantly
affect response-rate at follow-up in multivariate analyses. 
It can thus be concluded that people in less favourable socio-economic and
social circumstances, people with chronic diseases, functional disabilities and cogni-
tive decline, and men were relatively underrepresented at three year follow-up. This
is a common finding in community based studies such as the AMSTEL study.
Although the primary disorders under study and the whole array of potential risk fac-
tors were well represented in the study cohort, it cannot be ruled out that, especially
in the very frail, associations between risk factors might have been somewhat differ-
ent from the overall findings. A similar remark can be made about the studies on
course types (Chapters 3 and 5) in which selective attrition of depressed subjects to
the follow-up assessment of the study also occurred among the very frail. Depressed
subjects with functional disabilities or cognitive impairment were more likely to be
too ill to respond at follow-up. Most probably, the prognosis of depression in these
subjects was even worse than in those who were still included the study at three-year
follow-up. 
In the studies on cognitive decline described in chapter 6, differential loss to fol-
low-up may have somewhat affected the results. In the AMSTEL study, the overall
proportion of subjects lost to follow-up was considerable, although not associated
with baseline depression. In the LASA sample the overall loss to follow-up was
smaller, but depressed subjects did have higher attrition rates than subjects without
depression. As the main results were similar in both studies, it is unlikely that loss
to follow-up could have accounted for the highly statistically significant results.
11.2.3 Information bias
Systematic measurement errors may lead to misclassification of variables. If misclas-
sification is non-differential, the result may be an underestimation of the strength of
the association between determinant and outcome. If misclassification is differential,
measurement errors or differences in information retrieval are associated with the
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value(s) of other variables under study. This may significantly influence the results by
either over- or underestimating the strengths of associations, and thus affect the
internal validity of the study.
As an example of this, a person may appear depressed during the interview, and
as a result the investigator may be more inclined to elicit information about possible
previous episodes of depression than in subjects whom the researcher believes not
to be depressed (‘diagnostic suspicion bias’) (Bouter & Van Dongen 2000). 
Information bias may also play a role on the side of the subject who is inter-
viewed. Depressed subjects may report more negatively about their past, or about
their current health status; this is called recall bias (Raphael & Cloitre 1994) or
‘rumination bias’ (Bouter & Van Dongen 2000). Another example could be that, in
studies on gender differences in depression, women may be more inclined to report
depressive complaints, and therefore show higher depression scores (Angst &
Dobler-Mikola 1984). 
Apart from these forms of report bias, cross-sectional studies may also show
contamination, as the disorder under study is assessed at the same moment as its
possible determinants. A determinant may then be misclassified as a risk factor for
developing the disorder, whereas it is actually part of, or a result from the disorder
under study.
All of these types of information bias may have affected the results. However,
there are a number of arguments against a strong influence on the main findings.
First of all, the design of this study, with a fixed set of questions in a fixed order, and
psychiatric diagnoses made only after the interview by the computerised algorithm,
make diagnostic suspicion bias less likely to occur. As many subjects who were
found to be depressed were not recognised and diagnosed as such by the health
services, and thus did not define themselves as ‘officially depressed’, recall bias was
also less likely to have significantly affected the results. The possibility of women
over-reporting depression is contradicted by the growing consensus that, both in the
elderly (Sonnenberg et al. 2000) and in younger age groups (Wolk & Weissman
1995) higher levels of reported depressive symptoms in women reflect actual higher
levels of this type of psychopathology in women. In chapter 7, which is concerned
with sex differences, it is further argued that, if this type of bias had occurred, it
would have led to an overcorrection in multivariate analyses.
The most important argument against these types of information bias however is
the longitudinal design of the study, in which many of the determinants were meas-
ured before the outcome measure (incident depression, mortality) had occurred.
Furthermore, interviewers at follow-up were not aware of answers that respondents
had given at the first assessment. Report bias and contamination thus appears to be
improbable explanations for the main findings of this study.
11.2.4 Confounding
Confounding is present when the observed association between a risk factor and an
outcome is also independently determined by the presence of another factor that is
etiologically, prognostically or otherwise (e.g. as a marker of vulnerability) related to
that same outcome. If this factor is not corrected for, confounding may lead to either
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over- or underestimation of the strength of an association. In order to qualify as a
confounder, a risk factor (Bouter & Van Dongen 2000):
1 is an independent predictor of the outcome studied
2 is related to the risk factor under study
3 is not an intermediate factor in the causal relation between risk factor and out-
come 
The identification of confounders is not an easy task. First of all, the notion that a
certain risk factor may act as a confounder has to come from our theoretical under-
standing of the etiology of the studied condition. Detecting confounding is mainly
depending on having a good hypothesis. As good hypotheses are not as manifold as
we would like them to be, it may well be that in the future, new factors will be ‘dis-
covered’ as confounders that today seem completely trustworthy. Secondly, it may be
hard to determine whether a factor is an intermediate between a risk factor and the
onset of a disease, or an independent predictor. Thirdly, correcting for confounding
is simply impossible if the potential confounders are not included in the study
design.
The current study has a number of strengths that limit the possibility of con-
founding, but the above arguments illustrate that this can never be ruled out. Very
importantly again, the AMSTEL study is a longitudinal study. The prospective design
greatly facilitates the distinction between factors that co-occur with, or antedate and
may possibly be etiologically or prognostically related to the object of study. This is a
major advantage over cross-sectional studies in which it is impossible to make these
distinctions. Another important characteristic of the study is that it incorporates a
comprehensive set of risk factors associated with late-life depression. Almost all of
the analyses described in this thesis were based on the notion that depression is a
disorder determined by the interaction of a longstanding (genetic) vulnerability, a
number of social influences and loss events, physical health, disability and, specific
for the elderly, cognitive decline. Furthermore, multivariate analytic models were
used to control for confounding, and possible interactions between risk factors were
investigated. Examples of this approach are the tests for interaction and subsequent
stratification according to gender in the studies on course type (Chapter 3) and mor-
tality (Chapter 7), and according to different types of vulnerability (Chapters 2 and 3).
Still, as will be discussed in more detail in paragraph 11.2.6, the current study did
not include more specific biological and genetic parameters that may prove to be
highly relevant to understand, and model the incidence and course of depression. 
11.2.5 Measurement of depression 
Depression was measured using a computerised version of the Geriatric Mental
State schedule (GMS). The GMS was developed from the Present State Examination
(Kendell et al. 1968) and the Present Status Schedule (Spitzer et al. 1964) by a group
of British and American researchers that performed pilots in London and New York
to assess validity and reliability in diagnosing psychopathology in elderly people
(Copeland et al. 1976;Copeland, Dewey, & Griffiths-Jones 1986;Gurland et al. 1976).
In line with the primary aims of the AMSTEL study, the GMS items relating to
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depression, anxiety and cognitive disorders were incorporated in this study.
As GMS-AGECAT has proven reliability for epidemiological studies (Copeland et
al. 1988;Hooijer, Jonker, & Dewey 1991), it was possible to validly diagnose large
numbers of community living elderly through a computerised method with trained
lay interviewers. Another advantage is, that AGECAT attributes levels of caseness sig-
nifying increasing severity levels of psychopathology with a clear distinction between
cases and subcases. These rather unique diagnostic properties of GMS-AGECAT
were well suited for the type of research questions investigated in the AMSTEL study. 
Diagnosing depression using GMS-AGECAT also has a few disadvantages, espe-
cially when comparing with other diagnostic systems. First of all, diagnoses are cal-
culated from individual item scores using a computerised algorithm known only to
its designers. Although this enables valid comparisons between findings and inter-
pretations of depressive symptomatology in different parts of the globe, there is very
limited transparency as to how individual items are weighted in order to reach spe-
cific diagnoses. This is unlike other diagnostic and classification systems that are
currently in use. A second limitation in comparing findings is that, although AGECAT
does provide an assessment of depression severity, it does not diagnose Major
Depressive Disorder according to DSM or ICD criteria. It is evident that concepts
such as minor depression and subthreshold depression are highly relevant when
assessing levels of psychopathology in community living elderly, but ideally it should
also be possible to distinguish the most severe depressions according to interna-
tionally standardised criteria. Still, comparative studies have repeatedly shown that a
diagnosis of depression according to GMS-AGECAT shows moderate to fair agree-
ment with the combination of all diagnostic categories of depression according to
DSM criteria (described in chapter 1 of this thesis) (Ames & Tuckwell
1994;Copeland, Dewey, & Griffith-Jones 1990;Lobo et al. 1995). Nevertheless, other
authors have also stressed the need to be able to adapt the diagnostic threshold in
the algorithm depending on the purpose of specific analyses (Schaub, Linden, &
Copeland 2003).
11.2.6 Comprehensiveness of the data set
The AMSTEL study was a study on determinants of cognitive decline and depres-
sion. The implication of this is, that a relatively large amount of data on physical and
cognitive functioning, including a number of cognitive tests, were available for the
analyses. Other factors associated with depression, such as living situation / marital
status and functional abilities were also included. Independent variables were meas-
ured using internationally established and standardised research instruments that
are validated for a population of Dutch elderly. These data were obtained using
established research instruments such as the CAMDEX-interview(Roth et al. 1986),
the Mini-Mental State Examination (Folstein, Folstein, & McHugh 1975), the
Activities of Daily Living (ADL) scale (Katz et al. 1963), and the Instrumental
Activities of Daily Living (IADL) scale (Lawton & Brody 1969). 
A number of potential weaknesses of the data set deserve to be discussed here.
One is, that the data on medical illnesses were obtained from the respondents
themselves, and were not cross-checked with other sources. Ideally, we would have
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checked the health status of all subjects with their general practitioners. Earlier stud-
ies have however found that patients’ self-reports on selected chronic diseases are
fairly accurate, with the exceptions of atherosclerosis and arthritis. Differences in
reporting were reported to be non-differential with regard to depression status
(Kriegsman et al. 1996). 
Likewise, more detailed information on the personal and family history of depres-
sion or other psychiatric disorders would have yielded valuable additional informa-
tion on course types and possibly on specific vulnerability profiles. It can not be
ruled out that the fact that the associations between family history and depression
were not statistically significant is a result of the way this information was obtained. 
Another limitation is that data on current and former treatment of depressive dis-
order were rather crude. We did not obtain information on specific interventions and
medication. If more specific data on treatment had been available, these may have
demonstrated that subjects with more severe depressions received more intensive
treatment. However, even if such data had been available, treatment allocation was
not in any way randomised, and no conclusions could be drawn as to the potential
beneficial effects of treatment on long-term prognosis and mortality in community
living elderly. The low overall levels of treatment that subjects reported are in line
with other findings among Dutch elderly (Sonnenberg et al. 2003) and elsewhere
(Unutzer et al. 1997), and show that case-finding is still relatively poor in older per-
sons.
The level of social support was determined with a question that would elicit
answers on instrumental, rather than emotional support. Social support is often dis-
tinguished into instrumental and emotional/psychosocial support, and more elabo-
rate designs and screening methods exist to define these different types of support.
According to Cohen and Wills (Cohen & Wills 1985) a detailed assessment of the
availability of interpersonal resources that are responsive to the needs elicited by
specific stressful events is required to demonstrate a stress-buffering effect. Our
question of whether a person receives ‘help from family and/or others’ mainly refers
to instrumental support, which seems appropriate when faced with invalidating cir-
cumstances such as chronic illness or a decrease in functional abilities. More specif-
ic measures of emotional support might have shown even more pronounced buffer-
ing effects with respect to psychological distress and the association with the onset
of depression (Tijhuis et al. 1995). 
We did not obtain causes of death. As there is growing interest in the pathways
between depression, medical conditions and survival described in chapter 8, it
would have been highly informative to combine the current data with more specific
information on causes of death. In the LASA study, it was found that suicide
accounts only for a very small proportion of the excess mortality associated with
depression (Penninx et al. 2001) whereas cardiac mortality was significantly
increased. It is of considerable interest to examine whether these findings can be
replicated in the AMSTEL study.
A number of other factors were also not included in the study that would, ideally,
have been. In light of the recent developments in depression research, the most
important missing information would be biological correlates of depression.
Especially the functioning of the HPA-axis (Pariante 2003;Raison & Miller 2003) and
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inflammatory processes (Penninx et al. 2003;Raison, Marcin, & Miller 2002) are rap-
idly gaining attention as potential determinants or correlates of depression. More
detailed information on the functioning of the HPA-axis and inflammatory markers
in our subjects would have been useful to develop a more comprehensive under-
standing of the psychological and biological correlates of depression, and the associ-
ations with onset, course and comorbidity with other illnesses. Chapter 8 gives an
outline of the biological mechanisms that may be involved. 
The same applies for data on the genetic profile of the respondents. A recent
meta-analysis on the genetic epidemiology of major depression showed significant
familial vulnerability due to additive genetic effects, with a heritability of 37%
(Sullivan, Neale, & Kendler 2000). It was concluded that recurrence of depression
still is the most important clinical marker of genetic/familial aggregation. However,
it also showed strong support for individual-specific environmental effects (63%
including measurement error) in the etiology of depression. In line with this, the cur-
rent study has demonstrated the importance of longstanding vulnerability, exempli-
fied by a previous history of depression, as a factor determining future relapses and
a chronic course. Still, ideally it would have been of interest to investigate possible
genetic vulnerability profiles in more detail, together with the information we did
obtain on previous history and other risk factors for depression. Genes involved with
the serotonin transporter system (Caspi et al. 2003) and the functioning of glucocor-
ticoid receptors (Muller, Holsboer, & Keck 2002) have been suggested as possible
candidates.
A third domain that was not included in this study is an assessment of personali-
ty structure. The availability of factors such as mastery, neuroticism and possibly the
presence of personality disorders would have enabled investigating the interplay
between life events or long term difficulties, coping style and the onset and course of
depression. 
Lastly, traumatic (loss) events early in life are another potential predictor of
depression. These were also not included in our study and would possibly have dif-
ferentiated our view on the nature of longstanding vulnerability (through earlier
episodes of depression) that we found.  
It can thus be concluded that the AMSTEL study incorporated a large, although
not fully comprehensive, set of data that enabled the study of a relatively large num-
ber of aspects of late-life depression in a longitudinal design. The data set reflects
the dominant concepts of determinants of depression at the time this study was
started, and also adhered to rules of economy and pragmatism.
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11.2.7 Statistical methods
The statistical significance of bivariate associations between risk factors and out-
come was calculated using t-test, chi-2 test, anova, Mann-Whitney U test or logistic
regression. As depression is the result of the interplay between a larger number of
determinants, multivariate analyses were also performed, using logistic regression in
risk factor studies and Cox proportional hazards models in the survival analyses.
Chapter 8 and 9 use a hierarchical logistic regression model based on theoretical
notions. The advantage of this method is that is shows the contribution of different
sets of risk factors to the outcome of study (mortality) in a model that is build up
stepwise and reflects the main hypothesis of the study. In other chapters (2, 4, 5, 9),
parsimonous regression models were chosen to determine which of the risk factors
under study showed the strongest associations with outcome. This for example
enabled us to determine which symptoms of depression were specifically associated
with excess mortality (chapter 9). Also in chapter 9, separate analyses were per-
formed using symptom clusters that were based on both theoretical and statistical
(factor analysis) arguments. Investigating both a statistically driven model and a
model build on theoretical grounds can be seen as an acknowledgement of the fact
that hypotheses may very well miss important associations that can be found with a
non-hierarchical and purely statistically driven research method, and vice versa.
The studies described in this thesis have described the strength of the associa-
tion between risk factors and outcome through odds ratios or relative risk estimates
with 95% confidence intervals. In comparison with the ‘traditional’ p-value (P<0.05)
dichotomising significant or non-significant results, confidence intervals help to
determine the size of difference of a measured outcome between groups, rather than
providing a simple indication of whether or not it is statistically significant (Gardner
& Altman 1986).
Still, if one also attempts to study the importance of risk indicators for onset or
course of disorder on a population level, more information is needed than just the
strength of the association. It is necessary to know how many persons are exposed
to a certain risk factor, in order to determine the scale of both the problem and of a
possible intervention. This can be done by also providing the level of exposure to a
risk factor in the population, also called Expected Event Rate (EER). By combining
data on relative risk with the level of exposure to a risk factor in the population, the
absolute risk of developing a disorder can also be calculated. If a certain risk factor
shows a relative risk of 3.0, the chance that persons with this risk factor develop this
disorder is three times higher than in persons without this risk indicator. However, if
the EER, or baseline risk, is only 0.2%, the actual difference in the risk to develop
depression is ‘only’ 0.4% (0.6-0.2). If the EER would be 10%, the absolute risk differ-
ence, with a similar relative risk, would be much greater, namely 20%, and this may
lead to different decisions on whether or not to intervene. What counts for individual
patients (and hopefully also for clinicians and researchers) is an absolute risk reduc-
tion through treatment or prevention. Also in health politics, the scale of health
problems in terms of potential costs of illness and benefits of intervention are cru-
cial. Another way to describe these matters is in terms of the Numbers Needed to be
Treated (NNT) (Cook & Sackett 1995); how many persons with a certain risk indica-
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tor should we treat in order to prevent one case? This approach, of which chapter 10
is an example, adds a public health dimension to epidemiological studies such as
ours. By using these methods, target groups can be identified that may profit from
specific preventative interventions. 
11.3 Relevance and implications for clinical practice
The studies described in this thesis stress the importance of adequate, and timely
recognition and treatment of late-life depression for a number of reasons.
First of all, late-life depression carries a high chance of becoming a chronic or
chronic intermittent disorder. The NEMESIS study, a large longitudinal epidemiologi-
cal study in younger adults in the Netherlands, has shown that at least 20% of
depressed adults remained depressed for two years, and 43% of new depressions in
the study period were relapses or recurrences in subjects with prior depressive
episodes (Spijker et al. 2002). The natural history of depression in adults appears to
be characterised by incomplete remissions, relapses, recurrences and chronicity and
warrants timely interventions that should, ideally, be targeted to those subjects with
a high risk of chronicity (Ormel et al. 1993;Spijker, de Graaf, Bijl, Beekman, Ormel, &
Nolen 2002). Our data, and also recent findings from the LASA study (Beekman et
al. 2002) and the NIMH Collaborative Depression Study (Mueller et al. 2004) sug-
gest that in the elderly, the natural course may even be worse than in younger age
groups. As effective treatment is available also in this age group, the arguments in
favour of timely intervention are at least as pressing as in younger adults. 
Still, as treatment in itself constitutes a considerable investment from both
patient and the health care system, is would be of significant use if we were to know
which patients would be most in need of treatment, considering their chances of
spontaneous recovery or the development of chronic depression. As an advantage
over earlier work, the studies described in this thesis have yielded a number of pre-
dictors of course type that may prove useful in distinguishing subjects at high risk
for developing chronicity or other untoward consequences of depression. An impor-
tant predictor of both onset and prognosis was a longstanding vulnerability, signified
by a personal history of depression. Although this may not seem very surprising, ear-
lier studies on the course of late life depression have often not been able to incorpo-
rate this risk factor (Cole 1990;Cole, Bellavance, & Mansour 1999). This finding
underlines the clinical importance of a thorough patient history, including an assess-
ment of earlier episodes of psychiatric illness if one is to make predictions for the
individual patient. This is further underlined by the finding that, in depressed sub-
jects without a previous history of depression and in depressed men, a chronic
course is predicted by the presence of recent life stresses and disability. Actual life
circumstances and health characteristics should therefore be taken into account
when making projections about the prognosis of depression in an individual patient. 
Psychiatric comorbidity, especially generalised anxiety disorder, was also found to
be relevant from a clinical point of view. Subgroups with these characteristics
deserve special attention from the health services in order to try and prevent the
negative consequences of chronic depression. Subjects with mixed anxiety depres-
sion have more severe, and more longstanding depression with a poorer chance of
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spontaneous recovery (chapters 4 and 5). This would, if replicated, justify a more
systematic assessment of anxiety symptoms in elderly patients who present with
depression. As elderly subjects with generalised anxiety were shown to develop
either depression or mixed anxiety-depression relatively often, it could also be
argued that adequate and timely treatment of generalised anxiety disorder may
reduce the risk of further deterioration, especially in elderly women. However, the
current data do not provide the detailed information one would ideally have in order
to be able to decide after how many months the chance of spontaneous recovery
would become so small that intervention is warranted. Studies with more frequent
measurements are needed to assess these patterns in more detail. 
In younger adults, maintenance treatment with antidepressants has been shown
to reduce the overall relapse percentage from 41% (placebo) to 18% over a period of
at least one year (Geddes et al. 2003). The potential benefits of continued treatment
are larger in subjects with a higher risk of relapse. Although, to our knowledge, such
data are not specifically available for the elderly, it can be expected that elderly sub-
jects with the above characteristics may especially benefit from continued treatment
of their depression. Still, the efficacy of interventions to reduce chronicity in older
persons should also be demonstrated in Randomised Controlled Trials (Cairney
2004). 
Risk profiles were also delineated for excess mortality. It was shown that overall,
more severe and more chronic depressions are associated with excess mortality,
suggesting a dose-response mechanism. The finding that depressive thoughts, and
especially suicidal ideation and/or death wishes are associated with a higher mortali-
ty risk may also be of clinical relevance. Although we were not able to assess causes
of death, earlier work in the LASA study (Penninx, Beekman, Honig, Deeg,
Schoevers, van Eijk, & Van Tilburg 2001) and findings from other sources (Maris
2002) suggest that the excess mortality is not accounted for by a possible higher sui-
cide risk only, but also by death through a number of other causes. These findings
underline the importance of recognising such symptoms in elderly patients with
depression. 
As has been discussed in chapter 8, there is no consistent evidence that treat-
ment of depression would reduce the associated excess mortality. Still, adequate
treatment of depression in elderly subjects, with or without comorbid chronic illness-
es, would be hard to advise against. 
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11.4 Public health implications
Late-life depression, and especially chronic depression, is associated with high levels
of disability, functional decline, diminished quality of life, excess mortality, higher
demands on caregivers and higher service utilisation (Charney et al. 2003). As has
been stated in the introductory chapter, in comparison with other illnesses, depres-
sion accounts for the largest amount of non-fatal burden and for 12% of all years
lived with disability worldwide (Ustun et al. 2004). A recent meta-analysis showed
the overall costs of health care for elderly patients with physical illness to be 50%
higher if a comorbid depression is present (Katon et al. 2003). These facts underline
the importance of (late-life) depressive disorder for public health. Although depres-
sion is much less of a taboo subject in western countries than it was in earlier days,
and received substantial attention from the media, preventative strategies have only
recently come into focus in psychiatry (Beekman 2004;Cuijpers 2003). Considering
the above, this may seem somewhat surprising. After all, if it were possible to pre-
vent the occurrence of depression, or to intervene early in order to change the
course of illness, this may have substantial impact for both the individual patient
and the health care system. From an economic standpoint, prevention may also be
much more cost-effective than actual treatment of the disorder (Smit et al. 2004).
Chapter 10 shows how epidemiological data may further our understanding of per-
sons at risk, and offer statistical models that may help to determine the possible
health gains of different preventative strategies. Earlier studies described in chapter
2 and 4 have yielded risk factors associated with depression incidence. As case find-
ing is poor, and the risk of chronicity considerable, the idea that this condition could
be prevented using these risk indicators appears rather attractive. Future interven-
tion studies may take into account these risk profiles when investigating the poten-
tial gains of various preventative measures in terms of a reduction in both the indi-
vidual and societal burden of depression. 
11.5 Theoretical implications
Although the Brown and Harris vulnerability-stress model elegantly integrated
their findings and offered an attractive conceptual framework for the occurrence of
depression and the interplay between stress and vulnerability factors, it is now
becoming obvious that important determinants of depression were not included.
Brown and Harris themselves published a paper in 1994, acknowledging that a (rela-
tively small) group of patients with melancholic recurrent depression did not experi-
ence a severely threatening event before the onset of depression (Brown, Harris, &
Hepworth 1994). They concluded that this might be an explanation for the variability
of results in other studies on the association between life events and depression, as
samples differed markedly in the numbers of first onset versus recurrent (psychotic)
depressions. Brown and Harris suggested that the vulnerability-stress model would
therefore apply to all patients except those with recurrent melancholia. Still, ‘endoge-
nous’ depression, the recurrence of which is not necessarily preceded by threatening
life events, was considered to be of limited importance on a population basis. Our
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results seem to contradict this, as 29.4 % of subjects with depression at baseline,
and 24.6 % of those with a depression at follow-up were shown to have a history of
prior depression. In these subjects, both onset and persistence/chronicity of depres-
sion were not predicted by threatening events or difficulties. It was only in subjects
with first onset depression that such associations could be demonstrated. A meta-
analysis of all available studies on depression incidence in the elderly, in which the
AMSTEL data were included, also yielded a personal history of depression as one of
five remaining statistically significant predictors of onset (Cole & Dendukuri 2003).
Of course, one has to take into account the fact that in a cohort of elderly, depres-
sion often has had a longer history than in the sample of much younger women
studied by Brown and Harris, and it could be argued that the model was not
designed to suit all age groups. However, data from cohort studies of younger adults
also show that both onset and persistence (Spijker et al. 2001) of depression are in
part determined by earlier (and longer) depressive episodes. This suggests that, next
to social and psychological determinants of vulnerability, longstanding, most proba-
bly genetic vulnerability deserves a more prominent place in the model. As has been
discussed in paragraph 11.2.4, another issue that has received little attention in the
original vulnerability stress model are the pathophysiological changes underlying
both depression and medical illnesses. Nevertheless, also at a later age the majority
of depressive illness was found to be of recent onset and associated with actual life
stresses that fit well into the vulnerability-stress model.
11.6 Directions for future research
A number of research areas are proposed here that would merit further study. The
issue of comorbidity of depression with a large number of medical illnesses, and
especially with ischemic heart disease is of high interest to medicine, especially in
older patients with high levels of chronic illnesses. Depression is associated with
higher incidence of somatic illnesses, with an untoward prognosis of these disor-
ders, and with excess mortality. All of this can be taken to suggest that underlying
mechanisms, or common pathways, are responsible for these phenomena. It is
increasingly being recognised that vulnerability appears to cluster in individuals, with
high levels of comorbidity of depression and medical conditions (Clarke & Kissane
2002;Gallo et al. 1997;Koenig 1997;Lyketsos et al. 2001). The concept of ‘allostatic
load’ was introduced as a measure of the cumulative physiological burden exacted
on the body through attempts to adapt to life’s demands (McEwen 2002). A com-
bined scale of dysregulations of different biological regulatory mechanisms was
found to adequately predict mortality and declines in cognitive and physical func-
tioning in elderly persons (Seeman et al. 2001). Chronic stress has been suggested
as a common denominator to account for the dysregulations of various biological
mechanisms that make people with depression of post traumatic stress disorder vul-
nerable to develop disease (McEwen 2003). As described in chapter 8, both the
HPA-axis and inflammatory pathways may be involved. Indications for this come
from clinical studies (Pariante 2003), and from animal studies in which genetic
defects in the CRH limbic area are responsible for ‘depression’ in mice (Holsboer
2000;Muller, Holsboer, & Keck 2002). Recently it has been shown that epidemiologi-
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cal studies may also find associations between depression and higher levels of
inflammatory markers (Bremmer et al. 2004;Penninx, Kritchevsky, Yaffe, Newman,
Simonsick, Rubin, Ferrucci, Harris, & Pahor 2003). Cognitive deterioration is also
associated with higher levels of these markers (Engelhart et al. 2004), and depres-
sion may either proceed or co-occur with cognitive deterioration. Specific research
questions for old age psychiatry would be whether these types of clustering of disor-
ders can be associated with determinants of biological dysregulation, and whether
(specific) biological mechanisms are associated with onset and course of late life
psychopathology. The AMSTEL study may provide an interesting option, as blood
samples have been drawn from a selected number of subjects with different levels of
cognitive deterioration and depression.
Another aspect of comorbidity is that between depression and anxiety disorders.
The studies in this thesis have shown that comorbidity stands for higher severity and
longstanding vulnerability. Although Kendler’s theory of ‘same genes, different envi-
ronments’ could not be proven in the sense that specific risk factors were associated
with either phenotype, patients with mixed-anxiety depression are suggested as a
subgroup with high genetic vulnerability for depression and may prove to be a fruit-
ful subject for further studies. 
The studies on depression and excess mortality described in this thesis could be
extended to include also causes of death. This could provide relevant additional
information on possible pathogenic mechanisms explaining the association between
(onset and course of) depression, medical illnesses and survival, and would be even
more interesting if biological markers are included in the analyses. Furthermore,
recent findings in the LASA study suggest that anxiety disorders are also associated
with a higher mortality risk in men (van Hout et al. 2004). Replication of this in the
AMSTEL study seems appropriate, taking into account the different severity and
comorbidity levels of generalised anxiety disorder and depression.  
Drawing from the findings of chapter 10, which delineates profiles of subjects
with specific vulnerability to develop depression, it is of the utmost importance to
start and test preventative measures that may reduce the number of actual cases of
depression. As outlined, more elaborate work is needed in order to develop evi-
dence-based and cost-effective preventative strategies aimed at subjects with a high
risk of developing depression. 
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Summary
Summary “Epidemiology of Late Life Depression;
Longitudinal findings from the Amsterdam Study
of the Elderly (AMSTEL)”
In younger adulthood as well as in later life, depression is associated with a dimin-
ished quality of life, significantly higher levels of disability, functional decline,
demands on caregivers and service utilization. With a prevalence of 13.5% in older
persons, the importance of depression in terms of both individual suffering and pub-
lic health is uncontested. As the population in western countries is rapidly ageing,
adequate recognition and, if possible, prevention of the negative consequences of
late-life depression is a major public health issue. Studies in the community may
provide knowledge on prevalence, course and risk profiles of ‘common’ types of psy-
chopathology that do not reach through the consecutive filters in health care up to
the specialist level of psychiatry.
The Amsterdam Study of the Elderly (AMSTEL) is a longitudinal study among
4051 inhabitants of Amsterdam between the age of 64 and 85, with a three-year fol-
low-up. AMSTEL was designed to study incidence and course of dementia or cogni-
tive impairment, depression and generalised anxiety disorder in elderly people living
in the community. 
The primary aims of this thesis were to study late-life depression and its longitu-
dinal associations, keeping in mind the “vulnerability-stress model”, that clusters
variables according to their role in a causal model of the development of depression.
In this model, depression is a result of the interplay between stress factors, such as
loss events, and a wide array of endogenous/genetic, social and health related char-
acteristics. Keeping in mind the specific characteristics of later life and the vulnera-
bility-stress paradigm, consecutive chapters describe the factors associated with
onset of late life depression, the natural course and the associations of risk factors
with course types, comorbidity patterns and temporal associations between depres-
sion and generalised anxiety disorder, and between depression and cognitive decline,
and the associations of depression with excess mortality. The final study presents a
research agenda for prevention of depression in primary care according to vulnera-
bility characteristics of community living older persons.
In Chapter 2 the question is put forward whether, in line with the vulnerability-
stress concept, depression is the result of ‘social stress’ factors such as partner loss,
relocation and (the occurrence of) chronic diseases or disability, and whether the
influence of these is modified by the vulnerability or protective factors distinguished
in this study. Higher age, personal history of depression, death of spouse, health
related factors and comorbid organic or anxiety syndrome showed significant associ-
ations with depression incidence in bivariate analyses. Genetic/familial vulnerability
and organic vulnerability did not modify the association between the investigated
stress factors and incident depression. Vulnerability by environmental factors, did
act as effect modifier. This can be taken as modest support for the vulnerability-
stress hypothesis to model the incidence of depression.
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Chapter 3 describes the natural course of depression, assesses whether risk fac-
tors related to incidence of late-life depression are also related to prognosis, and
investigates whether a vulnerability-stress model can also be established for the
course of late-life depression. It was concluded that depression often has a chronic
course (50%), and that an important predictor of chronicity was a personal history of
depression. In subjects without a personal history, more recent life stresses were
related to prognosis. Comparing the risk profile for chronicity between sexes, it was
found that in women, the development of chronicity was more strongly associated
with a personal history than in men, whereas in men recent psychosocial and health
related characteristics were more important than in women. The risk profile for
depression onset differs from that associated with the development of chronicity, in
the sense that chronicity is associated with both longstanding vulnerability and gen-
der.
Chapter 4 reports on a cross-sectional study of risk patterns and comorbidity of
depression and generalised anxiety disorder. It was shown that comorbidity of
depression and generalised anxiety disorder increases with higher severity levels of
either category. Pure depression, pure generalised anxiety disorder or mixed anxiety-
depression did not show different associations with risk factors, but longstanding
vulnerability showed significantly stronger associations with mixed anxiety-depres-
sion than with pure anxiety and pure depression. Comorbidity was twice as likely in
women than in men. It was concluded that in the elderly, a dimensional classifica-
tion is more appropriate than a categorical classification of depression and gener-
alised anxiety. 
Chapter 5 describes the course types of pure depression, pure generalised anxiety
disorder and mixed anxiety-depression and investigates whether different risk pro-
files can be distinguished for onset in a prospective design. Remission rates were
poor for subjects with mixed anxiety-depression (27%). A pattern of temporal
sequencing was established, with anxiety often progressing to depression or mixed
anxiety-depression. Onset of depression and mixed anxiety-depression were predict-
ed by loss events, ill health and functional disability. Onset of pure generalised anxi-
ety, and more strongly that of mixed anxiety-depression, was associated with long-
standing, possibly genetic vulnerability. It was concluded that, in comparison with
either pure depression or pure anxiety, mixed anxiety-depression represents more
severe and more chronic psychopathology, associated with longstanding vulnerabili-
ty. 
Chapter 6 examines whether depression may be indicative of subsequent cogni-
tive decline and Alzheimer’s disease in older adults with normal cognition. The
research question was investigated in two independent samples of older people with
normal cognition: AMSTEL and the Longitudinal Aging Study Amsterdam (LASA). In
both studies depression was associated with an increased risk of subsequent AD
and cognitive decline respectively, but only among subjects with higher levels of edu-
cation. In a subgroup of more highly educated older persons, depression may be an
early manifestation of AD before cognitive symptoms become apparent, rather than
a psychological reaction to subjective and subclinical memory cognitive complaints.
Chapter 7 examines the association between depression and excess mortality
according to different severity levels of depression and according to gender, control-
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ling for potential confounders. It was found that neurotic (mild) depression was
associated with a higher mortality risk in men only, whereas psychotic (severe)
depression was associated with significant excess mortality in both sexes. In the eld-
erly, major depressive syndromes thus appear to increase the risk of death in both
sexes, whereas mild depressive syndromes only show this association in men.
Chapter 8 provides a review article examining mechanisms that may theoretically
be responsible for the excess mortality associated with depression. Depression
affects behaviour in the sense that depressed patients show more unhealthy living
habits, less compliance with medical treatment, and a higher number of accidents
and suicides. Biological correlates of depression such as dysregulation of the neuro-
immune system; hyperactivity of the HPA-axis, and autonomic dysregulation may all
have a negative effect on both the prognosis of somatic illnesses and longevity.
Although the literature suggests that treatment of depression positively affects some
biological parameters, it remains unclear whether successful treatment of depres-
sion may lead to better survival.
Chapter 9 then further examines specific characteristics of depression and asso-
ciations with excess mortality. Both moderate and severe depression predicted 10-
year mortality also after multivariate adjustment. Chronic depression was associated
with a significantly higher mortality risk compared to non-depressed subjects, sug-
gesting a dose-response relationship. Somatic depression items were predictive of
excess mortality in the full cohort, regardless of the presence of clinical depression.
In subjects with depression, only depressive thoughts were specifically associated
with excess mortality, albeit in opposing directions. Subjects with suicidal ideation
were at higher risk to die, whereas guilt showed a protective effect relative to the
other depression symptoms. 
Chapter 10 is an attempt to determine which older individuals are at high risk to
develop depression, in order to develop a rational model to guide preventative
measures to reduce the incidence of depression. A distinction was made between
indicated prevention, in subjects with early or subsyndromal symptoms, and selec-
tive prevention in persons who are at risk because they have been exposed to certain
risk factors. Prediction models for the onset of depression were calculated in terms
of Absolute and Relative Risk estimates, Numbers-Needed-to-be-Treated, and
Population Attributable Fraction. In the indicated prevention model, subsyndromal
symptoms of depression were associated with a risk of almost 40% to develop
depression, an NNT of 5.8, and accounted for 24.6% of new cases. Adding more risk
factors raised the AR up to 49.3%, with a lower NNT (3.2), but also lower AF values.
In the selective prevention model, loss of spouse showed the highest risk (AR 37%,
NNT 5.3, AF 8.2%), a risk that became even higher if subjects also had a chronic ill-
ness. Considering costs and benefits of both models in the context of the availability
of evidence-based preventative interventions, it was concluded that indicated preven-
tion aimed at elderly persons with depressive symptoms is the preferred option. 
Chapter 11 discusses the main findings, methodological considerations, and the
merits and limitations of the studies. From this study it can be concluded that late
life depression is a common disorder, associated with both concurrent life stresses
and long-term vulnerability, that often has a chronic course. Depression is often co-
occurring with other disorders, both somatic and psychiatric, and comorbidity repre-
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sents more severe disorder and a poorer prognosis. The association between
depression and excess mortality was confirmed in a community sample and further
explored, but more research is needed on possible underlying mechanisms. The last
study finishes with the conclusion that the exclusive focus on treatment of depres-
sive disorder should be readdressed, and more attention should be given to the pos-
sibilities of prevention in psychiatry. The thesis thus has a relatively optimistic
(although not ‘happy’) ending.
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Samenvatting
Samenvatting “Epidemiologie van depressie bij
ouderen; longitudinale bevindingen van de
Amsterdam Study of the Elderly (AMSTEL)”
Dit proefschrift gaat over depressie. Depressie zoals die voorkomt bij thuiswonende
ouderen. Het gaat om vormen van depressiviteit die veelal niet door de gezond-
heidszorg als zodanig worden herkend en behandeld, maar waar ouderen wel veel
nadeel van kunnen ondervinden. Negatieve effecten van depressie zijn o.m. een
slechtere kwaliteit van leven, een toename van beperkingen en handicaps in het
dagelijks functioneren, een verhoogde belasting voor de omgeving, en een toegeno-
men gebruik van medische en andere voorzieningen. In vergelijking met andere ziek-
ten, ook lichamelijke, blijkt depressie wereldwijd zelfs de belangrijkste aandoening
wanneer wordt gekeken naar het aantal jaren dat mensen leven met beperkingen als
gevolg van die aandoening. 
Over depressie is al veel bekend. Er zijn verschillende behandelingen met medi-
catie en met psychotherapie waarvan de effectiviteit uitgebreid is onderzocht en vast-
gesteld. Dan gaat het veelal over de ernstigste vorm van depressie, de zogenaamde
‘depressie in engere zin’ volgens het classificatiesysteem van psychiatrische aandoe-
ningen, de DSM-IV. Deze komt voor bij ongeveer 2% van de van de ouderen. Het
blijkt echter dat depressieve symptomen veel vaker voorkomen dan deze percenta-
ges suggereren. Verder is gebleken dat de negatieve effecten van depressie ook bij
deze ‘mildere’ vormen van depressie, met minder symptomen dan de depressie in
engere zin, worden gevonden. Bij ouderen heeft volgens deze definitie ongeveer
13.5% procent van de bevolking een depressie die het leven in ongunstige zin beïn-
vloedt, die ‘klinisch relevant’ is, en (therapeutische) aandacht behoeft.
Net als andere aandoeningen komt depressie vaker voor bij mensen met een
familiaire, waarschijnlijk genetisch bepaalde kwetsbaarheid. Omgevingsfactoren, en
psychologische factoren spelen echter ook een grote rol. Omgevingsfactoren zijn
dingen die mensen overkomen, zoals verlies van een dierbare, of het krijgen van een
chronische ziekte, maar ook de steun die iemand krijgt vanuit de omgeving.
Psychologische factoren zijn bijvoorbeeld karakter- of persoonlijkheidstrekken die
van invloed zijn op de manier waarop mensen tegenslagen verwerken. Ook speelt
een rol of mensen eerder in hun leven grote verliezen hebben geleden, of traumati-
sche ervaringen hebben meegemaakt. Het blijkt dat dergelijke ervaringen de vatbaar-
heid voor depressie op latere leeftijd verhogen. Wanneer wordt gepoogd om het ont-
staan van depressie in kaart te brengen, wordt vaak een stress-kwetsbaarheid model
als uitgangspunt genomen. Hierin vinden zowel uitlokkende factoren (stressoren)
zoals verlieservaringen en gezondheidsaspecten, als kwetsbaarheidfactoren zoals
een familiaire aanleg, of het ontbreken van een sociaal netwerk, een plaats.
Depressie kan dan worden gezien als de resultante van de interactie tussen dergelij-
ke factoren. In dit proefschrift wordt regelmatig gerefereerd aan het stress-kwets-
baarheid model.
Wanneer depressie bij ouderen wordt onderzocht, is het van belang om iets te
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zeggen over de specifieke risicofactoren voor depressie in deze leeftijdsgroep. Er is
sprake van het verlies van dierbaren, verlies van sociale rollen (o.a. werk), een afna-
me van sociale steun en een toenemende kans op vereenzaming. Verder hebben
ouderen veel meer lichamelijke ziektes (64% van de ouderen in de leeftijd van 65-74
jaar heeft een chronische ziekte) en de kans op cognitieve achteruitgang neemt sterk
toe na het 65e levensjaar. Dit is geen hoopgevende beschrijving van de oude dag, en
het is gelukkig ook niet zo dat men hier automatisch depressief van wordt. Toch is
het voor de bestudering van depressie van belang dat de verdeling van risicofactoren
in de bevolking op oudere leeftijd verschilt van die bij jongere volwassenen.
Opvallend is verder dat depressie vaak samen voorkomt met andere aandoeningen
zoals lichamelijke ziekten en andere psychiatrische aandoeningen. Dit wordt co-mor-
biditeit genoemd, en er zijn aanwijzingen dat patiënten bij wie dit speelt een ongun-
stiger prognose hebben. Er is veel discussie over de afgrenzing van depressie met
angststoornissen, en over de overlap met lichamelijke ziekten en cognitieve achter-
uitgang. Aangezien psychiatrische aandoeningen veelal gedefinieerd worden door
een combinatie van verschijnselen die geen van allen uniek zijn voor die specifieke
diagnose, is het niet eenvoudig daar harde uitspraken over te doen. 
Bij de start van deze studie was nog niet heel veel bekend over met name de
milde depressie zoals die wordt gevonden in de bevolking. Wat zijn aanleidingen om
een depressie te krijgen, hoe is het natuurlijk beloop, hoe hangt depressie bij oude-
ren samen met andere aandoeningen, en beïnvloedt depressie de levensduur? 
In deze dissertatie wordt, deels aan de hand van het stress-kwetsbaarheidsmodel,
onderzoek beschreven naar verschillende aspecten van depressie bij ouderen. 
De AMSTEL studie
In 1990 en in 1994 vond een groot bevolkingsonderzoek plaats onder 4051 thuiswo-
nende ouderen in Amsterdam. Alle respondenten werden thuis bezocht door
getrainde interviewers. Doel van het onderzoek was het in kaart brengen van een
scala aan demografische, somatische en psychiatrische gegevens van deze ouderen.
De onderzoeksinstrumenten waren: de electronische versie van de Geriatric Mental
State Examination (AGECAT), met daarin alle items betreffende affectieve, angst- en
organische stoornissen, de Mini-Mental State Examination, de Activities of Daily
Living (ADL) schaal en de Instrumental Activities of Daily Living (IADL) schaal, en
het CAMDEX-interview, dat onder andere informatie verschaft over  somatische ziek-
ten. Het GMS-AGECAT systeem stelt diagnosen van organische en depressieve aan-
doeningen. De diagnose dementie werd ook nog bevestigd in een apart diagnostisch
onderzoek. In 1996 en in 2001 werden verder bij de burgerlijke stand de overlijdens-
gegevens verkregen van de gehele oorspronkelijke onderzoekspopulatie.
Het AMSTEL project gaat uit van de vakgroep psychiatrie van de Vrije
Universiteit Amsterdam en is ingebed in het onderzoeksprogramma van het EMGO
instituut. Het onderzoek werd financieel ondersteund door het S.G.O, programma
(Stimulering Gezondheidszorg Onderzoek) vanuit het ministerie van VWS, dit liep af
in 1994. Sindsdien wordt verder onderzoek gefinancierd via projectsubsidies van o.a.
het Nationaal Fonds Geestelijke Volksgezondheid, en N.W.O.
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Onderzoeksvragen
Hoofdstuk 2 beschrijft een onderzoek naar mogelijke subtypen van depressie, te
weten; 1) de vroeg ontstane depressie die al eerder in iemands leven is opgetreden,
een chronisch beloop heeft gekregen en samenhangt met een genetische/familiale
kwetsbaarheid, 2) de laat ontstane depressie als gevolg van bij de oudere levensfase
behorende stressfactoren (bv. overlijden van partner, vereenzaming, ziekte) en 3) de
laat ontstane depressie die samenhangt met organische stoornissen en cognitieve
achteruitgang. Nagegaan werd welke factoren leiden tot depressie, en of een stress-
kwetsbaarheid mechanisme kon worden aangetoond waarbij mensen met een reeds
bestaande kwetsbaarheid sneller depressief worden als de belasting (stress) toe-
neemt. Het bleek dat hogere leeftijd, een voorgeschiedenis van depressie, verwedu-
wing, een slechtere gezondheid en cognitieve of angststoornissen ieder waren geas-
socieerd met het ontstaan van depressie. Het kon echter niet worden aangetoond
dat genetische/familiale kwetsbaarheid en organische kwetsbaarheid leidden tot een
verhoogd ontstaan van depressie bij toename van de belasting (effect modificatie).
Wel bleek dat de omgeving hierop van invloed was; mensen met een partner, en
alleenstaanden met sociale steun, werden minder vaak depressief bij negatieve
gebeurtenissen zoals het ontstaan van chronische ziekten en handicaps. Zij leken
dus weerbaarder te zijn in tijden van tegenspoed. Er werd dus enige steun gevonden
voor het stress-kwetsbaarheidsmodel in dit onderzoek.
Hoofdstuk 3 gaat in op de vraag naar het beloop van depressie bij ouderen. Het
bleek dat ongeveer 50% van de depressies een chronisch beloop heeft. Tevens werd
onderzocht of het risicoprofiel voor ontstaan van depressie hetzelfde is als die voor
een ongunstig beloop (chroniciteit). Gezien de negatieve effecten van met name de
chronische depressie, kan inzicht in voorspellers van beloop belangrijke praktische
consequenties hebben. Geconcludeerd werd dat een voorgeschiedenis van depressie
een sterke voorspeller is van een chronisch beloop, andere risicofactoren vielen daar-
bij in het niet. Alleen bij patiënten met een recent ontstane depressie, zonder een
voorgeschiedenis, bleken ongunstige levensomstandigheden en gebeurtenissen van
invloed te zijn op een ongunstig beloop (chroniciteit). Ook werd een vergelijking
gemaakt tussen depressie bij mannen en vrouwen, o.m. omdat in de literatuur stee-
vast hogere prevalenties van depressie bij vrouwen worden gevonden. Het zou kun-
nen dat depressie bij vrouwen minder snel opknapt (vaker chronisch wordt), en een
ander risicoprofiel heeft. Een verschil in het percentage chroniciteit werd niet gevon-
den. Het bleek wel dat chroniciteit bij vrouwen vooral samenhing met een voorge-
schiedenis van depressie, terwijl bij mannen een chronische depressie werd voor-
speld door actuele ongunstige levensomstandigheden.
Hoofdstuk 4 gaat in op de verschillen en overeenkomsten tussen depressie en de
gegeneraliseerde angststoornis. In de literatuur is veel discussie over de vraag of dit
verschillende aandoeningen zijn, of wellicht verschillende dimensies van eenzelfde
(‘onderliggende’) stoornis. Er werd onderzoek gedaan naar de overlap tussen gege-
neraliseerde angst en depressie, naar mogelijke specifieke risicofactoren, en naar
verschillen en overeenkomsten in beloop. In dit hoofdstuk wordt aangetoond dat de
overlap tussen deze twee psychische aandoeningen sterk toeneemt bij toenemende
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ernst van beiden. Tevens werd vastgesteld dat er weinig verschillen waren in risico-
factoren voor het ontstaan van ‘pure’ depressie, ‘pure’ gegeneraliseerde angststoor-
nis, en de mengvorm, de zogenaamde ‘mixed anxiety-depression’. Wel bleek dat een
voorgeschiedenis sterk is geassocieerd met de (ernstigste) mengvorm van beide
stoornissen. Overlap kwam verder bij vrouwen veel vaker voor dan bij mannen.
Geconcludeerd werd dat een dimensionele classificatie van angst en depressie, waar-
in angst en depressie in elkaars verlengde liggen, beter bij deze bevindingen past
dan de huidige categorale, waarin ze als wezenlijk verschillende stoornissen worden
gedefinieerd. 
Hoofdstuk 5 beschrijft vervolgens het beloop van pure depressie, pure generali-
seerde angststoornis, en de mengvorm, en richt zich tevens op de vraag of verschil-
lende risicofactoren geassocieerd zijn met ontstaan en beloop van deze verschillen-
de diagnostische categorieën. De gemengde vorm bleek in maar 27% van de geval-
len te zijn opgeknapt na drie jaar, en had daarmee een duidelijk ongunstiger beloop
dan pure angst of depressie. Verder bleek dat de angststoornis in de tijd weinig sta-
biel is, en vaak overgaat in een depressie. Voorspellers van het ontstaan van depres-
sie en ‘mixed anxiety-depression’ waren verlieservaringen, een slechte gezondheid en
functionele beperkingen. Een voorgeschiedenis van depressie en/of angst bleek
wederom vooral het ontstaan van de mengvorm in hoge mate te voorspellen.
Vastgesteld werd dat, in vergelijking met pure depressie en pure angst, ‘mixed anxie-
ty-depression’ een ernstiger en meer chronisch verlopende stoornis is, die sterk
samenhangt met een al langer bestaande kwetsbaarheid. 
Hoofdstuk 6 gaat in op de mogelijke relaties tussen depressie en cognitieve ach-
teruitgang. De vraag was of depressie bij ouderen zonder meetbare geheugenstoor-
nissen vooraf gaat aan het ontstaan van de ziekte van Alzheimer. Deze vraag werd
onderzocht in de AMSTEL studie, en in de LASA studie (Longitudinal Aging Study
Amsterdam), eveneens een grote Nederlandse bevolkingsstudie onder ouderen. In
beide studies bleek depressie geassocieerd te zijn met een verhoogd risico op het
optreden van M.Alzheimer, maar alleen bij ouderen met een hoger opleidingsnivo.
Een verklaring hiervoor zou kunnen zijn dat depressie een psychologische reactie is
op cognitieve achteruitgang die al wel door de (toekomstige) patiënt wordt opge-
merkt, maar nog niet meetbaar is bij een cognitieve test. Dit leek om verschillende
redenen minder waarschijnlijk. Eerder lijkt depressie een biologische samenhang te
vertonen met dementie. Het effect van opleiding zou kunnen liggen in het feit dat
dementie bij patiënten met een hoger opleidingsnivo in een verder gevorderd stadi-
um is wanneer een cognitieve functietest afwijkingen laat zien dan bij mensen met
minder opleiding. Dit wordt de ‘cognitieve reserve hypothese’ genoemd; mensen
met een hoger opleidingsnivo hebben meer reservecapaciteit die kan worden aange-
sproken voordat het cognitieve functioneren er duidelijk zichtbaar onder gaat lijden.
Hoofdstuk 7 beschrijft een onderzoek naar het verband tussen depressie en een
verhoogd overlijdensrisico, gemeten 6 jaar na de start van het onderzoek. Uit stu-
dies onder patiënten in het algemeen ziekenhuis is gebleken dat een bijkomende
depressie een verhoogde kans geeft om te overlijden. Daarbij ging het veelal om de
meest ernstige vorm van depressie (depressie in engere zin). Het was de vraag of dit
verband ook bestaat bij de mildere depressie die in de bevolking veel vaker voor-
komt. Ook waren er tegenstrijdige bevindingen over verschillen tussen mannen en
249Samenvatting
vrouwen waar het gaat om de relatie tussen depressie en overleving. In deze studie
werd nagegaan het verband tussen depressie en sterfte afhankelijk is van de ernst
van de depressie, en of dit verschilde tussen mannen en vrouwen. Hierbij werd
gecontroleerd voor andere mogelijke oorzaken van een vervroegd overlijden.
Gevonden werd dat mildere depressies geassocieerd waren met een verhoogd over-
lijdensrisico bij mannen, terwijl de ernstiger depressies bij beide seksen een ver-
hoogde sterftekans te zien gaven.
Hoofdstuk 8 gaat verder in op mogelijke verklaringen voor het gevonden verband
tussen depressie en sterfte. Diverse mechanismen kunnen dit verband verklaren. Op
het gebied van het (ziekte) gedrag is depressie geassocieerd met ongezonde leefge-
woonten, een slechtere therapietrouw en een hoger aantal ongelukken en suïcides.
Ook biologische aspecten van depressie, zoals neuro-immuun dysregulatie, HPA-as
hyperactiviteit en sympathoadrenerge dysregulatie, betrokken bij onder meer de
stressreacties en de afweer, kunnen verantwoordelijk zijn voor het ongunstige beloop
van lichamelijke ziekten en de verhoogde sterftekans. Hoewel gunstige effecten van
behandeling van depressie bij (somatische) patiënten zijn beschreven, is nog ondui-
delijk of de overleving hierdoor wordt beïnvloedt. Geconcludeerd werd dat zowel met
depressie verbonden gedrag, als verstoringen in de neuro-immuun regulatie factoren
zijn die het verband tussen depressie en sterfte kunnen verklaren. Verder onderzoek
is noodzakelijk naar het voorkomen en de onderlinge beïnvloeding van depressie en
lichamelijke ziekten, naar mogelijke pathogenetische verbanden die aan beide typen
aandoeningen ten grondslag liggen, en naar de effecten van behandeling van depres-
sie op de biologische ontregelingen en de overleving. 
Hoofdstuk 9 onderzoekt in meer detail het verband tussen depressie en sterfte,
gebruik makend van de gegevens van het 10-jaars beloop. Wederom bleken ernstiger
depressies, maar ook chronische depressies (beide metingen depressief) een hogere
overlijdenskans te geven, wanneer werd  gecorrigeerd voor andere mogelijke doods-
oorzaken. Er lijkt dus een dosis-respons relatie te bestaan tussen de hoeveelheid
depressie en de verkorting van de levensduur. Ook werd gekeken naar symptoom-
profielen, vanuit de gedachte dat ‘biologische’ depressiesymptomen (zoals slaap-
stoornissen) zouden kunnen verschillen van psychologische symptomen (zoals suï-
cidale gedachten) in de associatie met een verhoogd overlijdensrisico. Dit zou een
aanwijzing kunnen geven voor het achterliggende mechanisme. Het bleek dat soma-
tische/biologische symptomen op zich sterfte voorspelden, ook wanneer mensen
niet aan de criteria voor een depressie voldeden. Het bleek echter dat bij mensen
met een depressie vooral de depressieve gedachten geassocieerd waren met een ver-
hoogde kans op overlijden. Patiënten met suicidale gedachten en doodswensen had-
den een verhoogde kans om te overlijden. Bij patiënten met veel schuldgevoelens
bleek die kans juist kleiner te zijn. Geconcludeerd werd dat psychologische sympto-
men belangrijke voorspellers waren van overlijden. Het herkennen van doodswen-
sen, of ‘niet meer verder willen’, lijkt dus van groot belang om patiënten met een
verhoogd risico te identificeren. 
Hoofdstuk 10 onderzoekt de mogelijkheid van preventie van depressie. Uit ander
onderzoek, maar ook uit de AMSTEL studie, is gebleken dat de herkenning en
behandeling van depressie in de bevolking niet optimaal is. Verder mag worden aan-
genomen dat, zelfs wanneer iedereen met een depressie optimaal behandeld zou
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worden, niet meer dan 1/3 van de ziektelast ten gevolge van depressie zou kunnen
worden weggenomen. 
Het is dus verstandig om na te gaan of depressie voorkomen kan worden.
Hiertoe werden twee modellen gemaakt met als doel zoveel mogelijk toekomstige
depressies te voorspellen aan de hand van relatief simpele, goed herkenbare  risico-
factoren. In het ‘selectieve preventie model’ werden personen met een verhoogde
kans op het krijgen van een depressie geïdentificeerd aan de hand van blootstelling
aan risicofactoren zoals een slechte lichamelijke gezondheid, functionele beperkin-
gen, verlieservaringen e.d. Het ‘geïndiceerde preventie model’ omvat tevens zoge-
naamde subsyndromale symptomen, dit zijn symptomen van depressie die te licht
zijn om al van een stoornis te kunnen spreken. De sterkte van het verband tussen
risicofactoren en het ontstaan van depressie werd op verschillende manieren bere-
kend. Per (combinatie van) risicofactor(en) kan worden aangegeven hoe groot de
kans is dat iemand met die kenmerken depressief wordt (bijvoorbeeld 40% bij men-
sen met subsyndromale symptomen). Tevens kan worden berekend hoeveel van de
nieuw ontstane depressies kunnen worden toegeschreven aan die specifieke risico-
factor(en). Dat geeft een idee van het belang van een risicofactor voor de volksge-
zondheid. Ook kan worden berekend hoe groot de kans is op succes, wanneer men
middels preventie het effect van een risicofactor zou kunnen blokkeren. Dat wordt
uitgedrukt in Number-Needed-to-be-Treated; het aantal mensen dat moet worden
behandeld om 1 succes te behalen (hoe lager de NNT, hoe effectiever de interventie).
Als laatste is van belang om na te gaan welke ‘evidence-based’ preventieve interven-
ties op dit moment beschikbaar zijn voor de verschillende risicofactoren.  Wanneer
in een model deze aspecten in samenhang worden bekeken, blijkt dat het geïndiceer-
de preventiemodel de meeste toekomstige patiënten identificeert, met de gunstigste
balans tussen kosten en baten van preventie. Overigens; de daadwerkelijke effectivi-
teit van een dergelijke onderneming moet nog middels gerandomiseerd gecontro-
leerd onderzoek worden aangetoond. 
Hoofdstuk 11 omvat een overzicht van de belangrijkste bevindingen, de methodo-
logische overwegingen en de beperkingen van de in deze dissertatie beschreven stu-
dies. Er is veel gezegd over de ernst, het ongunstige beloop, de oversterfte en de
relatie met andere aandoeningen. Toch eindigt het proefschrift met een relatief opti-
mistisch pleidooi voor verder onderzoek naar preventie. Gesteld wordt dat de exclu-
sieve focus op (onderzoek naar) het behandelen van stoornissen in de psychiatrie
kritisch bekeken zou moeten worden. Wellicht is de kosten/baten afweging op indivi-
dueel en populatienivo veel gunstiger wanneer vroeger in het ontstaan van een
stoornis geïntervenieerd kan worden.
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